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ABSTRACT
The objective of this dissertation was to develop novel methods of patterning inorganic and
organic materials, develop biocompatibility evaluations, and subsequently apply these methods
toward developing biosensors and lab-on-a-chip devices, such as Interdigitated Electrodes (IDEs)
and Microelectrode Arrays (MEAs) on non-traditional (such as nanostructured and plasmonic)
polymer substrates or deploy these methods to enhance precision cellular placement on traditional
(glass) MEA substrates. It was hypothesized that a combination of such facile microfabrication
techniques and patterning technologies on traditional and non-traditional substrates would increase
the sensitivity and selectivity of such sensor platforms by several orders of magnitude, and
potentially introduce new modalities for cell-based biosensing. In order to demonstrate the
biological functionality of these new IDEs and MEAs, a variety of cell cultures were used (cardiac,
stem cell, and endothelial cells) to study the growth, proliferation, modes of increasing sensitivity
and response to various compounds in vitro (outside the body).
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CHAPTER 1: INTRODUCTION
The objective of this dissertation was to develop facile patterning technologies for organic
and inorganic materials such as metal layers, insulation, extracellular matrix (ECM) materials,
micro/nanoparticles, and cells to simplify the processes and provide sensitivity/selectivity
enhancements to these processes in order to develop cell-based biosensors, such as Interdigitated
Electrodes (IDEs) and Microelectrode Arrays (MEAs). The focus was on shadow or stencil mask
fabrication technologies, 3D bioprinting techniques, and the demonstration of cell-based
biosensors using these techniques.
Shadow mask (or stencil mask) fabrication technology is a fundamental component in the
fabrication of micro/nanostructures for prototyping in microelectronics, optical, microfluidics,
micro-electro-mechanical

systems

(MEMS),

packaging,

applications, including IDE and MEA fabrication.

and

biomedical

lab-on-a-chip

Conventional shadow mask fabrication

techniques are expensive and require cleanroom-based fabrication [1]. This factor has led to the
demand for alternative shadow mask fabrication technologies. Many groups have explored noncleanroom-based shadow mask fabrication technologies including inkjet printing of transparent
masks [2], gravure [3], shadow mask [3], and stamping [4]. While these methods can create
functional shadow masks, they tend to have highly limited resolution and little reusability.
Multimodal laser micromachining, on the other hand, provides the possibility of fabricating
shadow masks in a makerspace microfabrication environment with reduced costs, reduced
capacity, the ability to integrate a variety of materials, one-step, non-contact processing, and
universal applicability. Chapter 2 reports on the development of multimodal laser-based shadow
(or stencil) masks and on the definition of organic and inorganic materials with these masks.
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Since the turn of the century, cell printing has gained considerable traction in the field of
biology. The widespread adaptation of 3D printing has revolutionized manufacturing, specifically
in medical product design. In the field of cellular patterning, this version of 3D printing is known
as bioprinting. Here biomaterials are deposited through a computer controlled dispensing system
that places the material in designated areas with high accuracy in the micrometer scale [5]. A
variety of 3D printing technologies have been adapted for bioprinting applications including
powder bed fusion [6, 7], binder jetting [8], and vat photopolymerization [9], but the three main
techniques that have proven to be most suited for bioprinting are inkjet printing, laser-assisted
printing, and microextrusion [10, 11].

Each of these techniques has its advantages and

disadvantages, but inkjet bioprinting is the most popular despite having some major disadvantages,
and its less than ideal ability to translate to the clinical environment. Laser-assisted and extrusion
bioprinting have retained a reliance on costly commercial printing systems, which makes them far
less attractive for already strained research budgets in academic laboratories. Two-dimensional
fused deposition modeling (FDM)-based cell printing, or cell plating can be a viable approach to
enhance cell-electrode coupling in cell-based biosensors. Considering the relatively high cost of
human derived stem cells, cell printing can bring this additional benefit, as it reduces the cost of
each experiment by placing cells only where they are needed. Due to the extensive printing work
performed in this dissertation, electrogenic HL-1 cells were selected for this purpose because of
their ability to be serially passaged. Chapter 3 further describes the rationale for this selection, as
well as the preliminary characterization and biocompatibility testing using these cells. Chapter 4
reports the construction and characterization of a sterile bioprinter for printing HL-1 cells and the
characterization of droplet cellular prints using this printer. This chapter further reports on the
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utilization of extrusion printing to precisely couple human neurons and cardiomyocytes atop
standard MEAs and the characterization results from such assays.
The simplest cell-based biosensor is an IDE which has remained remarkably unchanged
over several decades. Classic IDEs consist of two individually addressable interwoven electrode
structures. IDEs are one of the most commonly used micro/nanosensors for chemical and
biological sensing because of their low cost, high sensitivity, and ease of fabrication [12]. IDEs
can easily be fashioned into a biosensor by incorporating a culture well into the design and
attaching wires to the contact pads. Monitoring changes in impedance of the IDEs over time allows
for the assessment of cell growth and proliferation. IDE and impedance-based biosensors are
currently available in the marketplace, but many of them require the use of expensive commercial
systems [13-20] for data analysis and involve complex and expensive cleanroom-based fabrication
approaches for micro- and nanostructuring [21] of the electrode design. These systems often use
densely packed electrodes, which cover much of the substrate surface, resulting in increased device
sensitivity but prohibits the optical tracking of cells, which is required for most biological assays.
Other approaches integrate MEAs with IDEs, which allows for more comprehensive
measurements, but also involves a much more complex fabrication process that are not
reproducible [22]. Additionally, they report on just electrical measures. Chapter 5 describes a new
take on IDEs where IDEs fabricated on nanoscale substrates for dramatically enhanced
sensitivities are reported for the first time. Further, the nanoscale substrate offers plasmonic
sensing mode and the evaluation of this mode, as well as the characterization of the sensitivity of
electrical, geometric, and optical modes for cell based biosensing are investigated. Up to 6 orders
of magnitude improved sensitivity with these devices are reported.
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Utilizing the developed facile micro/nanofabrication technologies, such as shadow or
stencil masking and FDM extrusion bioprinting, in this dissertation efforts have focused on truly
revolutionizing a standard IDE and MEA cellular biosensor. As a part of this dissertation, rapid
nanofabrication technologies have been utilized to develop IDEs on a nanostructured substrate
with a sensing modality in addition to impedance measurement that allows for optical probing with
plasmonics. Additionally, initial steps to develop a multimodal MEA that would allow for both
electrophysiological measurements and optical probing with plasmonics have begun.
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CHAPTER 2: LASER MICROMACHINING OF SHADOW MASKS
Laser micromachining is a direct write microfabrication technology that has several
advantages over traditional micro/nanofabrication techniques. This chapter presents a
comprehensive characterization of a QuikLaze 50ST2 multimodal laser micromachining tool by
determining the ablation characteristics of six (6) different materials and demonstrating two
applications. Both the thermodynamic theoretical and experimental ablation characteristics of
stainless steel (SS) and aluminum are examined at 1064 nm, silicon, and polydimethylsiloxane
(PDMS) at 532 nm, and Kapton® and polyethylene terephthalate at 355 nm. It was found that the
experimental data aligned well with the theoretical analysis. Additionally, two applications of this
multimodal laser micromachining technology were demonstrated: shadow masking down to
approximately 1.5 µm feature sizes and Interdigitated Electrode (IDE) fabrication down to 7 µm
electrode gap width.
Hypothesis and Publications
Laser micromachining could be used to fabricate shadow masks with features in the single
micron range for use in interdigitated electrodes and other Micro-Electro-Mechanical Systems
(MEMS) applications.
The work presented in this chapter has previously been presented at the 22nd International
Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2018) in Kaohsiung,
Taiwan [23] and has been published in Micromachines [24].
Introduction
Material ablation via pulsed light sources has been researched since the invention of the
laser [25, 26]; however, in 1982, reports of polymers etched by ultraviolet excimer lasers launched
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more widespread investigations into using the process for micromachining [27, 28]. In recent
years, laser technology has been examined as an exciting material processing method for both
industrial and academic researchers [29-32]. The high quality of laser beams allows for improved
micromachining precision for a variety of materials [33, 34]. Additionally, the compact size, high
efficiency, cost-effectiveness, direct machining, 3D fabrication, and ease of integration are
appealing to academic researchers with limited benchtop area and lean budgets.
Laser micromachining, specifically, involves the ablation of materials where the features
produced by the laser are in the micro-scale [33, 35]. Laser micromachining techniques are
currently employed in the automobile [36], medical [30, 37], semiconductor [38, 39], and solar
cell industries [40]. Lasers used in micromachining are available in a wide range of wavelengths
(ultraviolet to infrared), pulse durations (micro- to femtosecond), and repetition rates (single pulse
to megahertz) [33, 36]. Because of this flexibility, laser micromachining allows for the processing
of a variety of materials.
Figure 1 compares laser micromachining to three commonly used direct-write
microfabrication methods [41-47]. All these methods involve a mechanism for removing material
directly from a substrate in a desired pattern using computer-controlled machinery. While other
patterning methods, such as photolithography are often used, they are not direct-write techniques
and involve several steps to pattern materials; thus, a comparison to these other methods is not
provided in this figure. Photolithography is of course required for one of the methods depicted
(Reactive Ion Etching or RIE) for performing feature definition followed by RIE to “engrave’ the
feature in the substrate beneath [43-46]. Since RIE requires photolithography, the process involves
more steps when compared to the other methods depicted in Figure 1 [45]. Micromilling is a
technically simple process; however, this simplicity comes at the expense of frequent drill bit
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brakeage and the inability to produce features in the sub-100 µm range [42]. As with some RIE
technologies, Focused Ion Beam milling can define nanoscale features; however, the write process
can take days depending on the pattern complexity. Additionally, in FIB-based milling processes,
the material surface may become amorphous due to the implantation of gallium ions [41, 44-47].
The comparison depicted in Figure 1 is by no means comprehensive and has been included to show
the characteristics of laser-based micromachining with some other commonly used technologies
for patterning materials in micromachining and MEMS. Several other techniques for direct
subtractive fabrication of micromachined features are available such as Electrical Discharge
Machining (EDM) [48], ultrasonic drilling [49], water jet cutting [50] etc.
The lasers used in the above-reported research can produce shadow masks for MEMS
applications, but they are unable to micromachine highly precise features on the scale of a single
micron, unless they operate in the femtosecond regime [31, 35, 51-54]. The higher power of these
lasers allows for the processing of thicker materials in a more reasonable time scale; however, this
capability comes at the price of benchtop machining, high costs, space, high power usage (GW),
and absence of multimodality to micromachine several materials with the same tool.
Characterization of lasers used for materials processing is necessary for the proper use of such
tools. By understanding the necessary energy, repetition rate/frequency, spot size, and depths that
can be micromachined with various processing conditions in specific materials, users can
subsequently optimize their experiments for successful results in different applications.
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Figure 1 Comparison of three widely used direct-write fabrication methods (RIE [49, 51], micromilling [48], and FIB [47,50,53]) to laser micromachining. Each of these methods
allows for high aspect ratio, serial, single-substrate fabrication. In the case of RIE multi-wafer/multi-substrate parallel processing is also possible as with some laser
micromachining examples as well for higher throughput micro/nanofabrication.
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In this dissertation chapter, the full characterization of a multimodal laser micromachining
tool and two applications of the usage of microstructures fabricated using the tool is reported.
Multimodal laser micromachining allows for a wide range of materials processing capabilities;
however, this comes at the price of limited power and nanosecond ablation. These tools allow users
to operate at specific laser wavelengths (1064 nm, 532 nm, and 355 nm, in the case of the
QuikLaze) and reduced powers (2.6 mJ maximum energy). These conditions however provide
greater control over the material selectivity for laser micromachining and ablation depths.
Specifically, one can remove a material from a device while leaving the remainder of the
constituent materials unaffected [55].
Typically, such laser micromachining tools are employed in LCD repair, semiconductor
failure analysis, and removing shorts and passivation layers in integrated circuits [33, 56]. In this
chapter, the multimodal tool for the laser micromachining of six (6) different materials was
characterized: Stainless Steel (SS) and aluminum - machined with IR mode, Polyethylene
terephthalate (PET) and Kapton® - machined with UV mode, and Poly dimethylsiloxane (PDMS)
and Silicon - machined with green mode. Subsequent shadow mask patterning allowed for the
definition of organic and inorganic layers and the development of fully functional Interdigitated
Electrode (IDE) devices. These devices are further characterized in this chapter.
State of the Art
As previously stated, shadow mask, or stencil mask, technology is an integral part of the
fabrication of micro/nanostructures in microelectronics, optical, microfluidic, MEMS, packaging,
and biomedical lab-on-a-chip applications [57]. Typical shadow mask fabrication techniques, such
as photolithography and deep reactive ion etching, are expensive and rely on cleanroom-based
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fabrication, expensive vacuum equipment, ultra-pure air filtration, and advanced know-how [5862].
Laser micromachining provides an alternative solution to these cleanroom-based
fabrication technologies. Laser micromachining is a subtractive microfabrication technique, i.e.
you start with a bulk piece of material and selectively remove material based on a defined design.
The laser ablates away the substrate material in desired areas to produce a pattern. This method is
also known as direct-write patterning. Laser micromachining offers high precision, design
flexibility, material flexibility depending on the wavelength of laser light used, and requires no
chemicals (harsh acids, bases etc.) to produce features in the micro and the nanoscale in a variety
of materials. The laser can further be housed in a chemistry lab without the need for advanced
facilities and ultra-pure air providing an intimidation-free environment for accessing and
producing results with the tool. However, there is an inherent safety hazard from the laser light
which can be alleviated with appropriate safety equipment. Additionally, there is an initial
investment in laser systems, but being a one-time investment can offer advantages over other
microfabrication technologies that require continuous investments in terms of gases, chemicals,
mass flow controllers, etc.
Laser micromachining has occasionally been used for shadow mask fabrication; however,
the state of the art in laser micromachining (minimum feature size of 10 µm) [51] (to date) has
relied entirely on single-wavelength excimer, CO2, and Nd:YAG lasers [29, 31, 40, 49, 52, 53, 6373]. To the best of my knowledge, multimodal laser micromachining has not been used for shadow
mask fabrication. While the term “multimodal” in the laser field typically means that the laser
contains multiple transverse electromagnetic modes, the laser micromachining tool used in this
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work has the ability to operate at several wavelengths in the same tool, a rare capability not
afforded by many lasers.
Specifically, with respect to shadow mask microfabrication with lasers, several impressive
research efforts are reported in literature: Tahir et. al. used a 1064 nm Nd:YAG laser to fabricate
250 µm channels in wood, glass, plastic, and rubber [40]. Chung, et. al. fabricated shadow masks
with minimum feature sizes of 200 µm with a 785 nm Ti: Sapphire laser [64]. Shiu, et. al. machined
140 µm channels in low-carbon steel for use as a shadow mask using an excimer laser [71]. Yang,
et. al. fabricated nickel shadow masks with millimeter scale features for use in pulsed laser
deposition of thin film thermocouple sensors [74].
Kumar, et. al. used an excimer laser to make chromium shadow masks. They deposited a
1000 nm layer of Cr onto a glass slide and micromilled an aluminum mask that was 10X the desired
feature size of their final desired mask. This Al mask was then mounted to the laser and a
demagnified image of the mask was projected over the Chrome film. This demagnified image was
used to etch away the chromium layer and produce a shadow mask that was to be used for 2D
lithography. This work showed a minimum feature size of 10 µm [75].
Fan et. al. also fabricated shadow masks using laser micromachining. Here, a CO2 laser
was used to make wax shadow masks. The resultant mask has overly rough edges and minimum
feature sizes of only 500 µm. In addition, these masks are not reusable [59].
Other examples of laser micromachining feature sizes include a CO2 laser micromachined
85 µm microfluidic channel [76], CO2 laser micromachined cuts (100-190 µm) in PMMA
substrates [63], 10 µm microelectrode structures fabricated via excimer laser ablation [77], 10-65
µm microdevice channels in polymeric substrates [78], 10-150 µm laser micromachined feature
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sizes in alumina and stainless steel shadow masks [79], and 25 µm laser micromachined features
in Permalloy for a shadow mask [80]. The lowest resolution of these efforts was limited to ~10
µm.

Figure 2 Mechanisms of ablation in laser micromachining. Substrate removal can be a result of thermal ablation, physical
ablation, chemical ablation, or a combination of these mechanisms.

Microfabrication Method Overview
In laser micromachining, a laser beam is collimated into a small spot and patterning is
achieved by either moving the substrate within a fixed beam or rastering the laser across a surface
[33]. The desired machining patterns simply need to be drawn in a CAD program (such as
AutoCAD) and imported as a DXF file into the control program of the laser micromachining tool.
Once the program is executed with the laser, substrate material removal can be a result of
photochemical, photothermal, or photophysical ablation [81], as shown in Figure 2. Commonly
used processes include laser cutting, scribing, drilling, or etching to produce relief structures or
holes on a substrate in ambient temperatures [31, 36, 51, 63, 81-83]. The power of this technique
lies in the ability to construct desired patterns on arbitrarily shaped surfaces, with the only
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limitation being the degrees of freedom and the resolution of the motion controller. Laser
micromachining is considered a rapid prototyping technique because designs can be changed
immediately without the need to fabricate new molds or masks.
Every laser micromachining system is comprised of three parts, as shown in Figure 3a for
the multimodal laser micromachining tool: (1) the source laser, (2) the beam delivery system, and
(3) the substrate mounting stage. Obviously, the laser source is at the heart of the system, as it
determines which substrates and feature sizes can be micromachined [36]. The system used in this
work has a multimodal laser source that allows for switching between three wavelengths of light:
1064 nm infrared (IR mode), 532 nm visible green (Visible mode), and 355 nm ultra-violet (UV
mode). This wavelength switching allows for greater substrate compatibility and a wide array of
feature sizes in an extremely compact benchtop system. The laser source used in this work is
depicted in Figure 3b with greater detail.
Beam delivery involves optical components, including fixed focusing objects and mirrors,
galvanometric scanners, optical fibers, waveguides, apertures, and q-switches, that are used to
focus the laser spot. The selection of these optical components depends on the working distance,
desired spot size, and required energy [33, 36, 82, 84]. The combination of the laser source and
optical components of the beam delivery system determines the ultimate properties of the laser
beam.
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Figure 3 Laser Schematic a. External schematic of a QuikLaze 50ST2 Multimodal Laser Micromachining System. The three
components of every laser micromachining system are shown. (1) The laser source box. (2) The beam delivery system. (3) The
motorized substrate mount. b. Internal schematics of the laser source box. This shows the three crystals and a switch that create
the different wavelengths of light the system produces with the ability to switch between three wavelengths.

Lastly, the substrate mounting system depends on how the rastering occurs on the tool. If
the laser beam is to be rastered over the substrate surface, then a stationary substrate mount may
be used. In most cases, including the system used in this work, it is more desirable to raster the
substrate itself within a laser beam. In this instance, the substrate mount is manipulatable in the xand y-directions, and even in the z-direction in some cases.
In the multimodal laser system used in this work, the laser beam is initially generated as a
1064 nm IR mode, shown in Figure 3b. The IR laser beam is subsequently passed through two
crystals in the beam delivery system that produce the two additional wavelengths. The beam
delivery system employs filters prior to the microscope optics to filter out the unnecessary
wavelengths, allowing only the desired wavelength to interact with the substrate surface.
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Theoretical Background
A thermodynamic approach to calculating the theoretical “depth of cut” for the materials
tested in this work was adapted from Schütz, et. al. [39]. This formula is based solely on material
properties and laser energy. Examining the depth of cut in this manner allows for a more
fundamental understanding of the interaction between the laser and the material with fewer
assumptions when compared to a molecular approach used for photochemical ablation [39, 83,
85].
𝑎𝑎𝑝𝑝 =

𝛷𝛷

𝑇𝑇
𝑣𝑣
𝑐𝑐 (𝑇𝑇)𝑑𝑑𝑑𝑑+∑𝑛𝑛
𝑖𝑖=1 𝐻𝐻𝑝𝑝ℎ
𝑟𝑟𝑟𝑟𝑟𝑟𝑟𝑟 𝑝𝑝

𝜌𝜌 ∫𝑇𝑇 𝑣𝑣

− 𝑑𝑑

(1)

Equation 1 shows the relationship between the depth of cut per pulse (ap), the laser fluence
(Φ), and involved material properties, including density (ρ), vaporization temperature (Tv), heat
capacity (cp), and the phase change enthalpy (Hvph). The d term (right-hand side of the equation)
is a correction term that includes optical and thermal losses. This equation represented
schematically (Figure 4) balances intrinsic energy and enthalpy, which are state variables and
omits fundamental process parameters that are not state variables (i.e. particle dynamics) [86, 87].

Figure 4 Schematic showing the variables in the thermodynamic theory for evaluation of the depth of cut.

While the inclusion of these fundamental process parameters could lead to a more accurate
theoretical solution, the complexity would be vastly increased due to the use of non-linear partial
differential equations, as well as the need for sophisticated simulation software to solve such
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equations [33, 34, 39, 81, 85, 88]. Additionally, since this laser micromachining setup does not
operate in the femtosecond regime, ablation occurs through melt expulsion and redeposition driven
by the vapor pressure and the recoil pressure of light [85, 88, 89]. As a result, a simple
thermodynamic analysis was performed to extract the relationship between the “depth of cut” and
laser fluence which can be compared to the results obtained through experiments.
Materials and Methods
This section details the materials and methods used within this chapter.
Multimodal Laser
A QuikLaze 50ST2 multimodal laser (New Wave Research Inc., Freemont, CA) was used
for all the laser micromachining performed in this dissertation. A selection of three wavelengths
as mentioned in the previous sections allows the laser to be tailored to a specific application. The
microscope of the laser system is equipped with 10X, 50X, and 100X lenses, each with specific
wavelength limitations. Because of additional filters in the microscope lenses, the green
wavelength can be used through any of the lenses, while the UV and the IR can only be used
through the 50X and 100X lenses, respectively.
The laser outputs a 5 mm diameter Gaussian beam, which is then shaped into a rectangle
by the XY aperture. The size of this rectangle is determined by user inputs into the control
software. The maximum pulse duration of the laser is 5 ns for all wavelengths; however, it can be
adjusted by the user in the program. Additionally, the laser fluence depends on the user
specifications in the control software and the wavelength of light used, as the laser output energy
can be adjusted by the user. The fluence ranges from a maximum of 27,000 J/cm2 to a minimum
of 1.08 J/cm2.
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Materials Used
To ensure a comprehensive study of multimodal laser micromachining, several materials
were machined. Success in laser micromachining for a given material is typically determined only
by the choice of wavelength because each material reacts differently to a specific wavelength. In
general, metals absorb shorter wavelengths more effectively than longer wavelengths [33, 36];
however, there are limitations to how effectively material is removed at shorter wavelengths
determined by the microscope optics used. Because the amount of light transmitted through the
microscope objectives required for each wavelength varies, the “effective” absorption of the
material at a given wavelength is changed.
As shown in Table 1, 12.5 µm thick Stainless Steel (type 304) (Trinity Brand Industries,
Countryside, IL) and 16 µm thick Aluminum Foil (Reynolds Group Holdings, Auckland, NZ) were
machined using the 1064 nm IR wavelength through the 100X microscope lens. The absorbances
of these materials at this wavelength is 37% and 5%, respectively [61]. Kapton® of thickness 12.5
µm (DuPont, Wilmington, DE) and 25 µm thick polyethylene terephthalate (PET) (McMasterCarr, Elmhurst, IL) were machined using the 355 nm UV wavelength through the 50X microscope
lens. The absorbances of these materials at this wavelength are 22.5% and 12%, respectively [59,
62]. Finally, Silicon (University Wafer, Boston, MA) and polydimethylsiloxane (PDMS) (Dow
Corning, Midland, MI) were micromachined using the 532 nm green wavelength through the 10X
microscope lens. The absorbances for these materials at this wavelength are 25% and 72%,
respectively [17, 18, 68].
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Table 1 Materials characterized for use with the multimodal laser

Laser Characterization
To establish protocols for processing each material, characterization grids were machined
for all six (6) materials. These grids consisted of 100 spots, as shown schematically in Figure 5,
and were designed in SolidWorks (Dassault Systems, Waltham, MA).
DXF pattern files were subsequently uploaded into the New Wave Laser program, and each
spot was assigned a specific frequency (range of 5 Hz to 50 Hz) increasing by 5 Hz increments
along the x-axis of the grid, and a specific energy from 10% (0.27 mJ) to 100% (2.7 mJ) increasing
along the negative y-axis of the grid by 10%. The laser spot size was varied for each grid to provide
full characterization of the laser’s capabilities over a wide range of fluence. Grids were then
patterned in all 6 materials using the multimodal laser.
All grids were imaged using Scanning Electron Microscopy (JEOL JSM-6480, Tokyo,
Japan). Full images of the grids were obtained, as well as images of the individual spots in both
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flat and 45º angled orientations. ImageJ (NIH, Bethesda, MD) was used to characterize the depth
of the laser cut, as well as the resultant spot size.

Figure 5 Layout of the grid of spots laser cut into the materials. The grid was designed to have 100 µm distances between the
spots.

Shadow Masks
Shadow masks for the patterning of materials were fabricated from Kapton®, stainless steel,
PET, and aluminum substrates. These materials were chosen because they are all commonly
available in most microfabrication laboratories and it was determined that they could be ablated
all the way through the material using the multimodal laser, a necessity for shadow masks. Full
coverage, circle-on-line IDE shadow masks were designed using SolidWorks and machined using
the multimodal laser and the appropriate wavelength for the substrate material. The shadow masks
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were then imaged using the SEM (JEOL JSM-6480, Tokyo, Japan) to characterize the design
(CAD dimensions) to device (fabricated shadow mask) translation. These shadow masks were
subsequently used to pattern both metal and gelatin for design to device studies, as described
below.
Additionally, traditional interwoven comb IDE shadow masks were fabricated to test the
lowest feature size limits of the multimodal laser. These structures allow for more rapid shadow
mask fabrication at the lowest possible widths ensuring higher sensitivity in IDE assays; thus,
allowing for any necessary adjustments to achieve the desired electrode gap width. Due to the size
of these structures, Atomic Force Microscopy (AFM) (Anasys Instruments, Santa Barbara, CA)
and SEM (JEOL, Tokyo, Japan) were used to characterize the electrode gap widths of these
shadow masks.
Lastly, because of the widespread use of PDMS in microfluidics, several lines of 2 mm
length were laser micromachined into this material to determine the depth of cut for a given number
of laser passes. All lines were micromachined through the IR microscope lens with the green laser
at 2.7 mJ with an X-Y aperture area of 50 µm2. The number of laser passes was varied from 5 to
40 passes. In this mode of operation, the laser beam is continuously scanned across the surface of
the material in the desired pattern.
The process flow for the shadow mask fabrication and subsequent patterning of organic
and inorganic layers is depicted in Figure 6.
Patterning of Organic and Inorganic Layers
To access the accuracy of low power, multimodal laser micromachining, material
patterning through multimodal laser micromachined shadow masks was performed.
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Figure 6 Schematic of laser micromachined shadow mask fabrication and subsequent materials patterning demonstration.

Gelatin Patterning
Gelatin (Millipore Sigma, St. Louis, MO) and deionized (DI) water were mixed to make a
5%-wt. gelatin solution to act as a sample bioink. Kapton® IDE shadow masks were dipped in DI
water to allow for better adherence to the glass microscope slide substrates. The 5%-wt. gelatin
solution was subsequently pipetted onto the glass slides through the shadow masks. The gelatin
solution was allowed to set, then the shadow masks were carefully removed to expose the gelatin
IDE patterns. The resultant gelatin structures were imaged using a Nikon TS2 inverted microscope.
Metal Patterning
The Kapton®, stainless steel, aluminum, and PET multimodal laser micromachined shadow
masks were affixed onto glass microscope slides (Fisher Scientific, Hampton, NH) with Kapton®
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tape (DuPont, Wilmington, DE). Titanium-Gold (Ted Pella, Redding, CA) electrodes, traces, and
contact pads of 5 nm-30 nm thickness respectively were subsequently deposited (Deposition rate:
1 Å/sec at 1 x 10-6 Torr) through these shadow masks onto glass microscope slides via electron
beam evaporation (Thermionics, Port Townsend, WA). After metal patterning, the shadow masks
were removed by carefully detaching the Kapton® tape from the glass slide with tweezers.
Transmitted light microscopy (TS2 Inverted Microscope, Nikon, Tokyo, Japan) was used to image
the patterned metal structures. ImageJ (NIH, Bethesda, MD) was used for further optical analysis
of the captured images and measurement of the electrode structures.
Impedance Characterization of Metal Patterns
The full frequency spectrum impedance of each of the resultant patterned metal IDE
structures was measured with a BODE 100 impedance measurement system (Omicron Labs,
Klaus, Austria) in series-thru impedance measurement mode, as shown in Figure 7. Series-thru
organization of the system was chosen because the impedance of the sensors exceeded 1 kΩ at all
frequencies, meaning that the impedance is in the mid-to-high range that is ideal for this
measurement setup. The measurement is swept through a frequency range of 10 Hz to 10 MHz
with the voltage ranging from 14 mV to 2 V depending on the frequency.
Dulbecco’s phosphate buffered saline (DPBS) (Gibco, Waltham, MA) acted as the
electrolyte solution and Platinum-Titanium wire (eDAQ, Deniston East, NSW, Australia) was used
as a counter electrode used during the impedance measurements. Impedance data was extracted
and plotted with Origin 2016 (OriginLab, North Hampton, MA).
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Figure 7 Schematic of a Series-Thru impedance measurement on the Bode 100.

Figure 8 SEM images of the laser characterization grids for each of the six materials. Kapton®, SS, PET, and aluminum are all
at the maximum spot size for their respective wavelengths. Silicon and PDMS are both at 50% spot size to show the grid in its
entirety. All scale bars are 200 µm.

Results and Discussion
Here, we present and discuss the results of the experiments.
Laser Characterization
Laser characterization grids were fabricated for each of the six materials for a range of spot
sizes as described in Materials and Methods section. The spot sizes for the materials depended on
the microscope objective that was used for the ablation. The spot sizes ranged from 50 µm down
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to 2 µm for IR ablation through the 100X lens for stainless steel and aluminum, 60 µm down to 4
µm for UV ablation through the 50X lens for Kapton® and PET, and 250 µm down to 20 µm for
green ablation though the 10X lens for silicon and PDMS. SEM imaging of these grid structures,
and subsequent processing in ImageJ was used to calculate the depth of cut for each spot
micromachined by the laser. Figure 8 shows examples of the characterization grids for each of the
six materials at the maximum spot size for each wavelength. For PET, Kapton®, stainless steel,
and aluminum, full ablation (through vias, all the way through the substrate) is achieved for the
full range of power and frequency combinations shown in Figure 5. Since these materials were
fully ablated within the 10 pulses used, the ablation depth was averaged over the number of spots.
Some deviation from the theoretical calculation for these materials was observed. Ablation rates
of 46.3 µm/mJ for Kapton® and stainless, 92.6 µm/mJ for PET, and 59.3 µm/mJ for aluminum
were achieved. Neither silicon nor PDMS were able to be fully ablated through for any power and
frequency combination. Silicon began measurable ablation at a minimum of 35 Hz and 2.43 mJ
and had an ablation rate of 1.4 µm/mJ. PDMS began measurable ablation at a minimum of 35 Hz
and 2.16 mJ, which gives an ablation rate of 1.5 µm/mJ.
Traces (lines) were scribed in PDMS using the green laser through the IR lens with between
5 and 40 passes and a 50 µm laser spot size. Cross sectioning the scribed lines carefully using a
razor blade, followed by SEM imaging of the cross section, resulted in the measurement of the
depth of cut for each number of laser passes. Figure 9 shows the linear relationship that was found
between the depth of cut and the number of laser micromachining passes. Characterizing this
relationship allows for the fabrication of microchannels of specific depths in PDMS by varying
the number of laser passes.
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Figure 9 Results from scribing lines in PDMS with a varied number of laser passes. The depth of cut increases linearly with the
number of laser passes as expected. This allows for the direct tuning of channel depth by selecting the number of passes the laser
makes to cut PDMS.

Comparison to Theoretical Values
Figure 10 and Table 2 show the comparison between the theoretical ablation depth model
and the experimental results. For silicon and PDMS, the thermodynamic model fits well. The
comparison in ablation depth per pulse for both materials between theory and practice is in the
same order of magnitude. Further, the ablation depth per pulse/ depth of cut plots for both materials
show a clear correlation between the experimental and theoretical data. Neither one of these
materials are ablated all the way through by the laser.
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Figure 10 Comparison of theoretical and experimental ablation depth for a range of fluences in silicon.

Conversely, deviation from theory is observed in the experimental ablation depth per pulse
comparison for Kapton®, stainless steel, PET, and aluminum. Kapton® and stainless steel perform
similar to silicon and PDMS as observed in Table 2 with both the theoretical and experimental
values in the same order of magnitude with experimental values being smaller than theoretical
values. The discrepancy between PET and Aluminum is roughly an order of magnitude higher
predicted theoretical values. The laser ablated through these materials at some point (difficult to
measure experimentally in our current setup), so deviation is expected in all these materials. For
example, both Kapton® and stainless steel could have shown an average ablation depth of ~3 µm
per pulse, and both PET and aluminum could have shown an average ablation depth of
approximately ~16 µm per pulse. Because of the thickness of these materials, when the
normalization of the ablation depth to the number of pulses is performed, the experimental values
are determined to be substantially lower. The key results from the experimental data in this case is
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that the laser is capable of fully ablating these thicknesses and that a reasonable number of pulses
can be used to ablate even thicker samples of these materials. These results also show the
limitations of a thermodynamic approach, as the material thickness is not considered in the
calculations.
Table 2 Comparison of theoretical and experimental ablation depths. *Limited due to full ablation of materials in less than 10
pulses.

Applications
Two applications of this multimodal laser micromachining technique were additionally
demonstrated in this work namely the microfabrication of shadow masks and IDEs.
Shadow Masks
Shadow masking technology is an integral part of fabricating micro/nanostructures for
prototyping in microelectronics, optical, microfluidic, Micro-Electro-Mechanical Systems
(MEMS), packaging, and biomedical lab-on-a-chip applications [38, 51]. Typical methods for
producing shadow masks, such as photolithography and Deep Reactive Ion Etching (DRIE) or Ion
Beam Milling, are expensive, require cleanroom-based fabrication, expensive vacuum equipment,
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ultra-pure air filtration, and advanced know-how [1, 31]. Multimodal laser micromachining, on
the other hand, is simple, cost effective, and makerspace-compatible, all vital attributes for cellbased assays and microfluidics applications.

Figure 11 Images of sub-5 µm trace widths in Kapton®. a. AFM image of 3.5 µm trace width (white area). b. AFM image of 1.5
µm trace width (white area). c. SEM image of full comb finger electrode structure (approx. 5 µm trace width). d. SEM image of
shadow mask feature of approximately 2.43 µm trace width.

Fabrication of the shadow masks down to ~1.5 μm was successfully demonstrated, as
shown in Figure 11. To the best of my knowledge, this is the lowest feature size demonstrated for
laser defined shadow masks [31, 51]. Previous work with laser micromachining has produced
feature sizes down to ~10 μm. As a result, patterns that are an almost an order of magnitude better
than the state of the art are reported in this dissertation.
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Patterning Through Shadow Masks
The laser micromachined shadow masks were further used to pattern both metal and
gelatin/bio-ink. The organic and inorganic layer patterning can be utilized for applications such as
accurate cell placement in single cell and culture assays, precision confinement and growth of
cellular constructs, tissue engineering, metal micro/nanoelectrodes, definition of organic insulation
layers, and other lab-on-a-chip and diagnostic applications [31, 51, 82, 90, 91].

Figure 12 Design to shadow mask to device (IDE on glass) for the four materials that cut all the way through the substrate. a.
Stainless steel to Ti-Au metal IDE, b. Kapton® to gelatin IDE pattern, c. Aluminum to Ti-Au metal IDE, and d. PET to Ti-Au
metal IDE.

Design of a shadow mask to microfabricated device translation for the four materials that
the multimodal laser was completely able to micromachine through are shown in Figure 12.
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Aluminum, PET, and stainless-steel shadow masks were used to fabricate metal IDEs while
Kapton® shadow masks were used for fabricating a gelatin/bio-ink IDE. It was observed that
Kapton® and stainless steel demonstrated the best design to device translation for 125 µm to 7 µm.
Both stainless steel and Kapton® showed minimal thermal damage from laser microfabrication at
their respective laser wavelengths (1064 nm and 355 nm). Additionally, both materials have
coefficients of thermal expansion (both approximately 20 x 10-6 K-1) which are 2x larger than the
thermal expansion of glass (9 x 10-6 K-1) [46] theoretically suggesting better translation results and
experimentally verified in Figure 12 (for N = 3 measurements at the various design values). The
best design to device translation was observed to be ~98% for the 7 µm gelatin features due to the
rapid deposition and curing of the gelatin. The worst design to device translation for stainless steel
was observed to be 95% for 125 µm metal IDE on glass due to the higher run-off possibilities
during the electron beam evaporation process [34]. PET and aluminum demonstrated a deviation
from the designed IDE pitch by 11.2% and 25.8% at maximum pitch, respectively. PET has a
coefficient of thermal expansion (80 x 10-6 K-1) [87] that is nearly an order of magnitude larger
than that of glass, so some deviation from the design dimensions is expected due to thermal
mismatch effects during e-beam evaporation. The aluminum shadow mask exhibited physical
melting during the laser micromachining process, which could explain the large deviation from
design dimensions.
Figure 13 shows the design schematic, SEM images of the shadow masks, and transmitted
light microscope images of both Ti-Au metal patterning and gelatin bioink patterning for circular
fill IDE patterns with electrode gaps from 125 µm to 7 µm. Metal patterning appeared to work best
with Kapton® or stainless-steel shadow masks because their coefficients of thermal expansion are
closer to that of glass. Kapton® and PET shadow masks worked best for gelatin patterning. Both
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shadow mask materials allowed for simple adhesion to the glass substrate utilizing surface tension
effects by simply dipping the mask in DI water prior to attachment on glass substrates. Allowing
the gelatin to fully set prior to shadow mask removal was key in preventing the patterns from
bleeding.

Figure 13 Results of laser micromachining of the shadow masks, as well as inorganic and organic layer patterning. The design of
an Interdigitated Electrode (IDE) was translated into metal (titanium-gold) and bioink (gelatin).

The impedance of the metallized IDEs (Figure 14) was found to decrease with decreasing
electrode gap width as is expected [92] with the 1 kHz impedance decreasing by 33.47% between
the extremities of the designs tested. Table 3 further illustrates impedances at key frequencies,
clearly depicting resistive behavior at the lower and upper ends of the spectra and capacitive
behavior in the mid-band with increasing impedance values as expected [92].
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Figure 14 Full spectrum impedance measurements of several IDEs of varying pitch. The electrophysiologically significant
frequency of 1 kHz (green line) reports impedances from approximately 39 kΩ (7 μm) to 56 kΩ (62 μm).
Table 3 Values of the real part of the impedance at significant frequencies
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Conclusions
Complete characterization of the laser micromachining processes for six (6) commonly
used microfabrication materials was developed in this chapter using a multimodal laser
micromachining tool. Characterization of the QuikLaze 50ST2 multimodal laser for the laser
micromachining of six (6) different materials demonstrated that the ablation depth that were
experimentally obtained fit relatively well with a simple thermodynamic theory for most of the
materials. While more complex theories or analysis [88] one could improve the discrepancy, this
technique is accurate enough to allow one to readily calculate possible ablation depths of a new
material using such a laser micromachining tool. Additionally, two applications of multimodal
laser micromachining were demonstrated: shadow mask fabrication in the sub-5 µm range and
patterning of organic and inorganic materials in the sub-10 µm range. The ability for such a
technique which allows for rapid prototyping of shadow masks and devices, combined with the
compact, benchtop-friendly design gives multimodal laser micromachining tremendous promise
as an efficient fabrication method in both academic and industrial research settings.
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CHAPTER 3: HL-1 CELL LINE ESTABLISHMENT AND MATERIAL
BIOCOMPATIBILITY
The work presented in this chapter has been published in Biosensors in October 2020 [93].
This cell line also helped the group to report on its first electrophysiological data acquisition from
a 3D Microelectrode Array (3D MEA), which was the subject of a paper accepted in RSC
Advances in November 2020 [94] and a presentation in NanoFlorida 2019 [95].
Introduction
Since the development of cell-based biosensors was the focus of the work in this
dissertation, preliminary cell studies were needed. Initially, the idea was to rely on collaborators
(such as Prof. Hickman) for the cell studies and some of these collaborative results are presented
in

the bioprinting

chapter.

Two

things

became

evident

as

the facile biosensor

micro/nanofabrication methodologies were developed: (1) bioprinting on cell-based biosensors
required a lot of cell experiments; (2) biocompatibility of materials being used in the biosensors
was paramount and needed specific attention. As a result, it was decided to pursue a separate cell
line in the lab to facilitate these experiments.
Since a majority of in vitro biosensor research focuses on human induced pluripotent stem
cells [14, 16, 90, 96-98], specifically cardiomyocytes, this was where the cell studies had originally
focused. The requirements for handling and costs of these cells were researched and found to be
beyond what was required in this dissertation [99]. Additionally, further increase in cellular
population, known as passaging, is not possible with these cells [98]. The original idea was that
any intermittent testing could be done with lower overheads of handling, care, and costs with
human induced pluripotent stem cell derived retinal pigment epithelial cells. While these cells
were not electrogenic, they grew rapidly and, in a brick-like pattern, which quickly allowed for
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identification of any biocompatibility, impedance changes, or process issues that may have been
present.
As the work in this dissertation progressed, it became clear that extensive cell experiments
with passaging of a cell line would be needed. The promising results presented in the nIDE chapter
which follows later, as well as the cell consumption involved with developing a bioprinter made it
clear that we would need to establish a cell line in our lab.
To test material biocompatibility, a cell type that has been well studied and has predictable
growth patterns should be used. HL-1 cells are derived from rat atrial cardiac myocytes and are
the only cardiomyocyte cell line currently available that can continuously divide, spontaneously
contract, and maintain a differentiated adult cardiac phenotype [100, 101]. Additionally, this cell
line has been widely characterized using optical, electrophysiological, immunohistochemical, and
pharmacological methods [100, 101].

Figure 15 Fluorescent microscopic images taken from Peter et. al. of the three most employed cardiomyocytes. a. Neonatal rat
ventricular myocytes: the immaturity of the cells can be seen when compared to the b. HL-1 cells and c. human induced
pluripotent stem cell derived cardiomyocytes. [102]
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Cell Line Selection
Several decisions were to be made when choosing a cell line to establish in the lab. Since
we were interested in morphological and electrophysiological measures, electrogenic cells
addressed all our needs. A choice was subsequently made between neurons and cardiomyocytes.
Cardiomyocytes tend to be slightly easier to manage [103, 104], which was ideal for our lab since
cell biology experience was minimal and not the focus of the lab. Three cardiomyocyte cell types
are commonly used in biosensor research: the aforementioned human induced pluripotent stem
cell derived cardiomyocytes (hiPSC-CM), neonatal rat ventricular myocytes (NRVM), and HL-1
cells [104, 105]; and a decision needed to be made about which cell line would be the best choice
for our needs. Figure 15 shows fluorescent microscope images from Peter et. al. comparing the
three cell types [102].
The first cell type of the three is the most popular, and the ideal choice as far as clinical
translation, human induced pluripotent stem cell derived cardiomyocytes (hiPSC-CMs). These are
intrinsically heterogeneous consisting of three subpopulations: atrial-, ventricular-, and nodal-like
cardiomyocytes [106, 107]. This is beneficial because these cell types are all present in the heart,
meaning that any drug dosing experiments give a more realistic picture of potential reactions.
Additionally, these cells are human, which means that direct clinical translation of drugs is easier
to realize as reactions are human [102, 106]. These cells also set the tone for future “personalized”
medicine where cells from a patient can be used to determine any potential side effects or reactions
to treatments.
While hiPSC-CMs are the ideal choice, some significant downsides still exist. Despite the
successful differentiation of human induced pluripotent stem cells into spontaneously beating cells
with active cardiogenic marker genes, the resulting cardiomyocytes are an immature and highly
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variable cardiac phenotype [107]. Electrophysiology measurements have shown that the shapes
of the action potentials have varied significantly between studies and even within studies among
the same cell lines (derived from a different set of stem cells) and with different differentiation
methods [106]. An example of these different action potential morphologies, from He, et. al. is
presented in Figure 16 [98]. This high heterogeneity requires that many cells be analyzed to
generate statistically meaningful conclusions. The high cost of stem cell derived cardiomyocytes
makes maintaining such a cell line for a non-biology-based lab prohibitive.

Figure 16 Different shapes of action potentials that can be generated from stem cell-derived cardiomyocytes [98]
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Because human cells were not realistic for our needs, animal models needed to be explored.
There is no ideal animal model available for cardiac research [108]. The use of every animal
model is accompanied by its own set of advantages and disadvantages. Many disadvantages come
in the form of ethical questions of the use of animals that many consider pets in laboratory settings.
For this reason, only rodent models were considered, as people are generally more inclined to
accept this. Cardiac excitation, contraction, and relaxation of small rodents and humans many
similarities (Figure 17) [102, 106, 108-111]. Both groups express proteins with similar functions
and roles [108, 110]. Genetically modified mouse and rat models can be used to probe the function
of various genes in cardiac physiology and disease, which can address vital questions in physiology
and disease modelling. Despite their similarities, there are important differences in human and
small rodent models, mouse/rat models allow for rapid establishment of proof-of-principle that can
later be extended to human models [108].

Figure 17 Comparison of action potentials for human and mouse derived cardiomyocytes. The action potentials are of similar
amplitude, but the pulse duration differs by an order of magnitude. From Lin et. al. [106]

Neonatal rat ventricular myocytes (NRVM) solve some of the issues with hiPSC-CMs
[104, 105]. They are all ventricular-like, which means that the action potentials that they exhibit
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are homogeneous [103]. These cells are primary cardiomyocytes meaning they are terminally
differentiated cells and they are difficult to transfect [102]. While you can purchase primary cells
from several companies, it is much more economical to procure them yourself directly from the
rat [102]. This brings in a whole host of new institutional and ethical protocols since it involves
live animals, as well as the need for expensive new equipment. Additionally, their use is somewhat
limited because they lack many adult cardiomyocyte characteristics, such as becoming overgrown
by non-myocytes after a few days in culture, ceasing to divide after the neonatal period, and
difficult genetic manipulation [102, 108, 110].
HL-1 cells were the third option. The HL-1 cell line was derived from AT-1 cardiac
myocytes, which are atrial cardiac muscle cells obtained from transgenic mice in which the
expression of the SV40 large T antigen was controlled by the atrial natriuretic factor (ANF)
promoter [100, 101]. These cells can continuously divide, spontaneously contract, and maintain a
differentiated adult cardiac phenotype through indefinite passages in culture [100, 101]. HL-1
cells have been characterized using microscopic, immunohistochemical, electrophysiological, and
pharmacological methods [101]. The cells contain highly organized sarcomeres necessary for
mediating contraction and intracellular ANF granules characteristic of atrial myocytes [101, 102,
106]. Additionally, they exhibit an adult cardiomyocyte-like gene expression profile, meaning
that they should respond to chemical stimulation as typical adult cardiomyocytes would [101, 102,
106]. HL-1 cells spontaneously depolarize and express the necessary ion channels required for
generating action potentials characteristic of primary cardiomyocytes [101], which makes them a
good candidate for electrophysiological experiments. Some disadvantages of HL-1 cells include
their rapid uninhibited growth and their homogeneous atrial phenotype makes the cell line
incompatible with ventricular studies [101, 102, 106].
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Table 4 lays out the advantages and disadvantages of these cell lines [101, 102, 106, 108].
Because of the frequency of cell culture in our lab (often, but not continuous), HL-1 cells seemed
to be the optimal choice. The low cost and maintenance of this cell line combined with the
possibility for serial propagation gave the flexibility to bank billions of cells for future use to be
thawed as needed. Additionally, we already had much of the required labware. The support for
the cell line as well as a BioCane for cryogenic storage came from a generous UCF Doctoral
Research Support Award provided by CECS.
Table 4 Comparison of the advantages and disadvantages of the three most common cardiomyocyte cultures used in the
biosensor community

Materials and Methods
In this section of the chapter, the methods for establishment of the cell line and
biocompatibility testing of the cells follow.
Establishment of HL-1 Cell Line and Protocols
HL-1 cells were purchased from Millipore Sigma. The cells arrived in a cryovial and were
immediately thawed into prepared cell culture flasks. The following sections detail the protocol
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for thawing, passaging, and freezing the cells, as well as the recipes for the various mediums
needed for these protocols. All protocols and recipes were adapted from Dr. Claycomb’s original
paper and one that followed [100, 101]. Everything has been adapted to fit the specific needs of
our lab without sacrificing the health of the HL-1 cells. Significant trial and error have allowed
for the development of this protocol. The initial establishment of the cell line required nearly 24/7
lab work, which was thankfully shared with my colleague Dr. Frank Sommerhage. By combining
our time, we were able to establish an impressive cell bank, as well as determine to nearly the halfhour when we could expect the number of cells to have doubled.
Prior to starting the cell experiment, the centrifuge, water bath, and microscope were all
turned on. Additionally, the IPA/Ethanol bottle was filled, and the inside of the biosafety cabinet
was been sprayed and wiped down. Finally, it was determined that all needed consumables were
present inside the biosafety cabinet.
Most of the solutions used in culturing the cells required pre-mixing or aliquoting.
Gelatin/Fibronectin Solution
To make gelatin/fibronectin solution, 10 mL of 0.1% gelatin solution were added to 40 mL
of sterile water in a 50 mL centrifuge tube. This made a 0.02% gelatin solution. 250 µL of
fibronectin (1 mg/mL) was added to the 50 mL centrifuge tube of 0.02% gelatin solution and mixed
gently. The mixture was then sterile filtered using a 0.2 µm syringe filter aliquoted into 15 mL
centrifuge tubes. Aliquots were kept frozen at -20°C.
Norepinephrine
To make 10 mM stock norepinephrine, 0.59 g of ascorbic acid was added to 100 mL of cell
culture grade distilled water (30 mM ascorbic acid). Then 80 mg of norepinephrine was added to
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25 mL of the 30 mM ascorbic acid and filter sterilized using a 0.2 µm syringe filter. The solution
was then aliquoted into 1 mL working volumes in sterile microtubes and stored at -20°C. 1 mL of
stock solution was used per 100 mL of Claycomb medium for a final concentration of 0.1 mM of
norepinephrine.
L-Glutamine
L-glutamine came as a 100X solution. It was aliquoted into working volumes in sterile 1
mL microtubes and stored at -20°C.
Supplemented Claycomb Medium
Supplemented Claycomb Medium was required to maintain the desirable characteristics
(beating, differentiation, phenotype) of HL-1 cells. To make supplemented Claycomb medium in
working volumes for our needs, 87 mL of Claycomb medium, 10 mL of Fetal Bovine Serum, 1
mL of penicillin/streptomycin, 1 mL of 10 mM stock norepinephrine, and 1 mL of L-Glutamine
were mixed to make 100 mL of medium. The medium was stored in amber glass media bottles
and protected from light at 4°C.
Wash Medium
Wash medium was used to wash the cells of trypsin and trypsin inhibitor or freezing
medium during centrifuging by supplying them with necessary nutrients they may have been
lacking for a short time. To make 100 mL of wash medium, 94 mL of Claycomb medium, 5 mL
of fetal bovine serum, and 1 mL of penicillin/streptomycin were mixed in a glass amber media
bottle and protected from light. Wash medium was stored at 4°C.
Freezing Medium
Freezing medium was used for cryogenic storage of cells. To make freezing medium, 9.5
mL of fetal bovine serum was mixed with 500 µL of dimethyl sulfoxide (DMSO) in a 15 mL
42

centrifuge tube. DMSO was used to prevent the formation of ice crystals during the freezing
process, which would kill the cells.
Soybean Trypsin Inhibitor
Soybean trypsin inhibitor was necessary to stop the trypsinization of cells in culture. It
was necessary to use trypsin to remove the cells from the surface from which they were adhered,
but if the action of the trypsin was not halted, the cell surface proteins would begin to be digested
and cell functioning would be impacted.
To make soybean trypsin inhibitor, 25 mg of soybean trypsin inhibitor was weighed out
and placed into a beaker containing 100 mL of phosphate buffered saline. The solution was mixed
until the soybean trypsin inhibitor was dissolved. The solution was then filter sterilized using a
0.2 µm syringe filter and placed into a 50 mL centrifuge tube. Soybean trypsin inhibitor was stored
at 4°C for up to 1 month.
Pre-Coating Flasks with Gelatin/Fibronectin Solution
The required number of frozen 15 mL tubes of gelatin/fibronectin solution were thawed in
the 37°C water bath. Once thawed, sterile tissue culture flasks were coated with the required
volume of the gelatin/fibronectin solution. T25 flasks required 1 mL and T75 flasks required 3
mL. The flasks were capped and incubated at 37°C for at least one hour, preferably overnight.
The gelatin/fibronectin solution was removed from the flask via aspiration just prior to adding the
cells.
Initial Cell Culturing and Banking of Cells
Two T25 flasks were prepared for cell culture using the coating protocol above. The
gelatin/fibronectin solution was aspirated from the culture flasks and replaced with 4 mL of
supplemented Claycomb medium in each flask. The flasks were placed back in the incubator. A
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volume of 10 mL of wash medium was added to an empty 15 mL centrifuge tube and incubated in
a 37°C water bath. The cells were quickly thawed in the 37°C water bath (approximately 2
minutes). The cells were immediately transferred to the 15 mL centrifuge tube containing the
wash medium and centrifuged for 5 minutes at 500 x G. When centrifuging was complete, the
tube was removed from the centrifuge and the wash medium was aspirated while being careful not
to disturb the cell pellet. The cell pellet was resuspended in 2 mL of supplemented Claycomb
medium. 1 mL of the mixture was transferred into each of the two culture flasks. The medium in
each flask was replaced with 5 mL of fresh medium approximately 4 hours later after the cells had
attached. Figure 18 presents this procedure sequentially with optical images.

Figure 18 Schematic of the process for thawing and plating HL-1 cells.
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After the cells first arrived, it was recommended that they were split when they reached
confluency, that was when most of the surface became covered with cells. Each of the T25 flasks
was split 1:2, which resulted in four T25 flasks.
When the cells became confluent, they needed to be passaged to proceed further. The
procedure for passaging cells from a T25 flask follows and is shown in Figure 19. First, medium
was aspirated from the flasks. A volume of 3 mL of DPBS warmed to 37°C was added to each
flask by pipetting the DPBS onto the base of the flask (the side opposite the cap) trying not to
injure the cells. The cells were rinsed gently and the DPBS was removed via aspiration. Next, 1
mL of pre-warmed 0.05% trypsin/EDTA was added to each flask and incubated at room
temperature for 1 minute. The trypsin was then removed and fresh 0.05% trypsin/EDTA was
added and incubated at room temperature for an additional 2 minutes. The flasks were then
examined microscopically to confirm that cells were detached, as shown in Figure 20. If the cells
were still adhered, the flask was gently perturbed with hands on the benchtop to dislodge the
remaining cells. To inactivate the remaining trypsin, 1 mL of soybean trypsin inhibitor was added
to the flask. Cells and solution from the flask were transferred to a 15 mL centrifuge tube. The
empty flask was rinsed with 5 mL of wash medium, which was then aspirated and added to the
cells already in the 15 mL centrifuge tube. The total volume of 15 mL of cells and solution was
then centrifuged at 500 x G for 5 minutes. Meanwhile, the gelatin/fibronectin solution was
removed from each T25 flask that was previously prepared and 4 mL of supplemented Claycomb
medium was added to each T25 flask. The cells were removed from the centrifuge and the
supernatant was carefully aspirated as to not disturb to cell pellet. The cell pellet was resuspended
in 2 mL of supplemented Claycomb medium. Subsequently 1 mL of the cell suspension was
transferred into each of the two labeled gelatin/fibronectin-coated flasks.
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These flasks were then grown to confluency. Three of the flasks were passaged to T75
flasks and frozen as passage one (1). The fourth flask was kept as the working flask and further
passaged. It was important to try to freeze a flask or two from each passage in case an issue arose
with the cells at some point. This allowed us to return to that earlier, error-free passage. The
protocol for passaging to the T75 flasks was largely the same as passaging to the T25 flasks, except
the volume of supplemented Claycomb medium added after the gelatin/fibronectin was aspirated
was 9 mL.
Generally, the contents of one confluent T75 flask were frozen into 3 cryovials
(approximately 2.0 x 106 cells/vial). When cells were needed, one cryovial was thawed into one
T75 flask. The T75 flask containing the Hl-1 culture was briefly rinsed with 5 mL of DPBS
warmed to 37°C and removed by aspiration. Further 3 mL of 0.05% trypsin/EDTA was added into
the flask and incubated at 37°C for one minute. The trypsin/EDTA was removed from the flask,
replaced with 3 mL of fresh 0.05% trypsin/EDTA, and incubated at 37°C for 2 minutes. After 2
minutes, the flask was checked under the microscope to ensure that the cells were dislodged. If
they were not, the flask was gently perturbed on the benchtop to dislodge any cells that remained
adhered to the flask surface. A volume of 3 mL of soybean trypsin inhibitor were added to the
flask and transferred the 6 mL of solution into a 15 mL centrifuge tube. The empty flask was then
rinsed with 5 mL of wash medium, which was aspirated and transferred to the 15 mL centrifuge
tube containing the cells. The cells and solution were centrifuged at 500 X G for 5 minutes, then
removed and the wash medium was aspirated. The cell pellet was gently resuspended in 4.5 mL
of freezing medium. A volume of 1.5 mL of resuspended cells were pipetted into labeled cryovials.
The cryovials containing the cells were placed into a Nalgene freezing jar containing room
temperature isopropyl alcohol (IPA). The freezing jar was immediately placed into a -80°C
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freezer, which allowed the cells to freeze at a rate of -1°C/minute. Six to twelve hours later, the
vials were transferred into a liquid nitrogen dewar.
Maintaining the Cell Culture
Cells were fed with supplemented Claycomb medium every weekday. The media was fully
replaced every day. T25 flasks received 5 mL of fresh supplemented Claycomb medium daily,
while T75 flasks received 10 mL of fresh supplemented Claycomb medium daily. To avoid
feeding the cells on the weekends, double the supplemented Claycomb medium was added to each
flask on Friday afternoon. This medium was fully exchanged on Monday morning.

Figure 19 Schematic of the process for passaging HL-1 cells

Cell Counting
Cell counting is an extremely important part of maintaining a cell bank. It is pertinent to
know how many cells are being frozen away in cryovials. It is also important to keep track of cell
counts as this is one way to tell if there is a problem with your culture. When building our cell
bank, cell counts were also used to determine the doubling time of our cell cultures. This allowed
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us to eventually be able to time cell cultures so overnight and weekend passaging would no longer
be necessary.

Figure 20 Cells being trypsanized to dislodge them from the surface of a flask to which they are adhered. The red arrow shows a
layer of cells that have detached from the flask. The green arrow shows an area of cells which are still attached to the flask
surface. (Image taken with Keyence BZ-X800 All-in-One Confocal Microscope at 10X magnification)

Several methods are available for cell counting. The most common method is cell counting
using a hemocytometer. This protocol is an extremely common practice used in every cell biology
lab [112]. To use a glass hemocytometer, along with a coverslip, it was cleaned with alcohol
before use. The coverslip was then moistened with water and affixed to the hemocytometer. The
presence of Newton’s refraction rings under the coverslip indicated proper adhesion. Typically,
cells were counted after cells were resuspended after trypsinization and centrifugation.
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To count the cells, 100 µL of cells were pipetted into an Eppendorf tube. A volume of 400
µL of 0.4% Trypan Blue was then pipetted into the same tube and mixed gently, giving a final
trypan blue concentration of 0.32%. Using a pipette, 100 µL of the trypan-blue treated cell
suspension was applied to the hemocytometer. Both chambers were gently filled under the
coverslip, which allowed the cell suspension to be drawn out by capillary action. Using an inverted
microscope, the grid lines of the hemocytometer were focused on with a 10X objective. Using a
hand tally counter, the live, unstained cells (live cells do not up-take trypan blue) in one of 4 sets
of 16 squares on the corners were counted, as labeled in Figure 21. When counting, a system
where cells are only counted when they are within a square or on the right-hand or bottom
boundary line was used. The hemocytometer was then moved to the next set of 16 corner squares
and counting was continued until all four sets of 16 corners were counted.

Figure 21 Hemocytometer chamber: the four sets of sixteen squares in which cells are counted are labeled 1 to 4. The densely
gridded area is not counted.
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To calculate the number of live cells per milliliter the average cell count from each of the
sets of 16 corner squares was taken and multiplied by 10,000. Then, this number was multiplied
by 5 to correct for the 1 to 5 dilution from the trypan blue addition. This final number was the
number of viable cells per milliliter in the original cell suspension. When splitting an entire
centrifuge tube into flasks of cryovials, the entire volume of cells and medium needed to be
considered.
Cell Doubling Time
By maintaining stringent counts of each flask that was passaged while establishing the
culture in our lab, pinpointing how long it took for the cells to double was determined. By using
this information, the timeline for passaging was ascertained. Having this control allowed us to
avoid passaging over the weekends, as well as at odd times of the night. It was determined that
our HL-1 cells double in approximately 2.1 days. Given the number of cells typically seeded in a
flask, this means that flasks, whether T25 or T75, are typically ready to be passaged after
approximately 72 hours.
Necessity of Determining the Biocompatibility of 3D Printing Resins with HL-1 Cells
Once the HL-1 cell line was established in the lab, it was necessary to understand the
limitations of its biocompatibility with non-traditional materials that are often used in our group.
Specifically, in order to achieve the desired feature sizes to enhance biosensor sensitivity using
our 3D bioprinter that we developed in house in Chapter 4 it was necessary to develop our own
printer micro-nozzles, with openings ranging from 500 µm to 100 µm. To ensure the viability of
the cells was not further reduced in the printing process, it was necessary to select the proper 3D
printer resin to print the nozzles. An extensive study of the biocompatibility of HL-1 cells with
six 3D printer resins follows. The results of this study also led to improved fabrication of the
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culture wells utilized in the packaging of the nanointerdigitated electrodes and plasmonic
interdigitated electrodes as discussed later in this dissertation.
Biocompatibility of Blank, Post-Processed and Coated 3D Printed Resin Structures with
Electrogenic Cells
The widespread adaptation of 3D printing in the microfluidic and bio-MEMS community
has been stifled by the lack of investigation into the biocompatibility of commercially available
printer resins.

By introducing an in-depth post-printing treatment of these resins, their

biocompatibility can be dramatically improved up to that of a standard cell culture vessel
(99.99%). Additionally, encapsulating less biocompatible resins with materials that are common
constituents in biosensors further enhances the biocompatibility of the material. This investigation
provides a clear pathway toward enhancing extrusion bioprinting methodologies and developing
fully functional and biocompatible biosensor devices especially for interfacing with electrogenic
cells utilizing benchtop-based microfabrication and post-processing techniques.
Biocompatibility Testing of 3D Printed Resins
Conventional micro/nanofabrication techniques allow for the realization of micron- and
nanoscale features; however, these techniques have several disadvantages, including expensive
and time-consuming processes when altering the design of a device, difficulty in scaling up from
prototyping to bulk manufacturing, and 3D geometric design requirements [113-119]. 3D printing,
also known as additive manufacturing or rapid prototyping, has recently become an important
technology for revolutionizing biosensor and microfluidic device development because of its
ability to overcome most of the disadvantages associated with traditional microfabrication
techniques [113-120]. Unlike traditional microfabrication techniques, 3D printing does not require
the need for a cleanroom facility, thus allowing for simple implementation, low costs, and rapid
fabrication [118].
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3D printers generally define a three-dimensional object from a computer-aided design
(CAD) model layer-by-layer in an additive process [117, 119]. The most prevalent types of 3D printing
utilize polymers, and these types are namely fused deposition modelling (FDM), microstereolithography (µSLA), and digital light processing (DLP). FDM printing involves the extrusion of
small streams or beads of a material, such as polylactic acid (PLA), that immediately harden to form
the structural layers of the final device [117, 119]. FDM printing is the easiest to implement and the
most cost-efficient of these three methods; however, limitations exist in the shapes and feature sizes
that can be fabricated [117, 119]. Both µSLA and DLP printing produce objects in a layer-by-layer
fashion via the photopolymerization of a liquid resin. These technologies may also be referred to
as vat photopolymerization or resin 3D printing [117, 119, 121]. Both µSLA and DLP printing can
produce highly accurate, isotropic objects with micronscale feature sizes and a smooth surface
finish. The difference between these two types of printing lies in how the layers are cured. In µSLA
printing, a laser beam and digital mirrors are used to photocure each portion of every single layer
of the object, whereas in DLP printing, the entirety of each layer of the object is cured at once
using a projected display [116, 117, 119, 121, 122]. With respect to the application of these types
of 3D printed interfaces in biology, especially in the realm of in vitro studies, µSLA and DLP 3D
printing lend supplemental benefits outside of the ease of microfabrication. Many cell types prefer
micro/nano textured surfaces, which can be easily achieved by these methods. Such surfaces allow
cells to better sense and respond to their environment [123-125]. It is important to note that the
mechanical properties of such commercial resins are not suited for every application in the space
of biomedical micro-electromechanical systems (BioMEMS) devices, and the choice of
commercial resins can be motivated by a variety of factors, including the ability to rapidly structure
microsystems, access to ready-to-use materials and well mechanically characterized materials, as
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well as cost, consistency, and ease of procurement. If other material properties are desired such as
conformability, silcones and hydrogels remain as alterative 3D-printable materials potentially of
interest [126-128].
3D printing allows for the accurate and rapid design and fabrication of monolithic devices.
Although this technology has revolutionized MEMS and microfluidics fields, little investigation
into the biocompatibility of the most commonly used commercial 3D printing resins has been
performed to date. This is especially true for electrogenic or electrically active cells (e.g., neurons,
cardiomyocytes) where no biocompatibility reports have been published as far as our knowledge
goes [113, 114, 120-122, 129-139]. Many of these “off-the-shelf” 3D printing liquid resins can be
purchased directly from the individual printer manufacturers, and as a result their compositions
are proprietary. Thus, the constituent materials, specifically the photoinitiators, surfactants,
solvents, and shelf-life extending compounds, are unknown. This lack of information is a barrier
to wider adaptation of 3D printing in the bioelectronic, biosensor, and microfluidic communities,
as material biocompatibility is of utmost concern for cells interfacing with these materials. Some
groups have studied some of these resins with little luck in having any extended cell viability,
except for the few groups that add prolonged UV treatment to the usual post-print processing [100,
101, 113, 114, 116, 119, 120, 130, 131]. Several of these materials are methacrylate-based as
deduced from their materials safety data sheets (MSDS) [140-144]; however, their exact
compositions remain proprietary. Studying these resins in cell culture and improving their
biocompatibility through post-process treatments is of immense interest to the community and
provides multiple advantages. First, the ability to design constructs for in vitro biological work
solely based on 3D-printing microfabrication strategies means that novel and monolithic design
approaches can be explored. Second, the application of post-processing treatments begins to reveal
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a larger concept of compound material biocompatibility, by posing the questions of the exact
material changes occurring during each step. While some effects are readily known and the effects
of certain treatments can be hypothesized, these steps could allow for the identification of the exact
components of each resin.
To test material biocompatibility, a cell type that has been well studied and has predictable
growth patterns should be used. HL-1 cells are derived from rat atrial cardiac myocytes and are
the only cardiomyocyte cell line currently available that can continuously divide, spontaneously
contract, and maintain a differentiated adult cardiac phenotype [100, 101]. Additionally, this cell
line has been widely characterized using optical, electrophysiological, immunohistochemical, and
pharmacological methods [100, 101].
In this section of this chapter, the feasibility of using resin 3D printing for in vitro biological
applications by testing the biocompatibility of several commercial resins was explored. By
utilizing commercially available resins and standard BioMEMS coatings, it was demonstrated how
several standard processes can be combined to provide enhanced biocompatibility, which in turn
will create higher accessibility to 3D printed BioMEMS fabrication for the creation of novel, in
vitro electrogenic assays. With respect to the selection of postprocess treatments for 3D printed
constructs, the treatments themselves should also be accessible. To that end, coatings that are
known to enhance biocompatibility and are accessible to all labs, i.e., SU-8 [96, 145], gold [90,
96,

146],

polystyrene

[147],

Medco/polyethylene

terephthalate

(PET)

[148],

and

polydimethylsiloxane (PDMS) [149] to enhance biocompatibility, were tested for each material.
With respect to postprocessing surface treatments, we examined isopropyl alcohol (IPA) treatment
(a common solvent for cleaning freshly printed Methacrylate-based resin parts to remove the
uncured monomer [150]); ultraviolet (UV) post-curing (a common step to improve 3D printed final
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structural properties due to enhanced crosslinking, as well as a common sterilization method prior to
cell culture [121, 151, 152]); thermal baking (a common post-treatment for achieving final, post-print
properties [121]), and autoclaving (a common sterilization technique [153] that may encourage further
polymerization due to the high-pressure environment [154-156]). Additionally, several resins were
tested, as each offers varying mechanical and optical properties, which lends themselves to be
useful in multiple applications. Indirect and direct characterization of the biocompatibility of these
resins was then thoroughly characterized.
3D Printed Chips
Computer-aided design (CAD) of the sample chips (4 mm x 4 mm x 1 mm) was performed
in SolidWorks (Dassault Systems, Velizy-Villacoublay, France). The chips were subsequently
sliced and printed (Figure 22A) using Preform and a desktop Form2 µSLA 3D printer (both from
FormLabs, Somerville, MA) or Composer and an Asiga MAX UV27 DLP 3D printer (both from
Asiga, Sydney, Australia) depending on the resin type used. The Form2 uses a 405 nm laser with
a 140 µm spot size for curing, while the Asiga uses 385 nm LED light with a pixel size of 27 µm.
The resins tested for biocompatibility were Clear Resin (FLGPCL04), Flexible Resin
(FLFLGR02), Dental LT Clear Resin (DLFLCL01), and High Temp Resin (FLHTAM01) from
FormLabs (Somerville, MA, USA) and the GR-10 Clear from Pro3dure (Iserlohn, Germany). All
resins tested were printed on the Asiga printer, except for Flexible Resin, which was printed on
the Form2.
After printing, the 3D-printed chips were subjected to numerous treatments to increase cell
viability (Figure 22B). Figure 22B demonstrates the order in which the treatments were performed.
The post-processing treatment steps ranged from no treatment to a full treatment comprising all
the different steps, but they were always performed sequentially. The full regimen of the post55

processing treatments that could be combined is as follows, and the detailed methods are listed as
the following: sonication rinse in fresh 70% isopropyl alcohol (IPA), ultraviolet light (UV)
postprint curing, dry thermal postbaking at 80 °C, and full autoclaving cycle at 135 °C. The
individual variations were performed solely for the FormLabs Clear Resin, to rapidly and
efficiently idenitfy the major changes in efficacy of post-process treatments to biocompatibility,
which were then to be applied to all resins.

Figure 22 Resin chip fabrication: a. Schematic of the Asiga Max UV DLP 3D printer and the Form2 SLA 3D printer and
associated printed resin chips (flexible in black, clear/high temperature in grey and dental in brown). The printer can cure many
different commercial methacrylate-based photopolymer resins, allowing for a variety of sampling materials, provided the photoinitiator absorbs between 385-405 nm. Each chip comes printed on a raft and support structure (as shown in the schematic) and
must be singulated before post-processing. b. Resin chip post-processing stages. Each of the indicated steps and the order was
the final sequence used for a full regiment of resin treatment. After fully post-processing, the chips can then be assembled in 48well plates and sterilized for cell culture.

IPA-treated chips were washed and sonicated at 40 kHz in fresh 70% IPA (Cole Parmer,
Vernon Hills, IL, USA) for 15 min in a sonication bath (Fisher Scientific, Hampton, NH, USA).
UV-cured chips were cured for 6 minutes at 60 °C in the Form Cure UV postcuring station
(FormLabs, Somerville, MA, USA), which operates at a wavelength of 405 nm. The extended UV
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treated chip was cured for an additional 30 minutes in the same curing station. Thermally treated
chips (not shown in Figure 22B) were baked in a benchtop oven (Fisher Scientific, Hampton, MA,
USA) at 80 °C for 1 hour. Autoclave treated chips were affixed to glass slides (Fisher Scientific,
Hampton, NH, USA) using biocompatible Kapton® polyimide tape (Dupont, Wilmington, DE,
USA) and autoclaved in a SterilElite16™ autoclave (Fisher Scientific, Hampton, NH, USA) for a
two-hour cycle, which comprised one-hour heating followed by an one-hour drying cycle at 135
°C. Since autoclaving includes a thermal step, resin thermal treatment is not depicted in Figure
22B. As a measure between the negative controls (listed in the Negative and Positive Controls
section) and the post-treated resin samples described in the section above, we also prepared resin
chips that were not cleaned or treated in any way after removal from the 3D printers, aside from
gently wiping away of any excess uncured resin.
After the postprinting treatments, some of the chips were coated with materials that are
prevalent in BioMEMS and microfluidic devices. These coatings included 10 µm thick
polydimethylsiloxane (PDMS) (Sylgard-184, Dow Corning, Midland, MI, USA) mixed in the
standard 10:1 polymer to curing agent ratio; 5 µm thick polystyrene (PS, Millipore Sigma, St.
Louis, MO, USA) mixed into tetrahydrofuran (THF) (Fisher Scientific, Hampton, NH, USA) to
create a 10% w/v solution; 20 µm thick SU-8 (Gersteltec, Pully, Switzerland); 100 µm thick
biolaminate layer consisting of a polyethylene terephthalate (PET) film with a single side coated
with a Medco adhesive (Medco/PET) (Medco Labs, Bedford Heights, OH, USA); and 75 nm thick
gold (Ted Pella, Redding, CA, USA). Chips with PDMS, PS, and SU-8 were dip-coated and cured
at 60 °C for 1 hour. Gold coated chips were sputter coated in a Quorum Q150T Sputter Coater
(Quorum Technologies, Lewes, UK), and the biolaminate sheet was cut to size and applied to the
chips, with the Medco adhesive acting as the adhesive layer. All thickness measurements were
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performed using a scanning electron microscope (SEM) (JEOL, JSM-6480, Tokyo, Japan).
FormLabs Clear Resin chips were coated with each of the afforementioned materials to evaluate
the effect on biocompatibility as stated earlier, while each of the other resins were only coated with
PDMS.
The fabricated and post-processed chips were subsequently adhered to a sterile 48-well cell
culture plate (Fisher Scientific, Hampton, NH, USA) with biocompatible 353ND epoxy [157]
(Epotek, Billerica, MA, USA) mixed at a 50:1 epoxy to curing agent ratio for increased
transparency. The chips were placed in one side of the well (Figure 23A) in order to expose
sufficient area for the plate reader analysis. The plate was subsequently placed into an oven
overnight at 45 °C to allow the epoxy to cure. For each experimental set, n = 6 samples were
prepared.
The plates were then sterilized, first, by washing each well two times with phosphate
buffered saline (DPBS) (Gibco, Waltham, MA) for five minutes. As the next step, the wells were
washed with 70% ethanol (Fisher Scientific, Hampton, NH) for 10 minutes. The plate was
subsequently UV sterilized in a biosafety cabinet (NuAire, Plymouth, MN) for 30 minutes and
then washed with sterile water four times for five minutes each.
HL-1 Cell Culture for Biocompatibility Testing
A sterile 48-well plate with the chips affixed was first coated with a fibronectin/gelatin
(both Millipore Sigma, Burlington, MA) extracellular matrix solution to allow for cell adhesion to
the surface and incubated at 37°C with 5% CO2 overnight, as previously outlined. The
fibronectin/gelatin solution is aspirated just prior to cell plating and replaced with 500 µL of
supplemented Claycomb medium (Millipore Sigma, Burlington, MA).

58

HL-1 cells were thawed from a cryovial stored in liquid nitrogen and resuspended in
supplemented Claycomb medium via the protocol mentioned in the Materials and Methods section.
The cells were then counted using a standard hemocytometer protocol with trypan blue (Gibco,
Waltham, MA). Typically, each cryogenic vial contains around 1.5 million cells. Since the optimal
plating density for a 48-well plate is approximately 30,000 cells/well [25], approximately 20 µL
of the cell suspension was added to each well. The exact amount depends on the cell density in a
specific vial and is typically determined at this step in the process.

Figure 23 Luminescence assay: a. Image of 48-well plate with schematic close-up demonstrating the placement and relative size
of the resin chips in the wells. The grid of green dots represents the sampling points of the luminescence assay. b. Schematic view
of the luminescence assay process, illustrating the averaged luminescence leading to an output of percent viability.

Culture plates were incubated at 37°C with 5% CO2 and allowed to reach confluency (3
days). Cell culture medium was exchanged daily. After the cells reached confluency, an ATP
assay was performed to assess cell viability [158]. Promega CellTiter-Glo (Promega, Madison,
WI) ATP assay was prepared according to their protocol [158]: 200 µL of supplemented Claycomb
medium, along with an equal amount of the ATP assay reagent were added to each well, mixed
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for two minutes to induce lysis, and then incubated at room temperature for ten minutes to stabilize
the luminescent signal. Luminescence was then recorded for each well using a SpectraMax i3x
microplate reader (Molecular Devices, San Jose, CA) in a 48-point well scan mode (Figure 23A
and B).
HL-1 cells were also optically observed using inverted microscopy (Nikon TS2, Nikon,
Tokyo, Japan). Images of the cell growth over time and during beating were procured using a
camera (Amscope, Irvine, CA). Live/dead fluorescence images were taken of the cells plated on
standard microscope slide-sized (25 mm x 75 mm x 1 mm) treated resin pieces adhered to a glass
microscope slide using 353ND epoxy to make the resin transparent at DIV05 using a Keyence BZX800 All-in-One Confocal Microscope (Tokyo, Japan). Invitrogen Live/Dead Cell Imaging Kit
(Carlsbad, CA, USA) was used for fluorescent staining, where live cells fluoresced green (488 nm)
and dead cells fluoresced red (470 nm).
Negative and Positive Controls
To ensure the validity of the experimental protocol, both negative and positive controls
were designed to clearly demonstrate uninhibited cell death and growth, respectively. For the
negative controls, 6 mL of each uncured resin was mixed with 24 mL of supplemented media to
create a 1/4 (v/v) solution. The purpose of this solution was to “leach” the resin into the media,
leaving potential cytotoxic compounds (which are normally removed during curing and postprocessing steps), in the media. Cells were plated as described in the previous section until adhered
to the culture well surface (N=6 for each resin), at which time point the leached media was used
(moving forward) to supplement the cultures. For the positive control, cells were plated until
adherent as above, and cultured for the duration of each experimental protocol without any resin
(cured or uncured) present in the wells.
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Results and Discussion
The positive and negative controls each serve to highlight the findings of the
biocompatibility study described in the dissertation. Positive control wells were consistently
99.99% viable as expected. The negative control wells were nonviable (0% viability) within 12
hours of the “leached” supplemented media being introduced in culture. This result held for all
instances of every uncured resin leached media that was used. Uncured resin would most certainly
never be used in the fabrication of a BioMEMS construct, as uncured resins contain shelf-life
stabilizers, solvents, monomers, UV-blockers, and photoinitiators [139, 140, 159], and these are
likely polymerized with the solvent evaporating out of the construct as the 3D structure is cured.
Again, it is important to note that commercial resins are largely proprietary, so exact chemical
compositions remain unknown and are an area of interest for future studies. These controls serve
to demonstrate the necessity of the postcuring steps, including sufficient UV/thermal curing of the
resin, which would ensure the removal of these overtly cytotoxic compounds [160, 161] that may
still be present in trace quantities after the initial structural curing of the resin during 3D printing.
The resins selected were based on both their commercial availability and recommended
base resins (by the manufacturer) for the respective 3D printing platforms. These resins according
to the manufacturers are the most used products in BioMEMS, microfluidics, dentistry, artistic
endeavours, and other fields. As a starting basis for comparison, the various iterations of printed
materials are deemed biocompatible with HL-1 cells if cell viability exceeded 85.00% [162]. This
viability marker extends from both the ISO 10993-5 standard and the European Union Reference
Library European Centre for Validation of Alternative Methods (EURL ECVAM) [162], as well
as visual observations of cell growth and beating. The percentages shown are based on arbitrary
luminescence units, corresponding directly to a culture’s population viability (average n = 6). Each
experimental group was accompanied by a set of positive controls (no resin; n = 6; 99.99% average
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viability across experiments) that demonstrated the healthy viable nature of the cells used in a
culture experiment. For each of the resins as mentioned previously, a negative control consisting
of the uncured resin leached media (n = 6; 00.00% average viability) was performed.

Figure 24 a. Biocompatibility results of incremental improvements in biocompatibility during post-processing for FormLabs
Clear V4: Clear resin alone showed the lowest survival rate, while washing with IPA resulted in the greatest increase of survival.
Surprisingly, thermal treatment after IPA washing reduced the biocompatibility slightly even through the result was above the
accepted values for HL-1 cells. The combination of IPA + UV + Autoclave resulted in the greatest collective viability. b.
Coatings encapsulation of FormLabs High-Temp resin to improve biocompatibility: All samples were washed with IPA, exposed
to UV for 6 minutes, and subsequently autoclaved. SU-8 and polystyrene had a rather small impact on the biocompatibility.
Medco/PET and gold resulted in slightly better biocompatibility, and encapsulation in PDMS provided the best results and was
subsequently used. c. Biocompatibility of the different resins before and after PDMS coating encapsulation. d. Biocompatibility
results of the different resins where the chips were only coated with fibronectin/gelatin solution as opposed to the entire culture
well.

Experimentally, the FormLabs Clear Resin [140] was tested first (Figure 24A), as it is the
simplest and most widely available resin accessible for this type of work. All viability numbers
mentioned in this section are an average of n = 6 samples. Untreated (printed; no wash or postprocessing) FormLabs Clear Resin (FLGPCL04) was first tested as a basis of comparison and
demonstrated a 43.39% ± 0.70% (mean ± standard deviation for all such numbers from now on)
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viability. Such a high cytotoxicity was expected because of the presence of the various moities as
hypothesized earlier [52,53]. Next, the postprocessing treatments were tested in a compound
manner, beginning with the sonication in fresh 70% IPA, a step routinely recommended to clean a
resin-based 3D printed structure. The IPA wash alone resulted in a 91.99% ± 0.76% viability, a
dramatic increase in biocompatibility for this resin. This dramatic increase in viability was
expected as well, as the IPA rinse removes any uncured resin and other particles that remain on
the structure after the printing process [42]. Next, an IPA and a UV postcure was tested, resulting
in a 96.35% ± 0.71% viability. The combination of the IPA rinse and UV curing likely results in
an increase in viability due to the combination of the removal of uncured resin [42] and further
crosslinking of the polymer in the UV curing station due to free radical initiated polymerization
[9,43,44]. IPA and a thermal bake were then tested together resulting in 89.98% ± 0.39% viability,
prompting a comparison with an IPA and autoclave regimen, which resulted in a viability of
98.71% ± 0.24%. From this result, it was hypothesized that while the addition of only thermal
baking enhances the mechanical properties of the resin [9], no further crosslinking is achieved;
however, the high pressure environment of an autoclave step may in fact further crosslink
methacrylate-based resins, as previously mentioned in literature [46–48]. The clear benefits from
combining IPA washing with UV postcuring and IPA with autoclaving prompted the final
compound postprocessing treatment regimen comprising IPA sonication, UV postcuring, and
subsequently autoclaving, which resulted in the highest reported HL-1 cell culture viability for this
type of resin of 99.31% ± 0.17%.
Although the combined treatments greatly increased the overall viability of the cultures,
the Clear Resin itself suffered some minor visible damage from the heat and pressure inherent in
an autoclave step. Due to this, the next resin tested was the FormLabs High Temp Resin
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(FLHTAM01), which can withstand temperatures of approximately 200 °C [141]. The similar base
composition of these resins (both being methacrylate-based) [140, 141] allowed for the
extrapolation of the benefits of the full regiment of post-curing processes used in Clear Resin
(FLGPCL04). High Temp Resin showed a similar untreated performance viability as Clear Resin
at 45.26% ± 0.85% and was also able to be converted to be fully biocompatible (meeting the
established HL-1 biocompatibility metric [162]) with the full postprint treatment regimen and with
a viability of 87.74% ± 1.6%. Although this resin was significantly less biocompatible after
treatments than Clear Resin, it was obvious due to the lack of mechanical damage as observed
using optical microscopy that it qualitatively withstood the autoclaving process far better.
In order to assess the ability to improve this viability further, several common BioMEMS
and microfluidics materials coatings that are typically used in conjunction with 3D printing of
resins in microfabrication were added to the fully postprocessed FormLabs High Temp Resin chips
(Figure 24B). These coatings served to enhance biocompatibility: SU-8 demonstrated 88.89% ±
1.0% viability, polystyrene with 89.80% ± 1.2% viability, Medco/PET lamination with 92.31% ±
2.2% viability, gold with 93.1% ± 1.7% viability, and PDMS with 95.05% ± 0.75% viability. The
polystyrene coating was found to be porous [163], perhaps causing its lower viability numbers.
SU-8 was deposited in the same manner, so we suspect that it may be porous as well. The
Medco/PET lamination had a tendency to be detached from the surface of the chips after extended
exposure to the culture media, which could have influenced the viability obtained. Gold had
surprisingly good viability, which is ideal for exposed electrodes on a 3D-printed polymer surface.
PDMS demonstrated the highest viability of all of the coatings for the FLHTAM01 resin structures,
which resulted in its subsequent use as a coating for the remaining experiments.
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As an additional test for increasing the viability, this resin was subjected to an extended
30-min UV treatment to assess the possibility of potentially increasing the UV postcure time for
enhanced crosslinking of dangling polymer chains. The resulting viability of 92.09% ± 0.46%
(without any material coatings) suggests this is a potential course of action (result not shown in
Figure 24). The FormLabs Clear Resin, when fully treated and PDMS-coated, did demonstrate a
99.42% ± 0.11% culture viability, but it still suffered from failures in the structural integrity of the
material that were induced during the autoclaving cycle. As a result, the usage of High Temp Resin
is preferred for 3D printed architectures.
Other 3D-printing resins may additionally be options in the development of novel
BioMEMS, wearable, and microfluidics devices. In order to enhance the material palette
FormLabs Dental LT (DLFLCL01) [143], FormLabs Flexible (FLFLGR0) [142], and Pro3dure
GR-10 resins [144] were additionally tested after being subjected to post-treatment (IPA wash, 6
min of UV exposure, and autoclave) and material coating (Figure 24C). These resins were selected
because of their commercial availability, and because they are all designated as biocompatible
according to ISO standards [122, 129, 130, 132-136, 138, 139, 151, 152, 164-167]. Since PDMS
showed the best biocompatibility results among all the coatings used with High Temp Resin, it
was used as the coating in the abbreviated evaluation of these other resins. Surprisingly, the Dental
LT Resin, reported as a Class IIA long-term biocompatible resin [143], demonstrated a lower
assessed viability of 85.29% ± 3.4% when compared to the other two resins. Even with the PDMS
coating, the viability was found to be 89.66% ± 2.8%. Flexible Resin demonstrated
biocompatibilities of 90.00% ± 1.7% and 93.10% ± 2.7% respectively for post-treatment and
PDMS-coating, respectively. The drawback for Flexible Resin overall is its opacity, which limits
its use in in vitro biological research requiring transmitted light microscopy, but this resin could
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find applications in wearable microfluidics, for instance [168]. Finally, the GR-10 resin
demonstrated minimal biocompatibility both when fully post-treated (83.33% ± 5.2%) or coated
with PDMS (85.00% ± 2.9%). Biocompatibility with respect to HL-1 [162] is met with all of these
conditions with the exception of post-treated GR-10 structures. The reason for this result is
currently being evaluated.
Additional testing was performed to demonstrate that the reported results were from the
resin chips alone and material interactions with HL-1 cells, and not the result of the cells in the
surrounding well area. Six fully post-treated chips of each of the resins above were adhered to a
well in a 48-well plate and then carefully coated with gelatin/fibronectin solution so that only the
chip was coated. Cell viability was subsequently determined using trypan blue exclusion [169].
The resulting cell viabilities, shown in Figure 24D, mirror those shown in Figure 24C.
Surprisingly, the FormLabs Clear Resin and High Temp Resin performed better overall
than the commercial resins marketed as biocompatible. Obviously, nuanced differences in the
composition of both resins exist; however, the high temperature resin can meet the viability
threshold of 85.00% [162] while maintaining its integrity under higher heat and pressure, a
necessary requirement in microfabrication. The viability of this material can be further improved
with the addition of coating materials such as PDMS. This material appears to be a promising
material for BioMEMS, bioelectronics, wearable, and microfluidics researchers.
HL-1 cells are separated when seeded but grow to form mats (Figure 25A). These mats
subsequently begin to spontaneously beat, a direct measure of healthy, active cardiomyocyte
layers. This can be observed optically and can be interpreted as a direct measure of
biocompatibility since the cells will not grow or beat if their viability is compromised [170]. Cells
were found to spontaneously beat on all the resins except for the GR-10. Cells grown on the
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flexible resin were not optically observed due to the opacity of the material. Images of the cell
growth and matting over the course of the five-day testing period are shown in Figure 25A.
Expected cell growth and matting was observed for Clear Resin, High Temp Resin, and Dental LT
Resin; however, the GR-10 resin showed extensive cell death and minimal growth. Live/dead
fluorescence imaging of the cells on top of the Clear Resin, High Temp Resin, Dental LT Resin,
and the GR-10 resin was performed using a Keyence BZ-X800 Confocal Microscope (Figure
25B). Cells on top of the Clear Resin and High Temp Resin showed excellent viability, while those
on top of the Dental LT Resin and the GR-10 resin showed less desirable viability. This is expected
from the results presented above.

Figure 25 a. Images of HL-1 cell growth over the course of 5 days. Clear, High Temp, and Dental LT resins all demonstrated the
expected cell growth and matting. GR-10 resin, however, had extensive cell death with minimal growth. Confluency, or full cell
coverage of the surface is reached after DIV 5 (five Days in vitro). After this time, the cells begin to overgrow and die. b.
Live/Dead Fluorescence imaging of the HL-1 cells on top of the Clear, High Temp, Dental LT, and GR-10 resins. The cells show
excellent viability on both the Clear and High Temp resins, but poor viability on the Dental LT and GR-10 resins. All scale bars
are 100 µm.
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Conclusions
Through the establishment of the HL-1 cell line, the NanoBioSensors and Systems
laboratory now has a bank of several billion cells. This allows for further passaging of the HL-1
cell line, as well as an extensive future of cellular testing on a variety of biosensors.
Biocompatibility testing can easily be performed on new materials on an as needed basis. These
are being continually performed by the group.
The expansion of 3D printing into the microfluidic and BioMEMS fields has been
suppressed by the lack of transparency in the chemical compositions of commercially available
resins, as well as the minimal amount of biocompatibility data currently available in literature.
First steps towards establishing biocompatibility of various resins with respect to electrogenic
cells, utilizing both post-processing treatments and material coatings have been taken. Specifically,
the results presented here provide a clear pathway toward applying these resins toward 3D
printing-based 2D and 3D microelectrode array (MEA) devices [145, 163, 171], as well as cell
culture wells for use in biosensors [90, 146] and 3D printer extrusion micro-nozzles.
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CHAPTER 4: EXTRUSION PRINTING OF BIOMATERIALS
A portion of the work presented in this chapter has been previously published in IEEE
JMEMS in 2019 [96]. The “home made” bioprinter work has not yet been published but expected
to be submitted to IEEE Transducers 2021.
Introduction
In recent years, 3D printing has been widely accepted as a viable manufacturing technique
and has the potential to revolutionize micro/nanomanufacturing and medicine. In the field of
cellular patterning, 3D printing is known as bioprinting. Using several approaches, biomaterials
are deposited through a computer-controlled dispensing system in designated areas with high
accuracy in the micrometer scale [5] [172]. A variety of 3D printing technologies have been
adapted for bioprinting applications, but the three main techniques that have proven to be most
suited for bioprinting are inkjet printing, laser-assisted printing, and microextrusion (Figure 26)
[173-177]. Each of these techniques has advantages and disadvantages. Laser-assisted bioprinting
is accurate and reliable, but it is suitable only for cell deposition and prone to heating problems
which can cause cell damage [178-180]. Inkjet bioprinting is the most used bioprinting technique.
It is inexpensive, easy to set up because it typically involves the modification of off-the-shelf
printers, easily expandable, high-throughput compatible, digitally controlled, and non-contact;
however, print heads are prone to clogging, shear forces from printing can lead to cell damage,
bioink flexibility is limited because bioinks must fall within a specific viscosity and surface tension
range, and cells are comparable in size to inkjet channels [10, 178, 181-188]. Microextrusion
bioprinting, which is the focus of this work, has a larger nozzle size which leads to less clogging,
is capable of printing bioinks with a large range of viscosities and surface tensions, and is the most
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promising technique for clinical translation; however, it is a higher-pressure printing technique,
which leads to higher stresses, and thus, a possible decrease in cell viability [173, 189, 190].

Figure 26 Schematics of the three main bioprinting methods: a. Laser-assisted, b. Inkjet, and c. Microextrusion [191]

In extrusion bioprinting, material (bioink and cells) is dispensed through a nozzle (or
syringe) using either pneumatic or mechanical pressure (i.e. plunger, screw, etc.). The nozzle
moves in the x and z directions, while a stage moves in the y direction. This gives the user complete
special control of the deposition [192]. Extrusion bioprinting is typically a continuous flow
process; however, in some cases, discrete spots may be able to be deposited [173, 193]. The larger
nozzle size of extrusion printers leads to less clogging than in inkjet printing [189]. This means
that the potential to deposit higher densities of cells exists and that a wider range of bioinks with
varying viscosities can be used.
Commercial extrusion bioprinters are exceedingly expensive (upwards of $200,000); thus,
this technique is often overlooked in laboratory settings despite it being the most promising of the
three major bioprinting technologies for clinical translation [190]. Most “hobby” 3D printers are
extrusion printers, and they are extremely inexpensive and relatively open source now that the
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original patents for this technology (FDM, fused deposition modeling) have expired. For this
reason, there is potential for the cost to greatly decrease and implement all the advantages of this
technique by converting an off-the-shelf printer to a bioprinter, like many have done for inkjet
printing.
In addition to the cost and the ability to “Do it Yourself”, extrusion bioprinting has many
advantages over other techniques. Extrusion printing allows for greater deposition and printer
speed, which can facilitate scalability in a timely manner [194]. Extrusion bioprinting can
accommodate a wide variety of bioinks inks including cell aggregates [195-198], cell-laden
hydrogels [199-202], micro-carriers [203], and decellularized matrix components [204], while
other techniques are only capable of printing cell-laden hydrogels. Additionally, bioprinting at
high cell densities is currently feasible only using extrusion bioprinting [194]. The extrusion
bioprinting process is biocompatible with reasonably small process-induced cell damage and
injury compared to other techniques [192].

Extrusion bioprinting is capable of producing

anatomically correct porous constructs [205], which is challenging with other methods. Most
importantly as mentioned earlier, from an implementation perspective, extrusion bioprinting
techniques are easy to implement and can be used by those with limited exposure to the technology.
The major disadvantage of extrusion bioprinting is the limited resolution. The minimum
feature size is generally well over 100 µm [206]. This resolution is considerably lower than other
techniques [207]. Inkjet and laser-based bioprinting can achieve resolutions of 50 μm and 5 μm,
respectively [208].
Notable work on bioprinting using extrusion techniques has been performed by several
groups. Khalil et.al. spent time working on the extrusion bioprinting of 3D hydrogel scaffolds. In
this study, rat heart endothelial cells were encapsulated in various hydrogel solutions, including
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alginate, fibrin, and chitosan, and printed. Their minimum feature sizes were shown to be 250 μm
[209]. Bertassoni et.al. showed direct-write bioprinting of cell-laden methacrylated gelatin
hydrogels. This work involved printing HepG2 and NIH3T3 cells suspended in a methacrylated
gelatin hydrogel using a commercial extrusion bioprinter (NovoGen MMX Bioprinter). They
showed minimum feature sizes of 500 μm and their hydrogels needed ultraviolet exposure to set
into defined patterns [210].
As discussed in the Introduction section, cell printing has been gaining considerable
traction in the field of biology since the turn of the century. The technology that was first explored
was inkjet printing technology due to the availability of the technique and its application in the
printing of conducting and non-conducting polymers [174, 182]. Utilizing this technique cells were
typically either suspended in a bioink material or printed onto “biopaper” [10, 211-213]. More
recently, this field has progressed to newer, more cell-friendly techniques that are mostly used to
create 3D grafts, scaffolds, and cell structures and cellular spheroids in regenerative medicine and
associated research fields [214].
While most current research focuses on 3D cell laden structures, 2D cell printing can be a
viable technique acting as an alternative to lithographic definition of cells, reducing the number of
cultured cells and the number of steps required to define these cells in a biosensor device; thus,
improving the placement of cells, enhancing sensitivity, imaging, and reducing experimental costs
associated with any cell culture methodology.
Theoretical Background
Shear stress is of primary concern in the bioprinting process [215-217]. Moderate shear
stress has been shown to influence stem cell differentiation, while excessive shear stress can cause
cell rupture by disrupting the cell membrane [215, 216]. Excessive shear stresses caused by the
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small diameter of the printer nozzle, the high speed of printing, and the high viscosity of some
bioinks are easily generated during the printing process [218]. The level and distribution of shear
stress in the nozzle itself are directly influenced by the printing parameters including the driving
force, the printhead structure, and the rheological parameters of the bioink, as shown in Equation
1, where K is the consistency coefficient, l is the capillary length, n is the consistency index, P is
the dispensing pressure, r radial position, and v is the velocity [217].
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The extrusion bioprinting process can be a useful tool for studying cell injury models in
vitro, as it is essential to understand how cells respond to process-induced mechanical stresses
because they alter cell morphology and function [218].
A piezoelectric drop-on-demand printing computational fluid dynamics model simulation,
as well as some experimental work was developed by Shi et.al. to study the shear stress in nozzles
during printing [215]. Their experiments specifically examined the effect of the shear stress on
cell viability and cell proliferation. Their simulations and experiments demonstrated two results
that could translate to extrusion printing: (1) the backflow fluid pushed the fluid that entered from
the inlet down along the wall, which increased the wall shear stress simultaneously, and (2) fluid
viscosity and nozzle diameter have important effects on the value and breadth of the effect of shear
stress. Overall, they found that both cell viability and cell proliferation were decreased with
increased shear stress.

Individually, shear stress seemed to have a greater impact on cell

proliferation when compared to cell viability.
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Figure 27 Model from Nair et. al. showing increased shear stress with increased pressure during the printing process.[218]

Wei Sun and collaborators out of Drexel University in Philadelphia have extensively
studied extrusion bioprinting and its effects on cell viability, as well as determining optimal
printing parameters. Nair et. al. from this group conducted a theoretical study with different
printing process parameters to analyze and quantify how they impacted cell injury [218]. They
also aimed to optimize parameters for printing viable cells.
A phenomenological model that correlated the percentage of live (PL), injured (PI), and
dead (PD) cells to the process parameters nozzle diameter (x1) and pressure (x2) (Equations 2-4), as
well as an analytical formulation to predict the cell viability throughout the system as a function
of the maximum shear stress in the system was developed.
𝐸𝐸(𝑃𝑃𝐿𝐿 ) = 0.8563 + 0.655𝑥𝑥1 − 0.0268𝑥𝑥2 + 0.0061𝑥𝑥1 𝑥𝑥2 − 0.76𝑥𝑥12 + 0.000352𝑥𝑥22

𝐸𝐸(𝑃𝑃𝐼𝐼 ) = 0.037 − 0.0469𝑥𝑥1 + 0.00297𝑥𝑥2 − 0.002754𝑥𝑥1 𝑥𝑥2 − 0.00003488𝑥𝑥12 +
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0.0283𝑥𝑥22

(2)

(3)

𝐸𝐸(𝑃𝑃𝐷𝐷 ) = 0.099 − 0.561𝑥𝑥1 − 0.0242𝑥𝑥2 − 0.00496𝑥𝑥1 𝑥𝑥2 + 0.665𝑥𝑥12 −
0.000321𝑥𝑥22

(4)

They found that the dispensing pressure had more of an effect on cell viability than the
nozzle diameter. The relationship between dispensing pressure and shear stress is shown in Figure
27. In another study, Sun’s group tried to determine suitable printing conditions for embryonic
stem cells to achieve not only high cell viability, but also good printability [219]. Here the
rheological properties of gelatin/alginate bioinks were evaluated to determine the gelation
properties under different compositions, printing temperatures, and holding times.

They

determined that bioinks with longer gelation times resulted in poorer printability. Their live/dead
assay showed that cell viability increased with increased printing temperatures and lower gelatin
concentrations. Furthermore, they determined that there was an exponential relationship between
embryonic stem cell viability and the induced shear stress, shown in Figure 28.

Figure 28 Exponential relationship between cell viability and induced shear stress [219]
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Materials and Methods
Most extrusion-based cell printing relies on micro-dispensing units (commercial syringebased extrusion bioprinters) that are used as designed or with minor alterations to their design.
Such systems are not suited for depositing inks of different viscosities [220]. Micro-dispensing
units still typically use conventional pneumatic extrusion processes, which require homogeneous
bioinks to maintain a constant material flow rate [221].

Altering bioink functionality by

introducing nanoparticles, cells, or biopolymers may induce inhomogeneities resulting in irregular
material flow and nozzle clogging [221]. Additionally, they are expensive, with the cost of such
systems ranging from $15,000 to upwards of $200,000 [222]. This expense makes bioprinting
capabilities unobtainable for many research groups especially in low resource settings. Finally,
micro-dispensing units are not user friendly. They require specialized training for use.
Semi-Sterile Rep-Rap 3D FDM Printer Conversion
The dramatic reduction in implementation costs for bioplotting resulted in the investigation
of a cost-effective printer through the conversion of an off-the-shelf generic fused deposition
modeling (FDM) 3D printer (approximately $150, plus $80 in additional parts) to an extrusion
bioprinter was performed in a semi-sterile environment (Figure 29).

Figure 29 First homemade 3D bioprinter in the NBSS Lab.
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Some preliminary design and experimental work on the printer development were
performed by exchange students (Ms. Sandra Springer and Ms. Sarah Fremgen from Hochschule
Kaiserslautern in Germany) with my guidance (and in collaboration with Dr. Frank Sommerhage,
part-time Research Associate in our lab) that showed proof of concept results for droplet and cell
printing. For the cell printing, HL-1 cells from Dr. James Hickman’s lab were printed in a 3% w/v
gelatin solution at a high concentration (actual concentration was not specified by Ms. Springer).
Cells remained mostly viable, as shown in Figure 30. The size of the deposited dots was quite large
(~1mm radius), and the process was performed under non-sterile conditions. Figure 31 shows 3%
w/v gelatin dots colored with trypan blue for visibility printed with a 30-gauge flat needle. This
image allows for better visualization of the relative size of dots printed with this RepRap printer.

Figure 30 HL-1 cells printed with semi-sterile RepRap printer. a. Initial printed spot with radius of approximately 800 µm. b.
Cells after 2 DIV. c. Zoomed in view of cells after 2 DIV.
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The motion of the original 3D bioprinter was far from smooth, which often resulted in
inaccurate droplet placement. Additionally, the large size and number of parts made the possibility
of moving the printer to a sterile environment nearly impossible. As Figure 29 shows, the syringe
pump is also quite sizable. This led to two specific issues during the printing process. The first
issue was that the size and weight of the syringe pump meant that it could not be attached to the
printer itself. Long tubing needed to be attached to the syringe for printing, which sometimes
clogged. The second issue was that the pump often extruded more bioink than intended due to the
extruder control limitations of the printer.

Figure 31 "Line of dots" produced by the first homemade extrusion bioprinter in the Rajaraman Lab. The dots had an average
radius of about 1 mm.
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Conversion of a Tronxy X1 FDM 3D Printer to a Bioprinter
The limitations of this first printer led to the purchase of a new FDM printer for conversion
to a bioprinter. This new printer needed to be compact yet have a stage large enough to support a
multiwell plate (128 mm x 85.5 mm x 20 mm) [223]. It also needed to be assembled, so that it
could be built entirely inside of the biosafety cabinet to ensure sterility. A Tronxy X1 3D FDM
Printer, shown in Figure 32, was selected, as it fit all these specifications.

Figure 32 Tronxy X1 3D Printer.

The Tronxy X1 printer was fully assembled inside of a biosafety cabinet to ensure sterility
from the onset. All components of the printer, as well as tools, were heavily sprayed with 70%
isopropyl alcohol prior to introduction to the biosafety cabinet. The sterile environment of the
biosafety cabinet needed to be maintained, as well. The polymer extruder was not affixed to the
printer, as a custom-built syringe pump was to be attached in its place.
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Figure 33 Syringe pump schematics. a. and b. Final syringe pump body design. Designed to fit directly onto the extruder plate of
the Tronxy X1. c. Syringe holder designed to keep the syringe fixed to the syringe pump during printing. d. Syringe insert.
Designed to fit rubber syringe gasket for improved performance. The M5 hex nut is glued to the insert to ensure perfectly
coupled movement.

Custom Syringe Pump Design and Development
Measurements of the distance between the screws on the extruder-holder plate fixed to the
printer arm were taken to design a syringe pump that could be fixed to the printer. This distance
was 56.5 mm from center to center. The syringe pump was designed in SolidWorks and 3D printed
on the back-converted RepRap FDM 3D printer in 1.75mm polylactic acid plastic in a rectilinear
pattern with a 25% infill density at 35 mm/s with an extruder temperature of 200°C and a bed
temperature of 60°C. The syringe pump was comprised of three parts: (1) the body (Figure 33A
and B), (2) the syringe holder designed to keep the syringe fixed to the syringe pump during
printing (Figure 33C), and (3) the syringe insert (Figure 33D).
Printer Micro-Nozzle Design and Fabrication
Cells were printed using 30-gauge dispensing needles, as well as 3D printed nozzles. The
3D printed micro-nozzles were designed with a flared output to reduce the physical stress on the
cells [224], thus, decreasing the likelihood of cell death in the nozzle itself. The 3D printed nozzles
were designed in SolidWorks. Outer nozzle dimensions were height of 16.4 mm and width of 6.25
mm at the top and 250 µm at the bottom. The inner nozzle dimensions are 4.25 mm top opening
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with a height of 6.4 mm, followed by a tapered cone area with a height of 5 mm, followed by a 1
mm height by 100 µm cylinder, and finally another cone leading to the opening that starts with a
width of 100 µm and ends with 250 µm opening and is 500 µm mm in height. This design is then
printed on the Asiga DLP 3D Printer in High Temperature (FLAMHT01) resin from FormLabs
(Somerville, MA). After printing, the nozzles were subjected to the post-print treatment described
in Chapter 3 to increase biocompatibility. This treatment includes a six-minute wash in fresh IPA
followed by a six-minute UV treatment followed by autoclaving. The micro-nozzle opening is
rinsed with a syringe of IPA before and after each step to ensure that the opening is clear of any
residual uncured resin.
Results and Discussion
The Tronxy X1 3D printer was successful assembled inside of the biosafety cabinet (Figure
34); thus, making it sterile. After several iterations fixing some design flaws such as no room for
screws on the pump body, blocked screw holes, and realizing that the syringe pump body size
could be reduced, a successful print of the syringe pump was produced and subsequently installed
on the 3D printer. A small screwdriver is needed to attach and detach the syringe holder before
and after each use. This is also kept inside of the biosafety cabinet to maintain sterility.
Initial testing of the converted 3D printer required many test prints. While the focus
remained on dots due to the nature of the sensor design and cell coupling to microsensors in our
laboratory, several other patterns were explored. These patterns can be seen in Figure 35. During
this phase of test, it was found that blanket coating of the plating surface with fibronectin to
encourage cells to adhere to the surface caused full surface wetting upon droplet impact due to the
hydrophilic nature of both the petri dish and the fibronectin [225].
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Micro-nozzles made of high temperature resin were successfully printed and post-treated
using the pre-determined steps in Chapter 3. The nozzles were designed to have 250 µm channel
before the flared opening, as shown in Figure 36A. The actual results of the print are observed in
Figure 36B. Due to the feature size limitations of the Asiga 3D printer, as well as the physical
changes that occur in the resin during the post-print treatments, it was expected that the actual
channel would translate to be less wide. The opening width was found to be 150 µm ± 11.42 µm
(N=3) in the SEM image (Figure 36C), which is a deviation of 100 µm from the design dimensions.
Additionally, the flared opening did not print at all. Instead, the opening is a single channel that
averaged 150 µm wide. The channel prior to the flared opening was designed to be 100 µm, so
there was a deviation of 50 µm from the design here. The remainder of the micro-nozzle
dimensions printed as designed. Table 5 shows the full micronozzle dimensions.
Table 5 Design to printed micronozzle dimensions. Highlighted dimensions differ from design.
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Figure 34 Fully converted Tronxy X1 3D printer. Left: wide view showing the entire set-up including the control box, stage, and
syringe pump. Right: close-up of the syringe pump.
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Figure 35 Cells were printed in a variety of patterns. Initially, the petri dishes were grossly coated with fibronectin. This resulted
in full surface wetting due to the hydrophilic nature of both the petri dish and the fibronectin. To achieve the desired patterns, it
was necessary to print the coating, as well. Printed patterns include dots, lines, and an s-shape.

Figure 36 3D printed nozzle. a. SolidWorks schematic showing the intended design of the nozzle. b. SEM of the full nozzle. Scale
bar is 1 mm. c. SEM of the nozzle outlet. Scale bar is 500 µm.
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Figure 37 Comparison of sizes between spots that were hand plated, printed using a hypodermic needle, and printed using the
3D printed micronozzle. The 3D printed micronozzle provides the smallest spot sizes.

To demonstrate the effectiveness of the 3D printed micro-nozzles, it was necessary to
ensure that the radius of printed spots was reduced. A detailed experiment was carried out to
accomplish this task encompassing hand plating, hypodermic needle-based bioprinting and micronozzle-based bioprinting. Each group was plated in a separate 6-well plate for five days. Media
was changed daily, and cells were imaged daily. Cell growth was monitored over the course of
these five days, and a live/dead assay was performed on the fifth day to assess the viability of the
HL-1 cells through confluency for each condition. The results followed the expected trends very
well over the full assay of five days (Figure 37). The hand plated spots were consistently the
largest. They had a radius of 2,192 µm ± 111 µm when initially plated and grew as expected over
the course of the five days. The radius of the hand plated spots grew by 523 µm ± 81 µm over the
course of five days. The spots printed with the hypodermic needle were the “intermediate” sized
spots, with their average radius being approximately 1,351 µm ± 105 µm when printed and grew
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as expected over the course of the five days. The radius of the spots printed with the hypodermic
needle grew by 470 µm ± 56 µm. Finally, the spots printed with the 3D printed nozzle were the
smallest of the three with their radius being approximately 775 µm ± 49 µm when initially printed.
They also grew as expected over the course of the five days. The radius of the spots printed with
the 3D printed nozzles grew by 188 µm ± 24 µm over the course of the five days. All three
bioprinting conditions demonstrated excellent viability (Figure 38).

Figure 38 Live/Dead confocal images of the three plating conditions. Left: hand plated. Middle: printed using a hypodermic
needle. Right: printed using the 3D printed nozzle. All three conditions showed similar viability, meaning that the printing
process had little effect on the cells. All scale bars are 500 µm.

Precision Cell Plating via Micro-Dispenser Device on an MEA
As presented above, extrusion printed spots of sizes down to approximately 775 µm with
the 3D printed printer micro-nozzles were achieved. These nozzles also demonstrated extremely
good viability, as compared with both hand plating and cells printed with hypodermic needles as
nozzles. By applying theoretical understanding of how shear stress impacts cell viability and
optimizing printing speed, hydrogel viscosity, and micro-nozzle diameter, we were able to design
our printer and adjust its parameters to minimize this shear stress, and thus increase cell viability.
While these results are an improvement over other such 2D extrusion printing with cell-laden
hydrogels, the resolution is still not low enough to allow for ideal cell-electrode coupling in devices
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such as microelectrode arrays (MEAs) with individual electrodes sized at 30 µm and a pitch of
200 µm. While HL-1 cells are great for demonstration and materials testing purposes, the tissue
chips community is moving rapidly toward human cells. These electrogenic cells, such as hiPSCCMs and human motoneurons require vastly improved coupling methods with underlying
analytical tools such as microelectrodes. Additionally, a typical HL-1 cell assay is 5 days in vitro,
while most disease states and organ-chips need to be maintained and monitored a lot longer
(months rather than days).
In this part of the chapter, droplets of media containing a small number of cells were placed
onto protein-coated surfaces using a micro-dispenser device. This research was performed as a
collaboration; thus, our cell printer was not used here due to its limited resolution. This approach
introduces a method of precise, non-lithographic patterning of cells (more specifically electrogenic
cells, human motoneurons and human cardiomyocytes provided by Prof. James Hickman) on
precision nanomaterial enhanced microelectrodes (developed by my colleague in the group, Ms.
Nilab Azim) to increase the probability of cell-electrode coupling, while reducing inaccuracies and
expenses typically associated with cell plating [226]. The precision plating of cells using a microdispenser device was performed in collaboration with Dr. Frank Sommerhage and Prof. James
Hickman’s group at the NanoScience Technology Center in UCF.
Materials and Methods
Human electrogenic cells were cultured as described earlier [227]. In brief, human
motoneurons (Neural Stem, Rockville, MD, USA) and human induced pluripotent stem cells
(iPSCs) differentiated into cardiomyocytes (Cellular Dynamics International, Madison, WI, USA)
were thawed and subsequently plated in a 60mm petri dish coated with 1 mL of laminin (Sigma
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Aldrich, St. Louis, MO, USA) solution for motoneurons or 1 mL of fibronectin (Sigma Aldrich,
St. Louis, MO, USA) for cardiomyocytes three to four days prior to the precision plating step.
Precision plating of the cells on an 8 x 8 Microelectrode Array with precision enhanced
nano-porous platinum microelectrode coating (developed by my colleague Ms. Nilab Azim and
the subject of an accepted paper [163]) was performed using a modified regenHU 3D Discovery
Fluid Dispenser (regenHU Ltd., Villaz-St-Pierre, Switzerland) in a semi-sterile environment. The
programs which controlled the plating patterns were designed with BioCAD (regenHU Ltd.,
Villaz-St-Pierre, Switzerland) or simple GCode. Cells were transferred into dispenser syringes at
densities between 5 x 106 and 6 x 106 cells/mL (standard for both cell types). After precision
plating, the surfaces were placed into an incubator for 20 to 30 minutes to allow the cells to adhere.
For both motoneurons and cardiomyocytes, media with an antimicrobial (streptomycin) and an
antibiotic (penicillin) was used.
Chemical and electrical stimulation, as well as daily spontaneous recordings, of the
precision plated cells were performed to determine the specificity of precision plating. Chemical
stimulation of cardiomyocytes was performed by adding norepinephrine (Sigma Aldrich, St.
Louis, MO, USA) to the culture well in concentrations from 0 μM to 128 μM. Chemical stimulation
of motoneurons was performed by adding glutamate (Sigma Aldrich, St. Louis, MO, USA) to the
culture wells at concentrations from 0 mM to 4 mM. The electrophysiological activity of the cells
was measured by interfacing the MEAs with the Axion MUSE system and AxIS software (Axion
BioSystems, Atlanta, GA, USA). Cells were allowed to stabilize for five minutes, and then cellular
activity was recorded for three minutes before and after each chemical stimulation step.
Human motoneurons were electrically stimulated using a biphasic pulse (-500 mV for 50
ms followed by 500 mV for 50 ms) in the Axion BioSystems AxIS software. Cells were allowed
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to stabilize for five minutes prior to the experiment. Electrodes were selected for electrical
stimulation based on the strong signal amplitudes (>5 μV) exhibited by the cells. The selected
electrodes were stimulated within a three-minute recording window. This stimulation process was
repeated three times and the data was analyzed and averaged.
Results and Discussion
Cellular electrophysiological activity of human motoneurons was measured regularly after
approximately 14 days in vitro (DIV). The precision plated motoneurons produced a classic action
potential with highlighted average, as shown in Figure 39, and demonstrated increased spike
activity throughout their lifetime (Figure 40) [228]. Such classic action potential sequences were
measured across several microelectrodes proving precision plating through micro-dispenser is as
effective as normal hand plating. The cell cultures were maintained and showed successful spike
activity for more than two months in culture (Figure 40).

Figure 39 Example of a clearly repeating action potential for precision plated motoneurons recorded at DIV32 depicting a
classic extracellular action potential signal.

89

Figure 40 The cell cultures were successfully maintained in an in vitro setting for more than two months. The increased spike
activity with error bars and the range of the precision plated cultures is demonstrated for their lifetime.

On the electrodes that were not precision plated, no neuronal activity was seen. This result
demonstrates the power of the precision plating technique and the specificity to which human
motoneurons can be coupled on specific electrodes. In addition to recording, the stimulation
response data was post-processed using MATLAB and plotted in Origin, to show the specificity
of the stimulation. Additionally, specific electrodes were electrically stimulated, eliciting a
response on the stimulated electrodes with no elicited activity on the rest of the device, as shown
in Figure 41. Other researchers such as Wagenaar et. al. showed similar stimulation results with
hand plated neurons [229].
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Figure 41 The stimulated electrode (85) elicited a response from the cells that were precision plated on it. The control electrodes
(3 neighboring channels, 75, 76, and 86) showed some stimulation crosstalk, but the elicited response did not affect the
neighboring channels, nor was there any response elicited in these channels.

Figure 42 The mean spike count of precision plated human motoneurons chemically stimulated with glutamate is depicted as the
normalized data from three active electrodes. The spike activity increases with increased concentrations of glutamate with peak
activity observed at 1 mM. This is followed by a sharp decrease in spiking to zero, known as hormesis.

91

Chemical stimulation of motoneurons with glutamate showed a dose-dependent increase
in spike activity peaking at about 1 mM (Figure 42). The observed activity dropped to 0 Hz when
4 mM of glutamate was added to the culture well. This follows the work of Jiang et. al., which
showed that low levels of activation of receptors by glutamate engages the stress response
pathways of the neurons, but excessive activation of the receptors by glutamate kills the nerve cells
because of excitotoxicity [230].
Precision plating successfully allowed the human motoneurons to have localized growth
on specific electrodes, while preserving their expected electrophysiological behavior during
culture, as well as during stimulation. The electrical stimulation of specific electrodes was possible
with minimal to no interference from surrounding electrodes and minimal stimulation effects on
these electrodes. Precision plating offers a convenient method to yield significant results from
small populations of motoneurons cultured in synaptic isolation on the same device.
For human cardiomyocytes, cellular activity was measured on a regular basis starting after
2DIV. The precision plated samples showed a classic cardiac signal with uniform beat periods,
which varied from channel to channel due to the isolated populations. No signal was detected from
electrodes that were not precision plated. Cardiomyocyte chemical stimulation depicted a steady
decrease in cardiac action potential length with increasing concentrations of nor-epinephrine
(Figure 43). Figure 43 also shows that the frequency (in beats per minute) increased with increasing
concentrations of nor-epinephrine. The observed IC50 (concentration of an inhibitor where the
response is reduced by half) of approximately 5 μM agrees with values reported in literature as
depicted in the figure [231].
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[231]

Figure 43 Cardiac dosing data – Top: Beat period reduction with varying concentrations. The beat period decreases with
increasing concentrations of nor-epinephrine; Bottom: Beats per minute increase with increasing concentrations of norepinephrine in agreement with literature.

Precision plating allowed for small populations of cells to be placed precisely on and
around a specific electrode, or a group of electrodes, as opposed to classic techniques, such as hand
plating where cells tend to cover the entire surface area. As a result, precision plating is cost
effective compared to standard plating, which becomes significant in the case of expensive human
stem cells. The developed method becomes advantageous when optimizing for applications such
as personalized medicine where the number of cells that can be isolated from a diseased patient is
going to be limited and as a result maximal efficacy of plating of these cells is required. Figure 44
depicts “dot” pattern plating, as well as “semi-circle” pattern plated on a microelectrode and a grid

93

of electrodes, respectively. The “dot” pattern is intended to specifically cover one electrode with
cells and was the focus of this study; however, the “semi-circle” pattern demonstrates the
flexibility of this plating technique for future applications. Optically monitoring the “dot” pattern
on a device over time shows the change, or blurring, of the pattern for up to 30DIV. The precision
plated populations of motoneurons remained in nearly the same area for approximately 30 days,
as shown in Figure 45; however, an increased spot-size from approximately 150 μm to 360 μm in
diameter (N=3) indicated that the cells remained mobile and blurred the initial dot size. This
indicated the growth and survival of a healthy human motoneuron culture throughout the lifetime
of the cells.

Figure 44 Hand plating versus precision plating of human motoneurons – a. Cells hand plated on a device show a confluent
layer of cells. The cells are randomly distributed on the grid of microelectrodes; b. Cells precision plated in a spot right on top of
an electrode. The cells are plated in a specific area. c. Cells precision plated in an arc pattern. The cells only appear in the
designated area.
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Figure 45 Tracking of a precision plated spot of human motoneurons over time. The spot size increased over time, which shows
that the culture was healthy and growing. This observation held for N=3 experiments for approximately 30 days.

Summary
Classic cell plating techniques are useful when an overall picture of electrogenic cellular
activity is required for cells that are available aplenty. This precision plating technique developed
here allows for an order of magnitude or more improved coupling with electrodes, passive
recording responses for a long time (in excess of 2 months) as well as the study of electrical or
chemical stimulation responses of small populations of cells (valuable cells such as human cells
that are difficult to attain) on specific electrodes, or groups of electrodes. While the converted
micro-dispenser used here was extremely effective and could selectively couple on to 30 µm
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microelectrodes that are spaced 200 µm apart, the converted Tronxy X1 3D printer provides an
excellent “do-it-yourself” solution for cell printing. Although the printing resolution is still limited
to approximately 775 µm, it still provides better cell-electrode coupling than grossly plating a
biosensor device in addition to improving specificity and reducing costs of cell culture. This
resolution can be improved with higher resolution micro-nozzles. Moving forward such a
technique will be invaluable to emerging areas such as personalized medicine and “patient on a
chip”.
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CHAPTER 5: CELL-BASED BIOSENSOR PLATFORMS – nIDEs AND
pIDEs
Adverse cardiac events are a major cause of late-stage drug development withdrawals.
Improved in vitro systems for predicting cardiotoxicity are of great interest to prevent these events,
improve heart-on-a-chip models, provide greater experimental control, improve specificity, and to
reduce costs involved in the introduction of cardiac drugs into the marketplace. Additionally,
retinal pigment epithelial cells serve as regulators in the eye. Through the expression and activity
of specific proteins, this cell layer oversees the transport of nutrients and waste to and from the
retina [232, 233]. The ability of the retinal pigment epithelium to properly express and activate
these specific proteins becomes compromised with age and with other conditions that cause
toxicity.

This can lead to blindness.

Such diseases of interest are Age-Related Macular

Degeneration and Diabetic Retinopathy. Improved in vitro systems for studying the relationship
between blindness and the retinal pigment epithelium is of great interest to many researchers.
Interdigitated electrodes (IDEs) affixed with a culture well provide a simple, suitable
solution for in vitro analysis of cells because of their high sensitivity, ease of fabrication, and labelfree, nondestructive analysis. Culturing cardiomyocytes onto these IDEs allows for the use of the
IDE–cell combination in predictive toxicity assays. IDEs with smaller interdigitated distances
allow for greater sensitivity, but typically require cleanroom fabrication. Here the definition of a
simple IDE geometry on a printed nanostructured substrate, demonstrate a Cellular Index (CI)
increase when compared to an IDE on a planar substrate is reported. The nanostructuring results
in an increased sensitivity of each electrode gap width investigated. An additional measurement
modality may be introduced for the first time to our knowledge through plasmonic resonance
enhancement, thus a plasmonic interdigitated electrode (pIDE). The entire nanostructured IDE
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(nIDE) is fabricated and assembled in a rapid nanofabrication environment; thus, allowing for
iterative design changes and robust fabrication of devices. Both impedimetric and plasmonic
modalities are combined and demonstrated together. Further sensitivities from individual sensing
modalities have been isolated and studied separately.
Hypotheses and Publications
Several hypotheses are being evaluated in this chapter. The first hypothesis was that the
interaction of the nanostructured PAN substrate with the electrodes should increase the sensitivity
of the IDEs, and as a result, electrodes with a larger pitch should have the same performance as
electrodes that are orders of magnitude smaller on standard, planar substrates. The second
hypothesis was that the nanostructured PAN substrate layer can exhibit surface plasmon resonance.
Finally, the third hypothesis evaluated was that through careful experimental design the individual
contributions of each mode to the sensitivity enhancement can be determined: geometric,
nanostructured surface, and plasmonic. In summary, through the combination of fabrication and
measurement techniques the sensitivity of interdigitated electrode-based biosensors can be
dramatically enhanced by several orders of magnitude.
Some of the work in this chapter has been previously published in Biosensors in 2018 [90]
and IEEE JMEMS in 2020 [146], and will be presented at the 30th Anniversary World Congress
on Biosensors in Busan, South Korea in July 2021.
Introduction
Drug-induced cardiotoxicity accounts for one-third of safety-based withdrawn
pharmaceuticals, making it the number one cause of drug withdrawal, limitation, and development
termination [14-16]. As of 2016, the Tufts Center for the Study of Drug Development estimates
the cost of developing a new drug is on an average 2.89 billion US dollars [234]. Because of this
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high cost, improved in vitro systems for predicting drug-induced toxicity are of great demand in
the pharmaceutical industry to decrease late-stage drug attrition, advance rapid development, and
reduce monetary loss [15, 16].
Interdigitated electrodes (IDEs), which are generally comprised of two individually
addressable, interwoven, comb-like electrode structures, are one of the most favorable and widely
used transducers as chemical and biological sensors because of their low cost, high sensitivity, and
ease of fabrication [12]. By affixing a culture well to the IDE substrate, a biosensor can be easily
fabricated. This allows for cells to be cultured onto the surface and assessed with label-free
electrical and optical assays. A low-voltage signal induces a current between the IDEs. The cells
on the electrodes at the bottom of the culture well impede this current, and a change in impedance
results [14]. Measuring this impedance change across these electrodes gives an indirect measure
of the number of cells in each culture well, as well as an assessment of the interaction between the
cells and electrodes [15]. Cellular impedance measurements are useful for studying cell growth
and drug interactions in vitro without the use of destructive labelling procedures with fluorescent,
chemiluminescent, or radioactive chemicals [235]. Recently, these efforts are gaining industrial
acceptance with efforts of collaboration between various electrode manufacturers to introduce
rapid assays with uniform standards across industrial and academic testing laboratories for testing
cardiotoxicity [236].
Electrochemical impedance spectroscopy (EIS) can be combined with surface plasmon
resonance (SPR), as they are two of the most widely applied label-free monitoring methodologies
for cell-based biosensors [90, 237]. They are both non-invasive and allow for continuous
monitoring of cells over a long time; however, they are each based on different physical principles
and provide different types of information about the cells [237]. A combination of EIS and SPR
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measurements could provide a powerful means to monitor cells that overcomes the molecular
specificity of each of the individual techniques. Such measurements are useful in monitoring cell
growth, studying drug interactions, toxicity, safety, etc. all in a label-free fashion [12].
A nanoscale biosensor with thin, gold IDEs on a nanohole array substrate with dual-sensing
capabilities has been realized. SPR is induced by illuminating the surface with light having a
wavelength equivalent to the plasmonic resonance peak [238]. Exciting the surface plasmons while
measuring the impedance of the biosensor simultaneously results in increased device sensitivity.
These two simultaneous modes are further subdivided into geometric, surface conditioning,
plasmonic and other considerations.
Predictive toxicity assays on IDEs based on human pluripotent stem cells may aid in
predicting potential safety issues of drug candidates early in its development process, provide
information about the mechanisms of drug-induced organ toxicity, reduce the reliance on animal
testing, and increase the relevance of preclinical safety tests [15, 16, 236]. Human induced
pluripotent stem cell (iPSC) differentiated cardiomyocytes are the ideal candidate for
cardiotoxicity cell-based studies. They exhibit the molecular and functional properties of an intact
human heart, and their electrical signatures can be monitored using non-destructive impedance
sampling [15].
Several IDE and impedance-based biosensors exist, but many of them require the use of
expensive commercial systems [13-20, 239] for data analysis and involve cost prohibitive
cleanroom-based fabrication approaches for the IDE micro and nanostructuring [21]. These
systems use densely packed electrodes, which cover much of the substrate surface and prohibit
optical tracking of cells. Other approaches integrate microelectrode arrays with IDEs, which
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allows for more comprehensive measurement at the cost of more complex fabrication processes
[15].
Bioimpedance sensors offer an inexpensive, label-free solution for MEMS-based medical
diagnostics and cell tissue research. Typically, interdigitated electrodes (IDE) are used where high
sensitivity and high selectivity are desired. The output sensitivity and selectivity of an IDE is
controlled through careful design of the active area, width, and spacing of the electrodes. Improved
sensor impedance is achieved when the electrode spacing is comparable to the length of the
biomolecule of interest (typically 1 nm to 100 nm) [11, 178, 240]. In addition, the concentration,
growth, and alteration of the physiological state of cells during cultivation can be detected as
impedance changes [241].
One of the goals for cell-based bioimpedance studies is to maximize the device sensitivity.
“Circle-on-line” electrode array geometries are one way to improve the signal strength via greater
electrode surface area, thus increasing sensitivity. Another way is through decreased electrode
gaps. Most IDE biosensor studies have demonstrated a micron scale electrode gaps (minimum of
5 µm) [2, 3, 21, 92, 241-243]; however, some groups have demonstrated sub-micron electrode
gaps (300 nm or 500 nm) fabricated through wet etching and hot embossing lithography (typically)
for studying DNA [4, 244, 245]. Figure 46 shows some recent work with IDE biosensors [17, 246,
247].
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Figure 46 a. Indium tin oxide IDE on glass substrate fabricated via laser micromachining by Tandon et. al. Electrodes are 200
µm with 200 µm gaps. Scale bar is 200 µm. b. Screen printed silver/silver chloride IDE biosensors fabricated on a glass slide by
Mansor et. al. Electrodes are 400 µm wide with gap widths of 300 µm, 400 µm, and 500 µm. c. Zinc oxide IDE on silicon
substrates fabricated using conventional photolithography and etching techniques by Tasakaren et.al. Electrodes are
approximately 200 µm apart and 16 µm wide.

Bioimpedance sensors are an active commercial area of research, as well. Several
commercial systems for impedance-based biosensors exist; however, the cost is typically high, and
the main one requires specific form factors for devices. ACEA Biosciences [248] produces several
IDE-based systems (Figure 47) with “circle-on-line” electrodes of varying electrode gap widths
from 10 µm to 100 nm. Their system is essentially a form-specific impedance sensor with a special
software that converts impedance measurements to other useful metrics (cell index, beat period,
etc.). Their system is label-free, has high sensitivity, and allows for cells to be followed in real
time; however, the culture plates are not reusable, have transparency issues, are restricted to a fixed
form factor and are expensive. The approximate cost of their basic system is $200,000 with the
microsensor plates (Figure 47) costing $70 or more each, depending on the electrode gap width
and other features.
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Figure 47 Top: One of ACEA Biosciences current systems. This system is designed specifically for cardiac cells and is featured
in many of the cited papers within this chapter. Bottom: An example of one of the specially designed well plates required for
using ACEA’s systems.

Here a new impedance-based sensor that allows for long term in vitro cellular analysis with
high fidelity is presented. IDEs are placed atop a nanostructured polyacrylonitrile (PAN) substrate,
whose geometry is designed to maximize the interaction with the electrodes and cells. As a result,
the device is fashioned as nanostructured Interdigitated Electrodes (nIDEs). Both the IDE and the
nanostructured PAN substrate are fabricated utilizing the “Rapid Micro/Nanofabrication
Approaches” presented in the previous chapters in this dissertation.

This results in cost

effectiveness, rapid translation from design to a fabricated device, utilization of direct write
techniques, and the ability to reduce drug candidate testing times by an order of magnitude or more
with dramatically increased sensitivity despite coarser geometries.
Theoretical Background
Here, some basic theory behind impedance and plasmonics is presented.
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Figure 48 Simplified Randles circuit.

Impedance Theory
Impedance is the opposition of the flow of alternating current in a complex system when a
voltage is applied. Impedance is essentially the representation of resistance in an AC system.
Instead of just having a magnitude, it becomes complex and is comprised of both a magnitude and
a phase, i.e. real and imaginary parts [239]. In biosensor research, we measure impedance by using
electrochemical impedance spectroscopy (EIS). EIS allows for the study of the interface between
an electrode and an electrolyte, which is typically cellular medium in the case of this type of
research.
The simplest, but also most reasonable representation of EIS for the applications presented
within this dissertation, is the simplified Randles’ equivalent circuit [249-251]. This circuit,
pictured in Figure 48, is comprised of three components: (1) a solution resistance (Rs), (2) a charge
transfer resistance (Rct), and (3) a double-layer capacitance (Rdl). The solution resistance is simply
the resistance of the electrolyte. The charge transfer resistance is the resistance against the process
of electron transfer from one phase to another, in this case between the electrode and electrolyte.
Finally, the double-layer capacitance refers to the polarization of ionic charge at the surface of
electrodes in EIS systems. The capacitance here is directly related to the electrode surface area
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and the size of the ions. The double-layer capacitance increases with increased electrode surface
area. The complex impedance of a simplified Randles’ circuit is given in Equation 1 [249].
𝑍𝑍(𝜔𝜔) = 𝑅𝑅𝑠𝑠 + 1+𝑅𝑅

𝑅𝑅𝑐𝑐𝑐𝑐

𝑐𝑐𝑐𝑐 𝐶𝐶𝑑𝑑𝑑𝑑 𝑖𝑖𝑖𝑖

(1)

The complex impedance can be further separated into its real and imaginary parts given by
Equation 2 and Equation 3, respectively [249].
𝑅𝑅
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𝑐𝑐𝑐𝑐 𝑑𝑑𝑑𝑑

(2)

(3)

When cells are cultured on the IDEs, they are added to culture dishes in suspension. At
this point, the cells are spherical in shape. As the cells begin to reach the substrate, attachment
sites begin to form, and the cells gradually transform from spherical to a flattened shape and the
morphology becomes “spread out”. This process generally takes two to four hours for most
cultured cells [251]. The individual cells maintain this morphology until they divide, at which
time they once again become rounded, furrow, and divide forming two cells. These two cells,
termed daughter cells, spread out until another division occurs and the process continues. All these
processes impact the double layer capacitance of the IDEs and hence changes to the impedance
are observed.
Plasmonic Theory
Plasmonics is comprised of the science and applications of noble metal structures that can
guide and manipulate visible light at the nanoscale. The optical properties of metals are partially
determined by the resonant interaction between light and their surface free electrons at a metaldielectric interface [252].

These longitudinal surface change density waves of conduction
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electrons coupled to light are called surface plasmon polaritons (SPPs). To excite SPPs on a
surface using light, additional momentum must be provided either by patterning a grating structure
on the film or by evanescent coupling of light into the metal. Resonant excitations of these optical
fields, also called surface plasmon resonances (SPRs), are sensitive to the dielectric materials that
are in contact with the metallic surface [253]. SPRs in the visible/ near-infrared wavelength range
are of interest because there is favorable optical confinement at these wavelengths [253].
Nanohole arrays exhibit peculiar and complex optical properties due to the presence of
both localized and propagating plasmons, as well as their interacting effects [254]. The extinction
spectrum of nanoholes in thin films contains one peak, called a transmission minimum, that
corresponds to the grating-coupling SPR for the bonding mode [254]. Transmission of normally
incident light through nanohole arrays is enhanced at the wavelengths that satisfy the SPR
conditions given by [252, 255]:
𝜆𝜆𝑆𝑆𝑆𝑆 (𝑖𝑖, 𝑗𝑗) =

𝑃𝑃
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𝜀𝜀𝐴𝐴𝐴𝐴 𝜀𝜀𝑑𝑑

�𝜀𝜀
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Here, P is the periodicity of the nanohole array, i and j are integers, εAu is the permittivity
of gold (or whatever metal is used), and εd is the permittivity of the substrate adjacent to the metal.
Effective coupling of light energy by designing nanohole arrays as per Equation 4 and defining
metal layers of precise thickness can elicit a plasmonic signature in IDEs which has been
extensively studied in this chapter for cell-based biosensing applications.
Materials and Methods
This section contains the materials and methods used throughout this chapter.
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Figure 49 a. Schematic of nIDE device: A nanostructured polyacrylonitrile (PAN) layer is affixed to a glass substrate. A gold
Interdigitated Electrode (IDE) structure is then patterned on top using a shadow mask. Finally, a 3D printed culture well coated
with PDMS is attached to enable the IDE to be used with biological specimens. b. Process flow for spin-on nanoimprinting
(SNAP) fabrication of PAN nanostructures. c. Fully assembled device being plated with polystyrene beads/ cardiomyocytes.

Design of the nIDEs/pIDEs
SolidWorks (Dassault Systems, Waltham, MA, USA) was used to design the interdigitated
electrodes and the culture wells. A schematic of the nIDE device and its components are depicted
in Figure 49a-c. The gold IDEs are designed to be 800 μm wide and 1 mm long with a pitch of
either 1 mm, 250 µm, 100 µm, 64 µm, 10 µm, or 7 µm and a thickness of 30 nm, which gives a
peak resonance wavelength between 620 nm and 750 nm [256]. The resonance peak red shifts as
the thickness of the gold increases. At times, there were issues with the e-beam shutter that led to
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some thickness variation. Additionally, the Thermionics e-gun power supply and controller were
upgraded which seemed to consistently deposit a thickness to approximately 50 nm on the devices.
The nanostructured chip is comprised of a 5 mm by 5 mm nanomachined PAN layer of 10 μm
thickness with 50 nm nanoholes with a pitch of 200 nm. The fully assembled chip is designed to
be 10 mm by 10 mm.
The pitch of the electrodes was varied for each experiment. Initially, we focused on 1 mm
IDEs as our tool optimized to fabricate shadow masks at the time was the micromill which was
not optimized for micrometer feature sizes in 2018. As a result, the shadow masking was switched
to the laser micromachining tool. After optimizing the laser micromachining tool discussed in
Chapter 2, we were able to fabricate a much wider variety of shadow mask pitches, so the natural
progression of sizes came from starting at 1 mm and halving the value in succession. This led to
the use of the 250 µm, 64 µm, and 7 µm pitched electrodes. From these results, we were able to
determine that relating sizes by a factor of 10 would allow for more straightforward hypothesis
formation and result comparison. This led to the use of 1 mm, 100 µm, and 10 µm pitched
electrodes.
Fabrication of the Nanostructured Substrates
The PAN nanostructures and planar PAN substrates used in this work were fabricated by
Kowsik Sambath Kumar in Dr. Jayan Thomas’ Laboratory.
Typical methods for the fabrication of nanostructures include methods like
photolithography [257], e-beam lithography [258], and focused ion beam lithography [259]. Even
though these methods offer high quality nanostructures, they involve tedious procedures, long
processing time, limited scalability, and high cost. To achieve scalability, bottom-up approaches
like self-assembly have been used, but they are limited to select materials, and pattern versatility
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cannot be easily achieved using this approach. Sacrificial anodic aluminum oxide (AAO) templates
for developing nanostructures are also widely used [260] for fabricating nanostructures; however,
the sacrificial nature of AAO and the required use of strong chemical etchants places a serious
limitation on this method. Several unconventional lithographic methods have been developed to
circumvent the limitations posed by conventional lithographic techniques. Among these
techniques, nanoimprinting lithography (NIL) [261] has attracted considerable attention. In NIL
technique, many nanostructures can be replicated using an inexpensive NIL machine from a master
mold. The feature size depends on the mold used to print the nanostructures. These nanostructures,
pictured in Figure 50, can subsequently be used as substrates for various applications, including
interdigitated electrodes.

Figure 50 SEM of the mold used to fabricate the nanostructures.

Recently, the Thomas group developed a spin-on nanoimprinting process (SNAP), shown
in Figure 49b, to make nanostructures rapidly [262-264]. A polymer solution is prepared by
dissolving 8 wt.% of polyacrylonitrile (PAN, Mw=150,000) in dimethylformamide and heated at
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150 °C for 5 minutes. The PAN solution was then cooled and spin-coated on a pre-made Si mold
with the inverse of the pattern to be printed. The PAN film was subsequently peeled-off from the
mold, transferred to a glass substrate, and cured at 250°C. SNAP technique does not need high
temperature, pressure, or any other force during the printing process. We have successfully
developed nanoholes as small as 50 nm on PAN films to make IDEs. The silicon mold fabrication
is a one-time event and several 100s of nanostructures can be printed using the SNAP process from
the same master mold without any degradation [263].
Investigation of the Uniformity of the E-beam
Since thickness of the metal film deposited onto the nanostructured substrate is a key factor
in the device’s plasmonic performance, it was decided to investigate the uniformity of the e-beam
deposition. Standard sized microscope cover slips (22 mm x 22 mm x 1 mm) from Fisher Scientific
were placed on the 14 cm diameter sample holder to entirely cover the holder. A 30 nm gold metal
film as indicated by the quartz crystal monitor on the system was deposited onto the glass cover
slips using electron beam evaporation (Thermionics, Hayward, CA). Kapton® tape was affixed to
the center of each slide to create a step for thickness measurement. Thickness of the deposited
metal was measured using a Dektak3 surface profilometer (Veeco, Plainview, NY).
Fabrication of the nIDEs/pIDEs
The initial 1 mm pitch IDE shadow masks were fabricated using the IDE designs by
micromilling. A 90-degree T-8 Mill Tool (150 µm - 250 µm diameter; T-Tech, Peachtree Corners,
GA, USA) was spun at 55,000 rpm in a T-Tech J5 Quick Circuit Prototyping Systems to micromill
through an 80 μm thick stainless-steel sheet (Trinity Brand Industries, Countryside, Il, USA).
All subsequent shadow masks were fabricated on 12.5 µm Kapton® (DuPont, Wilmington,
DE) using 355 nm UV light at 50 Hz from a multimodal laser micromachining tool (QuikLaze
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50ST2, New Wave Research, Portland, OR). Masks were fabricated using two passes: the first to
cut through the Kapton®, and the second to ensure that the shadow mask had smooth edges.
The shadow masks were affixed to the 5 mm by 5 mm squares of nanomachined PAN atop
a glass carrier substrate using Kapton® tape. A metal film comprising of 30 nm to 50 nm of gold
(depending on whether the new or old e-beam system was used) was deposited onto the
nanostructured PAN/glass substrate (Figure 49a) using electron beam evaporation (Thermionics
Laboratory Inc., Hayward, California, USA) to metallize the interdigitated electrodes. The shadow
mask was released carefully after the metallization step to reduce the damage to the underlying
nanostructures.
Initially, to package the nIDE device, a 3D printed (Form2, FormLabs, Somerville, MA,
USA) culture well (10 mm inner diameter, 10 mm tall) was dip coated with polydimethylsiloxane
(PDMS) in its entirety to improve biocompatibility of the printed resin material [265], and attached
to the substrate using biocompatible 353ND epoxy (Epotek, Billerica, MA, USA) [266]. After
determining that post-printing treatments could improve the biocompatibility of the 3D printer
resin, culture wells were subsequently fabricated out of FormLabs High Temperature Resin
(FLHTAM01) (FormLabs, Somerville, MA) and 3D printed in an Asiga MAX UV27 DLP (digital
light processing) printer (Asiga, Sydney, Australia). After printing these culture wells were rinsed
with IPA for 6 minutes, then UV cured for 6 minutes, and autoclaved for one hour. These culture
wells were subsequently affixed on to the PAN/glass substrates using biocompatible 353ND epoxy
(Epoxy Technology, Billerica, MA).
Lead wires of sanded copper were subsequently attached to the contact pads using an
E2101 electrically conductive silver epoxy (Epotek, Billerica, MA, USA). The silver epoxy was
then covered with 353ND epoxy to ensure that the wires remained attached for the entire culture.
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Polystyrene Bead Assay
Prior to the cardiomyocyte assay, polystyrene (PS) latex beads of 1.1 μm particle size and
concentration of 0.1 mg/ml in De-Ionized (DI) water (Sigma Aldrich, St. Louis, MO, USA) were
used to emulate a cell-like material (Figure 49c). The aqueous suspension of PS latex beads was
diluted with DI water in a ratio of 1:10 and the diluted solution was uploaded into a syringe and
transferred to the culture well of the IDE device. The impedance measurements, using a frequency
sweep from 10 Hz to 10 MHz, were performed on an IDE fabricated on a PAN nanomachined
layer with a nanohole diameter of 50 nm and a pitch of 200 nm using a BODE Impedance Analyzer
(Omicron Labs, Klaus, Austria). The reported impedance values are an average of two devices
(N=2).
Cell Culture
The protocols for the different cell cultures used in this chapter are described in this section.
iCell Cardiomyocytes
Human induced pluripotent stem cell (iPSC) differentiated cardiomyocytes (iCell
Cardiomyocytes2, Cellular Dynamics, Madison, WI, USA) were used for cell studies. The iPSC
cardiomyocytes were kept frozen in liquid nitrogen until they were cultured according to the
manufacturer’s directions. To ensure that the cells adhere to the surface, the IDE devices were
coated with 5 μL of 1:20 fibronectin (Sigma Aldrich, St. Louis, MO, USA) and Dulbecco’s
Phosphate-Buffered Saline (DPBS) without Calcium and Magnesium (Gibco, Waltham, MA,
USA) solution and placed in an incubator (37°C with 5% CO2) for one hour. Cells were thawed
and counted to determine the density. This task was performed by mixing 100 μL of cells
suspended in media with 0.4% Trypan Blue (Fisher Scientific, Waltham, MA, USA). A droplet of
100 μL of this solution was subsequently applied to a glass hemocytometer and placed under a
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10X microscope objective of a Nikon TE200 Inverted Fluorescence Microscope (Nikon, Tokyo,
Japan) for observations. Live, unstained cells were counted in each of four sets of sixteen squares.
The cell counts from each of the four sets of squares was averaged and multiplied by 10,000 and
then multiplied by 5 to correct for the 1:5 dilution from the Trypan Blue addition. The fibronectin
was aspirated, and the thawed cells were plated onto the nIDE surfaces (N=8) and two 6-well
plates (control Polystyrene Plates from Corning Inc., Corning, NY, USA) and incubated for one
hour (at 37°C with 7% CO2). A measured droplet of 300 μL of iCell Cardiomyocytes maintenance
medium (Cellular Dynamics, Madison, WI, USA) was subsequently added to each of the eight
culture wells and the controls. Full media changes occurred every other day. Eight nIDE devices
were densely plated with iCell cardiomyocytes with an average cell count of 310,500 cells per
culture well. Each of the two 6-well plates (controls, N=12 wells) were plated with an average cell
count of 50,000 cells per well for the experiment that used these cells.
iCell Retinal Pigment Epithelial Cells
IDEs and nIDEs were prepared for cell culture by coating with 5 µL of 1:20 fibronectin
(Sigma Aldrich, St. Louis, MO) and incubated for 1 hour. To thaw the cells 25 mL of medium
were warmed to room temperature. From this solution, 8 mL of medium were transferred into a
sterile 15 mL centrifuge tube. The cryovial containing the cells was thawed in a 37°C water bath
for 3 minutes. The cells were then transferred to the centrifuge tube containing the 8 mL of
medium and the cryovial was rinsed with 1 mL of medium, which was then also transferred to the
centrifuge tube. The cells were centrifuged at 300 x g (~1,000 rpm) for 5 minutes. The supernatant
is aspirated and discarded. The cells were then resuspended by adding 2 mL of medium to the
centrifuge tube and gently mixing with the pipettor. A selected quantity of 50,000 cells were
cultured onto each device. Media was exchanged every 2 days.
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HL-1 Cells
HL-1 cells were passaged from T75 flasks and resuspended according to the protocol in
Chapter 3. A selected quantity of 50,000 cells were seeded onto each IDE device and medium was
exchanged daily.
Biocompatibility Assay
After one day in vitro (DIV01), nanostructured PAN was placed in the 6-well plate that
was plated with approximately 50,000 cardiomyocytes. Biocompatibility studies were performed
in the 6-well plates at DIV07 (days in vitro) to ensure that the nanostructured PAN surface was
suitably compatible with the iCell cardiomyocyte cell line. This study was performed using the
Promega Cell-Titer Glo Luminescent Cell Viability Assay Kit (Promega, Waltham, MA, USA). A
volume of reagent measuring 0.5 mL, was added to each culture well and mixed for two minutes
to induce lysis. The 6-well plate was incubated at room temperature for ten minutes to stabilize
the subsequent measurement of a luminescent signal. Luminescence was recorded using a Tecan
Infinite Pro 200 plate reader (Tecan, Männedorf, Switzerland) with the emission wavelength set
at 500 nm, the excitation wavelength set at 365 nm, and an integration time of 10 seconds. The
background and control measurements with only media in the culture well and media with cells in
the culture well, respectively, were performed in addition to the nanopatterned PAN
measurements.
Impedance Measurements
Electric cell-substrate impedance sensing (ECIS) was used to characterize the
electrochemical properties of the cell-substrate interface. A low-voltage signal is applied to the
nIDEs, which forms ionic currents in the cell culture medium. When cells are located on the nIDEs,
these ionic currents are affected by the number, morphology, and adhesion of these cells [18].
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Impedance will gradually increase during the normal cell growth and proliferation process; thus,
as more cells become attached to the nIDEs, an increase in electrical impedance is expected.
For the impedance measurement, a full spectrum of the frequency range from 10 Hz to 10
MHz, with an AC voltage perturbation of 20 mV, were scanned using BODE 100 impedance
measurement station (Omicron Labs, Klaus, Austria) Figure 51a. Impedance was normalized
using the cell index (CI) calculation [20, 239], which is represented in Equation 5, where ΔZ is the
change in real part of impedance from day to day and Zo is the background impedance on the nIDE.
CI = ∆Z ⁄ Zo

(5)

Since drug-induced cardiotoxicity is of great interest with these biosensors, impedance
measurements were additionally performed on the nIDEs with cultured iPSC cardiomyocytes
utilizing different concentrations of norepinephrine (Sigma Aldrich, St. Louis, MO, USA) as a
model drug compound. Concentrations of norepinephrine ranging from 0 μM to 250 μM were
introduced to the culture well and impedance was measured to detect any changes due to the
addition of the model drug. Cell index results from the model drug experiments were further
normalized by using the percent cell index (%CI) [20, 239], represented in Equation 6, where CIo
is the cell index with no norepinephrine and CIc is the cell index for a specific concentration of
norepinephrine.
%CI = CIc / CIo x 100

(6)

Normalization of cell index calculations is an established calculation for such assays with
IDE based approaches and this task was performed to compare our approach with others in this
space.
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Figure 51 a. Bode 100 impedance sensor schematic. The IDE device is attached via alligator clips to the output and channel 2
to allow for a series through impedance measurement. b. Agilent Cary 300 UV-Vis spectrometer used for plasmonic peak
measurements. Device is attached to a pinhole card and placed inside the chamber to determine peak. The pinhole is shifted to
multiple locations to allow for more comprehensive characterization.

UV-Vis Measurements
UV-Vis spectroscopy measurements were performed using an Agilent Cary 300 (Agilent,
Santa Clara, CA) UV-Vis Spectrometer (Figure 51b). Absorbance spectra of IDEs and nIDEs both
with and without cells were measured using a solid sample pinhole card positioned over one of the
gold electrodes. A planar PAN substrate on glass was used as the reference. Scans were performed
with a spectral bandwidth of 300 nm to 850 nm with an averaging time of 0.1 seconds (standard
for the program). Each scan was performed three times (N=3 measurements) and data was
averaged for presentation.
Light and Dark Impedance Measurements
Dark impedance measurements were performed in a completely dark room, apart from the
light from a fully dimmed laptop screen needed to perform the measurements. Light impedance
measurements were performed in a normally lit lab with fluorescent lighting. Laser impedance
measurements were performed in a completely dark room, except for the dimmed laptop screen
and the focused laser light. Laser wavelengths used included 450 nm blue, 532 nm green, 625 nm
red (all manufactured by Beam of Light Technologies, Clackamas, OR), and 650 nm red (OnPoint
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Lasers Ltd., Minneapolis, MN). All impedance settings used follow those provided in the prior
section.
Imaging
Images of the nIDEs were obtained with both a Nikon TS2 inverted microscope (Nikon,
Tokyo, Japan) and a Keyence BZ-X800 All-in-One Confocal Microscope (Keyence, Tokyo,
Japan).

Imaging of the nanostructures was performed using a Zeiss Ultra-55 FEG SEM

(Oberkochen, Germany) and an Anasys NanoIR AFM (Bruker, Billerica, MA). Live/Dead
fluorescence imaging was also performed using the Keyence BZ-X800 All-in-One Confocal
Microscope with the GFP and Texas Red filters. Cells were fluorescently stained using an
Invitrogen Live/Dead Cell Imaging Kit (Invitrogen, Carlsbad, CA) and allowed to incubate in the
dark at room temperature. Following this incubation time, the fluorescent stains were aspirated,
and the cells were immediately imaged.
Results and Discussion
This section presents the results and discussion from a series of nIDE/pIDE experiments
that build on one another.
1 mm nIDE vs. IDE
To ensure that the suitable thickness of gold was consistently deposited on the
nanostructured substrates due to the sensitivity of the SPR generation to thickness of the gold, we
performed a test of the consistency of the electron beam deposition. Figure 52 shows the results
of this test. The center of the sample plate gives the desired thickness of 30 nm, while a deviation
from the desired thickness is seen in the outer areas of the sample plate. The thickness of gold
deposited ranged from 30 nm in the center from ~22-23 nm at the outer edges of the sample holder.
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(nm)

Figure 52 Measured thickness of metalized glass cover slides with steps. The middle of the substrate holder gives the desired
thickness, while the outer half gives slightly thinner samples with thicknesses ranging from 20 nm to 26 nm.

Nanostructured IDEs (nIDEs) were successfully fabricated on the nanostructured PAN
substrates. The nanostructures on the PAN substrate remained defined after the deposition of the
gold IDE structure, as shown in Figure 53a. These SEM micrographs clearly depict the
nanostructured PAN with repeatable “nanoholes” of approximately 50 nm in diameter and the mmscale gold electrodes defined on top of these “nanoholes”. The gold IDE structures measured
within 99.37% of the designed dimensions representing an excellent translation from design. Fully
assembled devices, as shown in Figure 53b, remained intact throughout the entire life cycle of the
cardiomyocytes (DIV18).
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Human iPSC cardiomyocytes were successfully cultured onto the nIDEs as depicted in a
sample image in Figure 53c. One can clearly observe a mat of cells on top of the IDEs in the
images collected with transmitted light microscopy. The cell viability assay confirmed that the
nanostructured PAN substrate was cytocompatible for cell culture with iCell Cardiomyocytes2.
The other components of the nIDE (gold, PDMS, and 353ND epoxy), have previously been
established to be cytocompatible with cardiomyocytes [265, 266]. Fluorescence levels were well
above the background fluorescence, which indicates that most of the cultured cells were viable, as
shown in Figure 53d. Quantitatively, the nanostructured PAN and control wells (N=6 for both
types), both showed a fluorescence of nearly 40,000 RFU with a low standard deviation of
approximately 3000 RFU, which depicts excellent cytocompatibility performance (97.01% ±
2.15% of the control) with iCell Cardiomyocytes2.
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Figure 53 a. SEM image of electrodes deposited on top of the nanostructured PAN layer with zoomed in SEM images of the printed 50 nm PAN nanohole structures. Scales from
left to right are 250 μm, 1 μm, and 180 nm, respectively. b. Completed nIDE device with culture well and wires attached. c. Human iPSC Cardiomyocytes cultured on 1 mm pitch
nIDE at DIV01. The cardiomyocytes completely cover the surface of the IDE. d. Biocompatibility assay results - The nanostructured PAN substrate shows similar (97.01% ±
2.15%) biocompatibility (N=6) to control samples comprised of just cells in a 6-well plate.
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Figure 54 a. Representative full spectrum impedance measurements - The nIDEs with cardiomyocytes cultured on them show an increased impedance from the nIDEs that only
have an aqueous medium. In addition, as the cells proliferate an increase in impedance is observed. b. Variation of the Cellular Index (CI) of the cells cultured on the nIDEs for 18
days: it was observed that the CI of the nIDEs increased over time as expected because the cell coverage of the nIDE increases over time. The calculated mean value of N=8 wells
of nIDEs is represented by the square bullet point. A comparison to the data from Himmel et. al. tracks the CI changes observed in our assay. Since our IDE pitch is 100X the
pitch demonstrated by the IDE from Himmel, we believe the presence of the nanostructures result in improvement in device sensitivity. c. CI and d. %CI for norepinephrine
experiment: Mean values for N=6 is depicted with a square bullet point. The CI and %CI both show an exponential decrease, with excellent fits given by their R2 values of 0.974
and 0.954, respectively, as the concentration of norepinephrine increases because the cells are dying due to the dosage of the drug. This causes a departure from the impedance of
the nIDE with no norepinephrine added.
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Figure 54a depicts an example of the raw, full spectrum impedance data for polystyrene
beads, iCell Cardiomyocytes2 (average value of N=8 at two specific days: DIV10 and DIV18), and
aqueous media clearly delineating the three analytes. Further, this figure shows that the impedance
of the nIDEs with cells (110.19 kΩ at 1 kHz for DIV10 and 243.21 kΩ at 1kHz for DIV18) and
polystyrene beads (96.53 kΩ at 1 kHz) were higher than the nIDE with just aqueous medium (27.37
kΩ at 1 kHz), which follows expected trends due to the modification of the ionic currents due to
the presence of cells and the PS beads [14]. In addition, Figure 54a demonstrates a decrease in
impedance from an IDE without a nanostructured substrate to that of the nanostructured IDE, both
in aqueous media. Looking closely at the ECIS for the two sample DIV measurements (N=8),
they demonstrated an increase in impedance as the days in vitro increased. The cell index also
demonstrated an increase as the days in vitro increased (Figure 54b). This is an expected result as
reported by Himmel, et. al. The morphological changes in the cells leads to an increased impedance
as the cell coverage increases; and the cell coverage will inherently increase as the cells grow over
time [14, 267]. This result held until the assay was terminated at DIV18. To our knowledge, we
are the first to report this result with 1 mm pitch nIDEs over a period of 18 days with human
cardiomyocytes and a similar trend using a commercial system with 10 μm pitch IDEs on a glass
substrate fabricated with a complex photolithographic technique involving several steps [267] is
reported by Himmel, Hu et. al., and Lamore et. al. [14, 16, 268] Our devices are 100X larger than
these three other studies but report similar CI increases from cell growth (CI=1.1 on DIV10
increasing to CI equal to approximately 7-8 on DIV17). It is believed the comparable performance
is due to the nanoscale structure patterned onto the substrate of the nIDEs. As a result, we believe
that the nIDE shows an increased sensitivity compared to commercial IDE systems, which have
an electrode gap that is 100X smaller. It is believed that this increase in sensitivity is due to the
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increased electrode surface area provided by the nanoholes.

When surface area increases,

capacitance increases; thus, impedance decreases giving greater sensitivity [92, 231, 243, 269], as
shown in Equation 7, where C is the capacitance, ɛo is the vacuum permittivity, ɛr is the relative
permittivity of the electrolyte, A is surface area of the electrode, d is electrode gap, and Z is
impedance.
C = (εo εr A) / d ∝ 1 / Z

(7)

The model drug experiment with norepinephrine showed a decrease in both cell index
(from CI=2.34 at 0 μM of norepinephrine to CI=1.13 at 256 μM norepinephrine) (Figure 54c) and
percent cell index (86.91% at 0 μM of norepinephrine to 48.88% at 256 μm norepinephrine)
(Figure 49d) with increasing concentrations of norepinephrine (mean of N=7). Both the CI and
%CI for norepinephrine addition demonstrate exponential behavior with excellent fits of 0.974 and
0.954, respectively. This is expected because as the cardiomyocytes are exposed to higher
concentrations of norepinephrine, more cells are expected to die from the exposure [231]. As a
result, there was less active cellular coverage, which lowers the impedance, CI, and %CI.

Figure 55 Fabricated device images: a. Fully packaged nIDE device with culture well and wires attached. b. SEM of gold IDEs
on the nanostructured PAN substrate. c. AFM of an electrode. The nanoholes remain visible after gold deposition, which
provides an increased electrode surface area.
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Plasmonic Resonance of the Nanostructured Substrate
A fully packaged IDE with a culture well and wires attached is shown in Figure 55a. Figure
55b shows an SEM image of the gold electrodes on the nanostructured PAN surface and Figure
55c shows an AFM image of the electrode to show that the integrity of the nanostructures remains
after repeated use of the mold. Impedance values measured at 1 kHz were converted to cell index
(CI) and showed a trend of increasing CI and improved sensitivity for smaller gaps (Figure 56).
Additionally, the CI of the IDEs on the nanostructured substrate was approximately 100-1000X
greater than that of the IDEs on the non-nanostructured substrate. This indicates enhanced
sensitivity due to the nanostructuring. UV-Vis measurements showed a 12 nm to 22 nm red-shift
in the plasmonic peak of the devices with the addition of cells (Figure 57). Variation in peak
intensity and shift can potentially be attributed to the thickness of gold, number of cells, and cellnanostructure interactions demonstrating possibilities for cellular and sub-cellular manipulation.
Figure 58 shows the retinal pigment epithelial cells growing on the 250 µm nanostructured IDE
surface at DIV04. This expected growth helps confirm the biocompatibility of these PAN
nanostructures for retinal pigment epithelial cells.

Figure 56 Average cellular index (CI=[Zo-Zc]/Zo) for N=3 devices showing an increase in CI for nanostructured versus
standard IDEs. CI is a tool for normalizing the impedance, as every device will not be identical. CI results follow the expected
pattern of smaller electrode gaps having larger cellular indices. This indicates that smaller electrode gaps, as well as the
presence of nanostructures allow for greater device sensitivity.
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Figure 57 UV-Vis measurements for the devices. All nIDE devices show a red shift in the plasmonic peak, as indicated, with the addition of cells, as expected. The standard IDEs
show no plasmonic peak. Variations in the plasmonic peaks are expected due to varying thickness the gold electrodes, as well as the cell-electrode interactions. a. 7 µm, b. 62 µm,
and c. 250 µm electrode gap width
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Figure 58 Human retinal pigment epithelial cells (DIV04) cultured onto a 250 µm electrode gap nanostructured IDE device.
The cells grew on the devices, as expected, thus demonstrating good biocompatibility with the device materials.

Individual Contributions of Enhancement Modes
For the remainder of the experiments, HL-1 cells were used. They combine the quick matlike growth of the retinal pigment epithelial cells with the electrophysiological characteristics of
iCell cardiomyocytes. Figure 59a shows a schematic depicting the different enhancement modes
that were hypothesized and studied, while Figure 59b shows HL-1 cells growing on an IDE at
DIV03 showing typical mat-like growth. Impedance values were converted to CI (cellular index),
which is a method to normalize impedance as we have discussed before in this chapter [90] and
show a clear trend of increasing CI and improved sensitivity for smaller electrode gap widths or
pitches.

Figure 59 a. IDE sensitivity can be increased via nanostructuring of the substrate, designing smaller electrode gap widths, or
probing with incident light of a wavelength equal to that of the plasmonic resonance peak. b. HL-1 cells on an IDE at 3 DIV.
Cells show typical mat-like growth that is expected with this cell type.
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Figure 60 Cellular index measurements a. Cellular index (CI) measurements: decreased electrode gap width and the presence of
nanostructures on the substrate cause an increase in the cellular index. b. Comparison of the various device measurements. All
graphs are an average of N=3 devices.

This depicts the geometric trend with a calculated dramatic enhancement of 137,499X for
the design extremities (Figure 60a). The CI for the IDEs cultured on the nanostructured surface
reaches a maximum of 144.59X when compared to IDEs on the planar PAN at 5 DIV. Several
orders of magnitude enhanced sensitivity from geometric and nanostructuring modes of the
electrodes is observed (Figure 60b). The increased surface areas due to nanostructuring are
calculated as 68.3%, 45.5%, and 21.3% for 10 µm, 100 µm, and 1 mm electrode gap widths,
respectively. Since the measurements were all performed in ambient light, it was hypothesized that
fluorescent lighting might have an emission peak near that of the plasmonic resonance peak for 30
nm gold nanostructures (approximately 720 nm), which it does [270]. To isolate this mode,
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impedance measurements were performed in the dark for one of the designs (1 mm IDEs on
nanostructured and planar substrates). An increase in CI for the dark measurements was elicited,
but not to the same magnitude as that of the measurements performed in ambient light, resulting
in a maximum of 6X (Figure 61a). We suspect that further enhancement would be observed if the
incident light were of a discrete wavelength, as supported by the reflectivity measurement in Figure
61b. Individual contributions to the enhanced sensitivity from all three modes is further depicted
in Figure 61c for a subset of the designs.

Figure 61 a. 1 mm cellular index measurements. The cellular index for the dark measurement falls between the IDE and nIDE
performed in ambient light. This means that the fluorescent lighting is likely inducing surface plasmon resonance and causing an
increase in impedance. b. The reflectivity measurement performed here shows the extinction of the nanohole substrate with and
without cells. A 30 nm shift of the peak due to the change of the surface refractive index from the presence of the cells on the
nanohole structures can be seen. This is an important characteristic of plasmonics. c. Comparison of different enhancements.
Sensitivity can be increased by substrate nanostructuring, decreasing electrode gap width, introducing the proper wavelength of
light, or a combination of these as desired in various cell-based biosensing assays.

To further examine the enhancement contribution from SPR elicitation with lasers in the
range of 650-720nm, discrete wavelengths of incident light were tested. Figure 62a shows the
difference between the cellular indices of the IDEs and pIDEs procured in the dark. The CI of the
pIDE is higher than that of the IDE, as expected from prior experiments. Figure 62b compares the
enhancement from each of the laser wavelengths when compared to the dark pIDE measurement.
It is clear that as the laser wavelength nears the plasmonic peak of 720 nm [146], the sensitivity
enhancement factor for CI is increased. Comparing this to the data in Figure 61 shows that by
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choosing a wavelength close to the plasmonic peak, the CI can be increased by two orders of
magnitude over that of diffuse incident light exposure, or three orders of magnitude of no light
exposure.

Figure 62 a. 1 mm cellular index measurements. The cellular index for the pIDE exceeds that of the IDE, as expected from
previous work shown in this chapter. b. Comparison of enhancement due to different laser wavelengths. The 450 nm blue and
532 nm green lasers increase the cellular index when focused on the pIDE, but not much more than unfocused ambient light, as
shown in Figure 12a. The 635 nm red laser increases the cellular index further, but the 650 nm laser demonstrates the greatest
enhancement of cellular index likely due to its proximity to the plasmonic peak of the substrate.

Figure 63a shows cells growing on a pIDE electrode prior to termination of DIV05. Figure
63b and c show live/dead images of cells on an IDE and a pIDE, respectively. Here the green cells
(fluorescing at 488 nm due to dye uptake) are alive, while the red cells (fluorescing at 570 nm due
to dye uptake) are dead. Clearly, the cells remained largely viable over the course of the five-day
assay. Some cell morphology change is expected due to phototoxicity from the various laser
experiments [271]. Table 5 provides the maximum sensitivity enhancement in CI observed for
each of the enhancement modes. While decreasing the electrode gap width provides the most
dramatic sensitivity enhancement, it also becomes more and more difficult to produce
microelectrodes as the pitch is reduced below 10µm. Therefore, combining these enhancement
modes provides the greatest advantage. By producing the small (by the fabrication methods
presented within this dissertation) electrode gap widths on nanostructured substrates and
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measuring the impedance in a dark room while shining a discrete wavelength of laser light onto
the electrode surface in order to produce surface plasmon resonance, one is able to take advantage
of all of the sensitivity enhancement modes depicted in this chapter to achieve a highly sensitive
benchtop fabricated plasmonic interdigitated electrode.

Figure 63 Optical Images of Cells on IDEs/pIDEs. a. Phase contrast image of HL-1 cells on pIDE electrode at DIV05. b.
Live/Dead image of HL-1 cells on an IDE at DIV05. Most cells are living (green), while only a few cells are dead (red). c.
Live/Dead image of HL-1 cells on a pIDE at DIV05. As with the IDE, most of the cells are living (green), while few are dead
(red).
Table 6 Maximum enhancement for each enhancement mode of the pIDEs

Mode

Maximum Sensitivity Enhancement

Geometric

137,499X

Nanostructuring

144.59X

Ambient Lighting

6X

Discrete Laser Wavelength

1804.92X

Conclusions
This study reports for the first time the development of IDEs patterned onto nanostructured
PAN substrates using rapid micro/nanofabrication technologies. The resulting nanostructured
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IDEs (or nIDEs) demonstrated excellent design to device (99.37% translation of design features)
and biocompatibility of 97.01% ± 2.15% with respect to iCell cardiomyocytes2 control. The nIDEs
were developed as a tool for rapid screening of toxins with an impedance metric and they
demonstrated an impedance (110.19 kΩ at 1 kHz for DIV10 and 243.21 kΩ at 1 kHz for DIV18)
that was higher than the IDEs with just an aqueous medium (27.37 kΩ at 1 kHz) which was used
as a control. In addition, the nIDEs with cells showed increased impedance as evidenced by a Cell
Index (CI) increase from 0 to 7.7 with increasing days in vitro of cell culturing. This result is as
predicted because impedance should increase as cell coverage increases because of the cellelectrode interaction. Long term cell culture (18 days) was demonstrated with iCell
Cardiomyocytes2, and most significantly, an improvement in device performance when fabricated
on nanostructured substrates (100X larger electrode gaps than commercial systems) was
demonstrated through cellular index calculations. Finally, the cardiotoxicity testing utility of our
devices was successfully demonstrated with the expected response of decreased cellular index
from 2.34 to 1.13 in response to increased concentrations of a model drug, norepinephrine.
Additionally, it was demonstrated through UV-Vis spectroscopy that the nanostructured
substrate exhibits a plasmonic peak. This means that an additional plasmonic resonance sensing
mode can be activated by exposing the nIDE surface to the correct wavelength of light (and hence
a pIDE). It was subsequently shown that the sensitivity of micron and millimeter scale IDEs can
be enhanced via three individual alterations: two physical, and one optical: (1) increasing
microelectrode surface area through fabrication on a nanostructured substrate; (2) decreasing the
electrode gap width; and (3) probing the electrode surface with specific wavelengths of light. These
modes can be tailored to specific cell based biosensing applications or combined to achieve greater
device sensitivity.
131

CHAPTER 6: CONCLUSIONS & FUTURE WORK
Conclusions
In this dissertation, the development of several novel methods of patterning inorganic and
organic materials and biocompatibility approaches for HL-1 cells and 3D printed materials, as well
as the subsequent application of these methods to the development of biosensors and lab-on-a-chip
devices, specifically Interdigitated Electrodes (IDEs), on non-traditional plasmonic polymer
substrates as well as the deployment of these methods to enhance precision cellular placement on
traditional glass MEA substrates has been presented. It was hypothesized that a combination of
facile microfabrication techniques and patterning technologies on traditional and non-traditional
substrates would increase the sensitivity and selectivity of sensor platforms such as these by
several orders of magnitude, and even potentially introduce new modalities for cell-based
biosensing. This was demonstrated using pIDEs where minimum enhancement of 6X was
observed via exposure to incident ambient light alone not to mention 6 orders of improved
sensitivity enhancements by combining multiple modalities. The biological functionality of these
new IDEs was demonstrated through the use of a variety of cell cultures: cardiac, stem cell, and
endothelial cells to study the growth, proliferation, modes of increasing sensitivity, and response
to various compounds in vitro (outside the body).
Future Work
Given the results of this dissertation research, a gateway for a wide array of future work,
has been opened and these expected directions are provided below.
Laser Micromachining
Laser micromachining has been utilized for a wide variety of two-dimensional materials in
our laboratory. The natural progression of exploring the utility of this fabrication technique would
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be to attempt to micromachine non-planar materials. Additionally, further decreasing the spot
sizes that can be machined is paramount. Such an exploration would be particularly beneficial if
processes can be reduced to the nanoscale widths.
Extrusion Bioprinting
The spot sizes able to be printed are still larger than ideal. The aim to get spots down to
100 µm will continue in future work on this aspect of the dissertation. Further exploring 3D printed
micro-nozzles is a viable solution to reducing spot sizes, as well as looking into surface
functionalization to decrease the drop contact diameter. Additionally, branching out from 2D
cellular structures to 3D cellular constructs could potentially be explored, as cellular scaffolds are
of great interest in the bioprinting field.
nIDE/pIDE
Probing a cell laden pIDE with the correct wavelength of laser light, cell layers can be
encouraged to lift from the substrate surface, which could be interesting to the tissue engineering
application of the plasmonic IDE. Further low-level laser/LED light could optically stimulate the
cells. Potential probing of the pIDE with a low-power infrared laser for an extended period
(approximately 40 minutes or more) to determine if tissue lifting occurs could be explored. This
could be useful for tissue origami applications. Such plasmonic-based stimulation could provide a
brand-new way for non-invasive cellular stimulation technologies.
pMEA
Full development and testing of a pMEA needs to be explored. The nanostructured
substrates need to become more uniform to ensure that we can interface them with our modified
Axion MUSE system. A realistic insulation solution needs to be found. This solution could be
something as simple as an adhesive (e.g. Medco/Polyethylene Terephthalate (PET) layer). This is
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an example of a solution that can first be laser micromachined to have openings in the appropriate
areas for the electrodes and then carefully adhered to the pMEA surface. Another solution could
be parylene deposition and suitable laser ablation. We had initially intended to try this along with
SiO2 but were unable to do so due to extenuating circumstances due to COVID-19 since UCF does
not have a parylene deposition system. We had planned to go to UF or Georgia Tech to perform
these experiments. SiO2 is notoriously difficult to ablate, so perhaps a different material would
produce better results. Additional electrodes could be added outside of the nanostructured area to
allow for comparison with a planar substrate on the same device.
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APPENDIX A:
OTHER RESEARCH PERFORMED DURING PH.D.
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Development of a Plasmonic Microelectrode Array (pMEA)
Introduction
Microelectrode array (MEA) biosensors have been the standard in electrogenic cell
measurements since the 1970s [272]. Electrogenic cells, such as cardiomyocytes and neurons,
generate momentary changes in potential across the cell membrane. These changes in potential
are called action potentials and can be thought of as electrical pulses. These electrical pulses can
be recorded by the means of microelectrodes. MEA sensors involve a layer of patterned insulation
atop a layer of patterned metal on a substrate, such as a glass or polymer wafer. While this
technology has proliferated the marketplace, several issues with their microfabrication still exist.
One such example is that the fabrication technology for most MEAs is silicon or glass-based; thus,
it is highly reliant on expensive cleanroom-based processes, such as photolithography and
chemical etching, which require advanced know-how [243, 272-276]. Alternative fabrication
techniques for micro- and nanostructuring that allow for the same sensitivity, feature sizes and
functionalities as cleanroom fabricated MEAs on a variety of substrates are required. Another
such example is that impedance-based measurements using MEAs are time consuming, as each
electrode must be measured individually. While this is not necessarily an issue for simple device
characterization tasks, one could not perform such measurements on a cell laden device quickly
and accurately enough to maintain the proper environment for ideal cell viability (humidity,
temperature, etc.) [276].
Commercial MEA systems that allow for more comprehensive device measurements exist
[214], but typically require biosensor devices to be of specific form factors; thus, the ability to
fashion a device to needed specifications would be necessary for less tedious measurement
processes. Axion BioSystems [277] makes a commercial form factor-specific MEA system. Their
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proprietary software allows for the automatic application of filters for specific electrophysiological
phenomenon and stimulation. Axion offers MEAs in a high throughput format of a multi-well
plate. Multichannel Systems [278] also manufactures commercial MEA systems and typically in
a low throughput, research scale, single well format. Their systems allow for the use of MEAs with
varying number of electrodes. These systems are non-form specific to a point, label-free, high
sensitivity, and allow for cells to be followed in real time. However, addition of other modalities
of sensing are important in these systems and are just beginning to be evaluated.
In this appendix chapter, we present the development of a plasmonic microelectrode array
(pMEA). Our lab has successfully used non-cleanroom-based techniques to fabricate a variety of
MEAs in the past few years [145, 147, 148, 165]; however, the ability to reduce the signal-to-noise
ratio (SNR) of the electrodes to enhance sensitivity and developing other modalities of sensing are
under evaluation. In this appendix, we explored the preliminary processing-based integration of
plasmonics with MEA technologies.
Hypothesis
One of the challenges for the plasmonic architectures we have demonstrated in the previous
chapters is the fragile nanostructures. It is hypothesized that through careful metallization and
insulation choices and processing conditions along with the use of facile microfabrication
technologies discussed in the previous chapters, the integrity of the nanostructures can be
preserved.
Additionally, it is hypothesized that by combining the nanostructured PAN substrate with
an MEA, a reduction in SNR can be achieved; thus, giving the pMEA a greater device sensitivity.
Also, by probing the device with light, a surface plasmon resonance can be induced, which
introduces an additional sensing modality.
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Materials and Methods
Shadow masks were designed in SolidWorks (Dassault Systems, Velizy-Villacoublay,
France). Shadow masks were subsequently fabricated via laser micromachining on 12.5 µm thick
Kapton® using the UV setting at 50 Hz and a 50 µm by 50 µm spot size.
Gold microelectrodes of approximately 50 nm thickness were deposited onto the
nanostructured substrates using electron beam evaporation.

Silicon dioxide (SiO2) was

subsequently deposited using electron beam evaporation atop the gold electrodes layer as an
insulation layer. The SiO2 insulation layer deposited was approximately 300 nm thick. The SiO2
insulation layer was subsequently ablated using the green and UV settings to expose the electrodes.
These test conditions for micro-ablation of the SiO2 layer are shown in Table 6.
Table 7 pMEA laser ablation test conditions

pMEA SiO2 Insulation Laser Ablation Tests
Spot
Sample Electrode Objective
Size
Wavelength Energy Density
2
1
1
10X
50 µm
532 nm
0.027 mJ/µm2
2
10X
50 µm2
532 nm
0.0054 mJ/µm2
3
10X
50 µm2
532 nm
0.0044 mJ/µm2
4
10X
50 µm2
532 nm
0.0031 mJ/µm2
5
10X
50 µm2
532 nm
0.0022 mJ/µm2
2
1
50X
25 µm2
355 nm
0.0088 mJ/µm2
2
50X
25 µm2
355 nm
0.0044 mJ/µm2
3
50X
25 µm2
355 nm
0.0018 mJ/µm2
3
1
10X
45 µm2
532 nm
0.0029 mJ/µm2
2
10X
45 µm2
532 nm
0.0024 mJ/µm2
3
10X
45 µm2
532 nm
0.0019 mJ/µm2
4
10X
45 µm2
532 nm
0.0014 mJ/µm2

Ablated electrodes were then imaged using the Keyence BZ-X800 All-in-One Confocal
Microscope (Tokyo, Japan) in the standard brightfield imaging modality. Select electrodes were
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also examined via the AFM (nanoIR2, Anasys, Billerica, MA) in both tapping and contact mode
in order to characterize the micro-ablation.
Results and Discussion
The pMEA consists of 100 µm on a side microelectrodes (square size) with a 400 µm pitch,
as shown in Figure 64a. In this test design 16 electrodes were arranged in a 4x4 array. The contacts
were designed to be rather large (1 mm x 0.5 mm) to interface with our modified Axion MUSE
system.

Figure 64 Schematic of a. pMEA design and b. pMEA insulation ablation mask.

Figure 64b shows the schematic for the pMEA insulation shadow mask. This shadow mask
is aligned over the electrodes during laser micromachining of the insulation to ensure that only the
electrodes area is ablated.
Due to an issue with the silicon mold for the fabrication of the spin on nanostructures, the
effective nanostructure chip area was reduced from 5 mm x 5 mm to 4 mm x 4 mm. The initial
metallization and SiO2 ablation tests were performed with this chip size. The metallized pMEA
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structure was smaller than the glass slide onto which the PAN and the PAN nanostructures are
immobilized (Figure 65), as the glass slides used by the Thomas group vary each time. This
condition would need to be consistent over time to interface effectively with the modified Axion
MUSE during pMEA fabrication.

Figure 65 Metallized pMEA. This is one of the first iterations, so some shadowing can be seen from the shadow mask.

After gold deposition as depicted in the photo micrograph in Figure 65, silicon dioxide was
deposited as an insulation layer. The deposition rate of SiO2 in the e-beam was not able to be
maintained at a constant rate, so the thickness and the surface roughness of the deposited materials
needed to be tested. Additionally, it was necessary to determine whether the SiO2 filled in the
nanostructures. Figure 66 shows an AFM of a pMEA electrode with gold and silicon dioxide. The
SiO2 deposited evenly despite the rather uncontrollable deposition rate suggested by the quartz
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crystal during deposition; however, the nanostructures became filled during the deposition process
which is clear from this AFM image. This filling could invalidate the nanostructure and hence the
fabrication of the pMEA microelectrodes. As a result, this first attempt was not successful and
alternate insulate layers (e.g. atomic layer deposition, aluminum oxide, parylene etc.) need to be
considered for the pMEA process.

Figure 66 AFM of a pMEA electrode with SiO2 insulation. The SiO2 filled the nanostructures resulting in a completely smooth
surface.

Figure 67 Example of an ablated electrode.

141

Figure 67 shows the one of the series of micrographs captures for the laser ablation of the
silicon dioxide insulation layer as per the conditions provided in Table 6. From this micrograph,
one can see that the laser micromachining conditions resulted in the entirety of gold being removed
from the electrode surface along with the SiO2 insulation layer at even the lowest energy density.
All the other images taken for the microelectrode definition look similar or worse with the ablation
of the entire structure.
Conclusions
Shadow masks for a pMEA device and for the laser ablation of insulation were successfully
designed in CAD software. These shadow masks were successfully laser micromachined to allow
for gold deposition. Insulation definition using e-beam evaporation of SiO2 was attempted,
followed by the laser micro-ablation of the SiO2 insulation. A variety of low-power conditions
were tested in the laser micromachining process to attempt to preserve the integrity of the
nanostructured PAN layer. Despite our best efforts, laser micromachining of SiO2 does not seem
to be a viable insulation solution for the realization of pMEAs.

Makerspace Microfabrication of a Stainless-Steel 3D Microneedle Electrode Array (3D MEA)
on a Glass Substrate for Simultaneous Optical & Electrical Probing of Electrogenic Cells
NBSS REU student Paola M. Morales Carvajal designed and fabricated a stainless-steel
3D MEA on a glass substrate with the guidance of lab members Avra Kundu and Chuck Didier.
This paper has been accepted to RSC Advances and will be published in December 2020 [94].
After the 3D MEA had been fabricated, the ability of the device to capture
electrophysiological activity needed to be determined in order to test the device from design to
biological data generation. Figure 68 shows the device and the results of biological data capture.
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Figure 68a and Figure 68b shows the fully packaged 3D MEA device interfacing with the Axion
BioSystems MUSE electrophysiology system. Figure 68c shows the noise from one of the 3D
MEA electrodes. Figure 68d shows HL-1 cells (plated and maintained per the protocol in Chapter
3) on the 3D MEA at 2 DIV. Figure 68e shows the cardiac beats as they appear in a screen capture
from the AxIS software on the Axion MUSE, while Figure 68f provides a post-processed, averaged
plot of repeatable single beats from the HL-1 cells cultured on the 3D MEA.

Figure 68 3D MEA device: a. and b. The fully packaged 3D MEA device interfacing with the Axion MUSE. c. Representative
noise plot of one of the microelectrodes of the 3D MEA. d. HL-1 cells after 2 DIV. e. Cardiac beats as they appear on the AxIS
software. f. Post-processed, averaged plot of repeatable single cardiac beats from HL-1 cells cultured on the 3D MEA.
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MATLAB CODES
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Plotting Axion Raw Data
Axion MUSE files are output in raw data file form. MATLAB is the best tool to plot and
analyze this raw data. The MATLAB code for this data plotting is denoted below:
Data=AxisFile('FILENAME.raw').DataSets.LoadData, ('C2','34',[0 90]); %Loads the first 90
seconds of data for electrode 34
[t,v]=AllData{3,2,3,4}.GetTimeVoltageVector; %Get time and voltage vectors
plot(t,v) %Plot the voltage vs time data
AllData=AxisFile('NeuralDemoData_SpikeFile.spk').DataSets.LoadData; %Loads spike data
spikes=AllData{2,8,4,4}(1:5).GetVoltageVector; %Get the voltage data from the first 5 spikes of
electrode 44
time=AllData{2,8,4,4}(1).GetTimeVector; %Get the time vector from the first spike
plot_time=time-repmat(time(1),size(time)); %Shift the time vector back so it starts from zero
plot(plot_time,spikes); %Plot the 5 spike waveforms overlaid
Plotting Raw Impedance Data
Raw impedance data from the BODE 100 is comprised of hundreds of data points. Using
MATLAB to directly plot this data simplifies the process. The MATLAB code for this data
plotting is denoted below:
imp=dlmread('DATA.txt'); %Load real impedance data file
x1 = imp(:,1);
y1 = imp(:,2);
Re = 200:10:300; %4700:100:44000;
Rct = 15000; %100:100:5000;
Cdl = 0.0020*10^-8; %10^-9:10^-8:10^-6;
freq = 100:100:10^7; %Set frequency range
for k=1:1:length(Re)
Z(:,k) = Re(k) + 1.;
RealZ = real(Z);
ImagZ = imag(Z);
% AngleZ = phase(Z)
% DegreeZ = 180.*AngleZ./pi
end
figure (1)
plot(x1,y1,freq,RealZ)
set(gca, 'XScale', 'log')

145

APPENDIX C:
COPYRIGHT PERMISSIONS FOR CHAPTER 3, FIGURE 1

146

147

148

149

150

APPENDIX D:
COPYRIGHT PERMISSIONS FOR CHAPTER 3, FIGURE 2

151

152

153

154

APPENDIX E:
COPYRIGHT PERMISSIONS FOR CHAPTER 3, FIGURE 3

155

156

APPENDIX F:
COPYRIGHT PERMISSIONS FOR CHAPTER 4, FIGURE 1

157

158

159

160

161

APPENDIX G:
COPYRIGHT PERMISSIONS FOR CHAPTER 4, FIGURE 2

162

163

164

165

166

167

APPENDIX H:
COPYRIGHT PERMISSIONS FOR CHAPTER 4, FIGURE 3

168

169

170

171

172

APPENDIX I:
COPYRIGHT PERMISSIONS FOR AUTHOR’S PUBLISHED MATERIAL
INCLUDED WITHIN THIS DISSERTATION

173

The author’s publications in Biosensors and Micromachines are MDPI journals, which
are eligible for sharing under the Creative Commons license.

174

175

176

REFERENCES
[1]

X. W. H. Wang, P.Dong, C. Wang, J. Wang, Y. Liu, and J. Chen, "Electrochemical
Biosensor Based on Interdigitated Electrodes for Determination of Thyroid Stimulating
Hormone," International Journal of Electrochemical Science, vol. 9, pp. 12-21, 2014.

[2]

P. Y. P. Adelyn et al., "Transparent mask design and fabrication of interdigitated
electrodes," in 2015 IEEE Regional Symposium on Micro and Nanoelectronics (RSM),
19-21 Aug. 2015 2015, pp. 1-4, doi: 10.1109/RSM.2015.7355014.

[3]

A. Rivadeneyra, J. Fernández-Salmerón, J. Banqueri, J. A. López-Villanueva, L. F.
Capitan-Vallvey, and A. J. Palma, "A novel electrode structure compared with
interdigitated electrodes as capacitive sensor," Sensors and Actuators B: Chemical, vol.
204, pp. 552-560, 2014/12/01/ 2014, doi: https://doi.org/10.1016/j.snb.2014.08.010.

[4]

H. Schift, R. W. Jaszewski, C. David, and J. Gobrecht, "Nanostructuring of polymers and
fabrication of interdigitated electrodes by hot embossing lithography," Microelectronic
Engineering, vol. 46, no. 1, pp. 121-124, 1999/05/01/ 1999, doi:
https://doi.org/10.1016/S0167-9317(99)00030-1.

[5]

I. T. Ozbolat, K. K. Moncal, and H. Gudapati, "Evaluation of bioprinter technologies,"
Additive Manufacturing, vol. 13, pp. 179-200, 2017/01/01/ 2017, doi:
https://doi.org/10.1016/j.addma.2016.10.003.

[6]

J. M. Williams et al., "Bone tissue engineering using polycaprolactone scaffolds
fabricated via selective laser sintering," Biomaterials, vol. 26, no. 23, pp. 4817-4827,
2005/08/01/ 2005, doi: https://doi.org/10.1016/j.biomaterials.2004.11.057.

177

[7]

Q. Hamid et al., "Fabrication of three-dimensional scaffolds using precision extrusion
deposition with an assisted cooling device," Biofabrication, vol. 3, no. 3, p. 034109,
2011/07/05 2011, doi: 10.1088/1758-5082/3/3/034109.

[8]

S. Tarafder, V. K. Balla, N. M. Davies, A. Bandyopadhyay, and S. Bose, "Microwavesintered 3D printed tricalcium phosphate scaffolds for bone tissue engineering," (in eng),
J Tissue Eng Regen Med, vol. 7, no. 8, pp. 631-641, 2013, doi: 10.1002/term.555.

[9]

S. A. Skoog, P. L. Goering, and R. J. Narayan, "Stereolithography in tissue engineering,"
(in eng), J Mater Sci Mater Med, vol. 25, no. 3, pp. 845-56, Mar 2014, doi:
10.1007/s10856-013-5107-y.

[10]

W. C. Wilson Jr. and T. Boland, "Cell and organ printing 1: Protein and cell printers,"
The Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evolutionary
Biology, vol. 272A, no. 2, pp. 491-496, 2003, doi: 10.1002/ar.a.10057.

[11]

P. Calvert, "Printing Cells," Science, vol. 318, no. 5848, pp. 208-209, 2007, doi:
10.1126/science.1144212.

[12]

N. S. Mazlan et al., "Interdigitated electrodes as impedance and capacitance biosensors:
A review," AIP Conference Proceedings, vol. 1885, no. 1, p. 020276, 2017, doi:
10.1063/1.5002470.

[13]

L. E. Delle et al., "ScFv-modified graphene-coated IDE-arrays for ‘label-free’ screening
of cardiovascular disease biomarkers in physiological saline," Biosensors and
Bioelectronics, vol. 102, pp. 574-581, 2018/04/15/ 2018, doi:
https://doi.org/10.1016/j.bios.2017.12.005.

[14]

H. M. Himmel, "Drug-induced functional cardiotoxicity screening in stem cell-derived
human and mouse cardiomyocytes: Effects of reference compounds," Journal of
178

Pharmacological and Toxicological Methods, vol. 68, no. 1, pp. 97-111, 2013/07/01/
2013, doi: https://doi.org/10.1016/j.vascn.2013.05.005.
[15]

L. Guo et al., "Estimating the Risk of Drug-Induced Proarrhythmia Using Human
Induced Pluripotent Stem Cell–Derived Cardiomyocytes," Toxicological Sciences, vol.
123, no. 1, pp. 281-289, 2011, doi: 10.1093/toxsci/kfr158.

[16]

N. Hu et al., "High-performance beating pattern function of human induced pluripotent
stem cell-derived cardiomyocyte-based biosensors for hERG inhibition recognition,"
Biosensors and Bioelectronics, vol. 67, pp. 146-153, 2015/05/15/ 2015, doi:
https://doi.org/10.1016/j.bios.2014.07.080.

[17]

N. Tandon et al., "Surface-patterned electrode bioreactor for electrical stimulation," Lab
on a Chip, 10.1039/B917743D vol. 10, no. 6, pp. 692-700, 2010, doi:
10.1039/B917743D.

[18]

Y. Qiu, R. Liao, and X. Zhang, "Real-Time Monitoring Primary Cardiomyocyte
Adhesion Based on Electrochemical Impedance Spectroscopy and Electrical
Cell−Substrate Impedance Sensing," Analytical Chemistry, vol. 80, no. 4, pp. 990-996,
2008/02/01 2008, doi: 10.1021/ac701745c.

[19]

T. Wang, N. Hu, J. Cao, J. Wu, K. Su, and P. Wang, "A cardiomyocyte-based biosensor
for antiarrhythmic drug evaluation by simultaneously monitoring cell growth and
beating," Biosensors and Bioelectronics, vol. 49, pp. 9-13, 2013/11/15/ 2013, doi:
https://doi.org/10.1016/j.bios.2013.04.039.

[20]

D. Krinke, H.-G. Jahnke, O. Pänke, and A. A. Robitzki, "A microelectrode-based sensor
for label-free in vitro detection of ischemic effects on cardiomyocytes," Biosensors and

179

Bioelectronics, vol. 24, no. 9, pp. 2798-2803, 2009/05/15/ 2009, doi:
https://doi.org/10.1016/j.bios.2009.02.006.
[21]

M. Contreras-Saenz, C. Hassard, R. Vargas-Chacon, J. L. Gordillo, and S. CamachoLeon, Maskless fabrication of a microfluidic device with interdigitated electrodes on
PCB using laser ablation (SPIE BiOS). SPIE, 2016.

[22]

F. Qian et al., "Simultaneous electrical recording of cardiac electrophysiology and
contraction on chip," Lab on a Chip, 10.1039/C7LC00210F vol. 17, no. 10, pp. 17321739, 2017, doi: 10.1039/C7LC00210F.

[23]

C. R. Hart, Swaminathan, "Multimodal Laser Micromachined Shadow Masks for Rapid
Patterning of Sub-5um Organic and Inorganic Layers for Lab-on-a-Chip Applications,"
presented at the 22nd International Conference on Miniaturized Systems for Chemistry
and Life Sciences (MicroTAS 2018), Kaohsiung, Taiwan, 2018.

[24]

C. Hart and S. Rajaraman, "Low-Power, Multimodal Laser Micromachining of Materials
for Applications in sub-5 µm Shadow Masks and sub-10 µm Interdigitated Electrodes
(IDEs) Fabrication," Micromachines, vol. 11, no. 2, 2020, doi: 10.3390/mi11020178.

[25]

G. Bloembergen, "Laser-material interactions, fundamentals and applications Laser
Ablation: Mechanisms and Applications II," in AIP Conf. Proc. JC Miller, DB Geohegan
eds, 1994, vol. 288.

[26]

J. Miller, "History, scope, and the future of laser ablation," in Laser Ablation: Springer,
1994, pp. 1-10.

[27]

Y. Kawamura, K. Toyoda, and S. Namba, "Effective deep ultraviolet photoetching of
polymethyl methacrylate by an excimer laser," Applied Physics Letters, vol. 40, no. 5, pp.
374-375, 1982.
180

[28]

R. Srinivasan and V. Mayne‐Banton, "Self‐developing photoetching of poly (ethylene
terephthalate) films by far‐ultraviolet excimer laser radiation," Applied Physics Letters,
vol. 41, no. 6, pp. 576-578, 1982.

[29]

J. P. K. Henning Klank, and Oliver Geschke, "CO2-laser micromachining and back-end
processing for rapid production of PMMA-based microfluidic systems," Lab on a Chip,
vol. 2, pp. 242-246, 2002.

[30]

R. J. M. R. Rox Anderson, Shinichi Watenabe, Thomas Flotte, George J. Hruza, adn
Jeffrey S. Dover, "Selective photothermolysis of cutaneous pigmentation by q-switched
Nd:YAG laser pulses at 1064, 532, and 355 nm," Journal of Investigative Dermatology,
vol. 93, pp. 28-32, 1989.

[31]

H. L. Y. Fan, Y. Yi, and I.G. Foulds, "Laser micromachined wax-covered plastic paper as
both sputter deposition shadow masks and deep-ultraviolet patterning masks for
polymethylmethacrylate-based microfluidic systems," Journal of Micro/nanolithography,
MEMS, and MOEMS, vol. 12, no. 4, p. 049701, 2013.

[32]

H.-L. C. Yu-Hsuan Hung, Yung-Chun Lee, "Excimer laser three-dimensional
micromachining based on image projection and the optical diffraction effect," Applied
Sciences, vol. 8, p. 1690, 2018.

[33]

R. D. Schaeffer, Fundamentals of Laser Micromachining. Boca Raton: CRC Press, 2012.

[34]

M. S. B. a. C. B. Arnold, "Fundamentals of Laser-Material Interaction and Application to
Multiscale Surface Modification," in Laser Precision Microfabrication, vol. 135, M. M.
K. Sugioka, and A. Pique Ed. Berlin: Springer, 2010.

181

[35]

N. H. Rizvi and P. Apte, "Developments in laser micro-machining techniques," Journal
of Materials Processing Technology, vol. 127, no. 2, pp. 206-210, 2002/09/30/ 2002, doi:
https://doi.org/10.1016/S0924-0136(02)00143-7.

[36]

C. B. A. a. A. Pique, "Laser Direct-Write Processing," MRS Bulletin, vol. 32, pp. 9-15,
2007.

[37]

P. R. Miller, R. Aggarwal, A. Doraiswamy, Y. J. Lin, Y.-S. Lee, and R. J. Narayan,
"Laser micromachining for biomedical applications," JOM, vol. 61, no. 9, pp. 35-40,
2009/09/01 2009, doi: 10.1007/s11837-009-0130-7.

[38]

M. Gower, Laser micromachining for manufacturing MEMS devices (Micromachining
and Microfabrication). SPIE, 2001.

[39]

U. S. V. Schutz, and A. Horn, "Thermodynamic investigations on the laser ablation rate
of silicon over five fluence decades," Physics Procedia, Lasers in Manufacturing
Conference 2013, pp. 640-649, 2013.

[40]

R. A. Bashir Ahmed Tahir, M.G.B. Ashiq, Afaq Ahmed, and M.A. Saeed, "Cutting of
nonmetallic materials using Nd:YAG laser beam," Chinese Physics B, vol. 21, no. 4, p.
044201, 2012.

[41]

C. C. F. D. Petit, S. Johnstone, D. Wood, and R.P. Cowburn, "Nanometer scale patterning
using focused ion beam milling," Review of Scientific Instruments, vol. 76, p. 026105,
2005.

[42]

T. E. d. G. David. J. Guckenberger, Alwin M.D. Wan, David J. Beebe, and Edmond
W.K. Young, "Micromilling: a method for ultra-rapid prototyping of plastic microfluidic
devices," Lab on a Chip, vol. 15, p. 2364, 2015.

182

[43]

H. G. Henri Jansen, Meint de Boer, Miko Elwenspoek, and Jan Fluitman, "A survey on
the reactive ion etching of silicon in microtechnology," Journal of Micromechanics and
Microengineering, vol. 6, p. 14, 1995.

[44]

P. H. Ivo Utke, and John Melngailis, "Gas-assisted focused electron beam and ion beam
processing and fabrication," Journal of Vacuum Science & Technology B, vol. 26, p.
1197, 2008.

[45]

F. Karouta, "A practical approach to reactive ion etching," Journal of Physics D: Applied
Physics, vol. 47, no. 3, p. 233501, 2014.

[46]

G. M. Peake et al., "A micromachined, shadow-mask technology for the OMVPE
fabrication of integrated optical structures," Journal of Electronic Materials, journal
article vol. 29, no. 1, pp. 86-90, January 01 2000, doi: 10.1007/s11664-000-0100-x.

[47]

A. A. Tseng, "Recent developments in micromilling using focused ion beam technology,"
Journal of Micromechanics and Microengineering, vol. 14, p. R15, 2004.

[48]

A. A. Anbesh Jamwal, Nishant Gautam, Akhil Devarapalli, "Electro-Discharge
Machining: Recent Developments and Trends," IRJET, vol. 5, no. 2, pp. 433-448, 2018.

[49]

S. K. a. A. Dvivedi, "On machining of hard and brittle materials using rotary too microultrasonic drilling process," Materials and Manufacturing Processes, vol. 34, no. 7, pp.
736-748, 2019.

[50]

Z. L. Xiaochu Liu, Guilin Wen, Xuefeng Yuan, "Waterjet Machining and Research
Developments: A Review," International Journal of Advanced Manufacturing
Technology, vol. 102, no. 5-8, pp. 1257-1335, 2019.

[51]

A. G. A. Kumar, R. Kant, S.N. Akhtar, N. Tiwari, J. Ramkumar, and S. Bhattacharya,
"Optimization of laser machining process for the preparation of photomasks and its
183

application to microsystems fabrication," Journal of Micro/nanolithography, MEMS, and
MOEMS, vol. 12, no. 4, p. 041203, 2013.
[52]

H. M. J. Heo, M. Lee, "Laser micromachining of permalloy for fine metal mask,"
International Journal of Precision Engineering and Manufacturing - Green Technology,
vol. 2, no. 3, pp. 225-230, 2015.

[53]

M. R. H. Knowles, G. Rutterford, D. Karnakis, and A. Ferguson, "Micro-machining of
metals, ceramics and polymers using nanosecond lasers," The International Journal of
Advanced Manufacturing Technology, vol. 33, no. 1, pp. 95-102, 2007/05/01 2007, doi:
10.1007/s00170-007-0967-2.

[54]

X. Liu, D. Du, and G. Mourou, "Laser ablation and micromachining with ultrashort laser
pulses," IEEE Journal of Quantum Electronics, vol. 33, no. 10, pp. 1706-1716, 1997, doi:
10.1109/3.631270.

[55]

K. Oblov et al., "Fabrication of Microhotplates Based on Laser Micromachining of
Zirconium Oxide," Physics Procedia, vol. 72, pp. 485-489, 2015/01/01/ 2015, doi:
https://doi.org/10.1016/j.phpro.2015.09.057.

[56]

R. Moser et al., "Laser processing of gallium nitride-based light-emitting diodes with
ultraviolet picosecond laser pulses," Optical Engineering, vol. 51, no. 11, p. 114301,
2012. [Online]. Available: https://doi.org/10.1117/1.OE.51.11.114301.

[57]

M. Apanius, P. B. Kaul, and A. R. Abramson, "Silicon shadow mask fabrication for
patterned metal deposition with microscale dimensions using a novel corner
compensation scheme," Sensors and Actuators A: Physical, vol. 140, no. 2, pp. 168-175,
2007/11/10/ 2007, doi: https://doi.org/10.1016/j.sna.2007.06.028.

184

[58]

P. Y. P. Adelyn et al., "Transparent Mask Design and Fabrication of Interdigitated
Electrodes," in RSM2015 Proc., K. Terengganu, Malaysia, 2015.

[59]

Y. Fan, H. Li, Y. Yi, and I. G. Foulds, "Laser micromachined wax-covered plastic paper
as both sputter deposition shadow masks and deep-ultraviolet patterning masks for
polymethylmethacrylate-based microfluidic systems," J. Micro/nano-litho, MEMS,
MOEMS, vol. 12, no. 4, p. 049701, 2013.

[60]

F. Alexander Jr., D. T. Price, and S. Bhansali, "Optimization of interdigitated electrode
(IDE) arrays for impedance based evaluation of Hs 578T cancer cells," J. Phys: Conf.
Series, vol. 224, no. 1, p. 012134, 2010.

[61]

A. Bratov et al., "Three-dimensional interdigitated electrode array as a transducer for
label-free biosensors," Biosensors & Bioelectronics, vol. 24, pp. 729-735, 2008.

[62]

K.-S. Chou and C.-H. Lee, "Fabrication of Silver Interdigitated Electrode by a Stamp
Method," Adv. Mat. Sci. Eng., vol. 2014, p. 5 pages, 2014.

[63]

J.-Y. Cheng, C.-W. Wei, K.-H. Hsu, and T.-H. Young, "Direct-write laser
micromachining and universal surface modification of PMMA for device development,"
Sensors and Actuators B: Chemical, vol. 99, no. 1, pp. 186-196, 2004/04/15/ 2004, doi:
https://doi.org/10.1016/j.snb.2003.10.022.

[64]

I. L. Y. Chung, J.-D. Kim, and K.-H. Kang, "Ablation drilling of invar alloy using
ultrashort pulsed laser," International Journal of Precision Engineering and
Manufacturing, vol. 10, no. 2, pp. 11-16, 2009/04/01 2009, doi: 10.1007/s12541-0090021-4.

185

[65]

J. Ihlemann and K. Rubahn, "Excimer laser micro machining: fabrication and
applications of dielectric masks," Applied Surface Science, vol. 154-155, pp. 587-592,
2000/02/01/ 2000, doi: https://doi.org/10.1016/S0169-4332(99)00464-X.

[66]

J. H. Lee, J. W. Yoon, I. G. Kim, J. S. Oh, H. J. Nam, and D. Y. Jung, "Fabrication of
polydimethylsiloxane shadow masks for chemical solution deposition of CdS thin-film
transistors," Thin Solid Films, vol. 516, no. 18, pp. 6492-6498, 2008/07/31/ 2008, doi:
https://doi.org/10.1016/j.tsf.2008.02.041.

[67]

J. Li and G. K. Ananthasuresh, "A quality study on the excimer laser micromachining of
electro-thermal-compliant micro devices," Journal of Micromechanics and
Microengineering, vol. 11, no. 1, pp. 38-47, 2000/12/05 2000, doi: 10.1088/09601317/11/1/307.

[68]

N. C. Nayak, Y. C. Lam, C. Y. Yue, and A. T. Sinha, "CO2-laser micromachining of
PMMA: the effect of polymer molecular weight," Journal of Micromechanics and
Microengineering, vol. 18, no. 9, p. 095020, 2008/08/13 2008, doi: 10.1088/09601317/18/9/095020.

[69]

W. Pfleging, W. Bernauer, T. Hanemann, and M. Torge, "Rapid fabrication of
microcomponents – UV-laser assisted prototyping, laser micro-machining of mold inserts
and replication via photomolding," Microsystem Technologies, vol. 9, no. 1, pp. 67-74,
2002/11/01 2002, doi: 10.1007/s00542-002-0197-3.

[70]

G. Ricciardi, M. Cantello, F. Mariotti, P. Castelli, and P. Giacosa, "Micromachining with
Excimer Laser," CIRP Annals, vol. 47, no. 1, pp. 145-148, 1998/01/01/ 1998, doi:
https://doi.org/10.1016/S0007-8506(07)62804-2.

186

[71]

P. P. Shiu, G. K. Knopf, M. Ostojic, and S. Nikumb, "Rapid fabrication of tooling for
microfluidic devices via laser micromachining and hot embossing," Journal of
Micromechanics and Microengineering, vol. 18, no. 2, p. 025012, 2008/01/04 2008, doi:
10.1088/0960-1317/18/2/025012.

[72]

D. Teixidor, T. Thepsonthi, J. Ciurana, and T. Özel, "Nanosecond pulsed laser
micromachining of PMMA-based microfluidic channels," Journal of Manufacturing
Processes, vol. 14, no. 4, pp. 435-442, 2012/10/01/ 2012, doi:
https://doi.org/10.1016/j.jmapro.2012.09.001.

[73]

D. Yuan and S. Das, "Experimental and theoretical analysis of direct-write laser
micromachining of polymethyl methacrylate by CO2 laser ablation," Journal of Applied
Physics, vol. 101, no. 2, p. 024901, 2007, doi: 10.1063/1.2409621.

[74]

D. Yang, V. Pankov, L. Zhao, and P. Patnaik, "Laser deposited high temperature thin
film sensors for gas turbines," Aircraft Engineering and Aerospace Technology, vol. 92,
no. 1, pp. 2-7, 2020, doi: 10.1108/AEAT-11-2018-0292.

[75]

A. Kumar et al., "Optimization of laser machining process for the preparation of
photomasks, and its application to microsystems fabrication," J. Micro/nano-litho,
MEMS, MOEMS, vol. 12, no. 4, p. 041203, 2013.

[76]

H. Klank, J. P. Kutter, and O. Geschke, "CO2-laser micromachining and back-end
processing for rapid production of PMMA-based microfluidic systems," Lab Chip, vol. 2,
pp. 242-246, 2002.

[77]

R. Pethig, J. P. H. Burt, A. Parton, N. Rizvi, M. S. Talary, and J. A. Tame, "Development
of biofactory-on-a-chip technology using excimer laser micromachining," J. Micromech.
Microeng., vol. 8, no. 2, pp. 57-63, 1998.
187

[78]

V. V. Kancharla and S. Chen, "Fabrication of biodegradable polymeric micro-devices
using laser micromachining," Biomed Microdevices, vol. 4, no. 2, pp. 105-109, 2002.

[79]

S. B. Blickenstaff, T. R. Nelson, and A. M. Sarangan, "Techniques for shadow mask
deposition of nonplanar dielectric layers," in Proc. of the 16th Annual Meeting of the
IEEE Lasers and Electro-Optics Society, Tucson, AZ, USA, 2003.

[80]

J. Heo, H. Min, and M. Lee, "Laser micromchining of permalloy for fine metal mask,"
International Journal of Precision Eng. & Manuf. Green Tech., vol. 2, no. 3, pp. 225230, 2015.

[81]

J. T. C. Yeh, "Laser ablation of polymers," Journal of Vacuum Science & Technology A,
vol. 4, p. 653, 1986.

[82]

V. V. K. a. S. Chen, "Fabrication of Biodegradable Polymeric Micro-devices using Laser
Micromachining," Biomedical Microdevices, vol. 4, no. 2, pp. 105-109, 2002.

[83]

L. J. L. Patrick Lorazo, and Michel Meunier, "Thermodynamic pathways to melting,
ablation, and solidification in absorbing solids under pulsed laser irradiation," Physical
Review B, vol. 73, p. 134108, 2006.

[84]

N. B. B. Lukyanchuck, M. Himmelbauer, and N. Arnold, "UV-laser ablation of
polyimide: from long to ultra-short laser pulses," Nuclear Instruments and Methods in
Physics Research B, vol. 122, pp. 347-355, 1997.

[85]

D. Z. Yu Zhang, Jianjun Wu, Zhen He, and Xiong Deng, "A thermal model for
nanosecond pulsed laser ablation of aluminum," AIP Advances, vol. 7, p. 075010, 2017.

[86]

R. DeHoff, Thermodynamics in Materials Science, Second ed. Boca Raton: CRC Press,
2006.

188

[87]

R. E. Taylor, CINDAS Data Series on Materials Properties: Thermal Expansion of
Solids. ASM International, 1998.

[88]

N. S. Yeqing Wang, Getachew K. Befekadu, and Crystal L. Pasiliao, "Modeling pulsed
laser ablation of aluminum with finite element analysis considering material moving
front," Inernational Journal of Heat and Mass Transfer, vol. 113, pp. 1246-1253, 2017.

[89]

J. Cheng et al., "A review of ultrafast laser materials micromachining," Optics & Laser
Technology, vol. 46, pp. 88-102, 2013/03/01/ 2013, doi:
https://doi.org/10.1016/j.optlastec.2012.06.037.

[90]

A. K. Cacie Hart, Kowsik Kumar, Sreekanth J. Varma, Jayan Thomas, and Swaminathan
Rajaraman, "Rapid nanofabrication of nanostructured interdigitated electrodes (nIDEs)
for long-term in vitro analysis of human induced pluripotent stem cell differentiated
cardiomyocytes," Biosensors, vol. 8, p. 88, 2018.

[91]

H. H. a. Z. Guo, "Ultra-short pulsed laser PDMS thin-layer separation and microfabrication," Journal of Micromechanics and Microengineering, vol. 19, p. 055007,
2009.

[92]

F. Alexander, D. T. Price, and S. Bhansali, "Optimization of interdigitated electrode
(IDE) arrays for impedance based evaluation of Hs 578T cancer cells," Journal of
Physics: Conference Series, vol. 224, p. 012134, 2010/04/01 2010, doi: 10.1088/17426596/224/1/012134.

[93]

C. Hart, C. M. Didier, F. Sommerhage, and S. Rajaraman, "Biocompatibility of Blank,
Post-Processed and Coated 3D Printed Resin Structures with Electrogenic Cells,"
Biosensors, vol. 10, no. 11, p. 152, 2020. [Online]. Available:
https://www.mdpi.com/2079-6374/10/11/152.
189

[94]

P. C. A. Kundu, C. Didier, C. Hart, F. Sommerhage, and S. Rajaraman, "Makerspace
Microfabrication of a Stainless Steel 3D Microneedle Electrode Array (3D MEA) on a
Glass Substrate for Simultaneous Optical and Electrical Probing of Electrogenic Cells,"
RSC Advances, 2020.

[95]

A. K. P.M. Morales Carvajal, C. Didier, C. Hart, F. Sommerhage and S. Rajaraman,
"Microfabrication and Assembly of a 3D Microelectrode Array (MEA) for Simultaneous
Optical and Electrical Probing of an Electrogenic "Organ-on-a-Chip" Model," presented
at the NanoFlorida 2019, Tampa, FL, November 2019, 2019.

[96]

N. Azim, C. Hart, F. Sommerhage, M. Aubin, J. J. Hickman, and S. Rajaraman,
"Precision Plating of Human Electrogenic Cells on Microelectrodes Enhanced With
Precision Electrodeposited Nano-Porous Platinum for Cell-Based Biosensing
Applications," Journal of Microelectromechanical Systems, vol. 28, no. 1, pp. 50-62,
2019, doi: 10.1109/JMEMS.2018.2879577.

[97]

A. D. Gitler, P. Dhillon, and J. Shorter, "Neurodegenerative disease: models,
mechanisms, and a new hope," Disease Models &amp; Mechanisms, vol. 10, no. 5, pp.
499-502, 2017, doi: 10.1242/dmm.030205.

[98]

J.-Q. He, Y. Ma, Y. Lee, J. A. Thomson, and T. J. Kamp, "Human Embryonic Stem Cells
Develop Into Multiple Types of Cardiac Myocytes," Circulation Research, vol. 93, no. 1,
pp. 32-39, 2003, doi: doi:10.1161/01.RES.0000080317.92718.99.

[99]

"iCell Cardiomyocytes User Guide." (accessed 01 December 2017.

[100] W. C. Claycomb et al., "HL-1 cells: A cardiac muscle cell line that contracts and retains
phenotypic characteristics of the adult cardiomyocyte," Proceedings of the National
Academy of Sciences, vol. 95, no. 6, pp. 2979-2984, 1998, doi: 10.1073/pnas.95.6.2979.
190

[101] S. M. White, P. E. Constantin, and W. C. Claycomb, "Cardiac physiology at the cellular
level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure
and function," American Journal of Physiology-Heart and Circulatory Physiology, vol.
286, no. 3, pp. H823-H829, 2004, doi: 10.1152/ajpheart.00986.2003.
[102] A. K. Peter, M. A. Bjerke, and L. A. Leinwand, "Biology of the cardiac myocyte in heart
disease," (in eng), Mol Biol Cell, vol. 27, no. 14, pp. 2149-2160, 2016, doi:
10.1091/mbc.E16-01-0038.
[103] B. X. E. Desbiolles, E. de Coulon, A. Bertsch, S. Rohr, and P. Renaud, "Intracellular
Recording of Cardiomyocyte Action Potentials with Nanopatterned Volcano-Shaped
Microelectrode Arrays," Nano Letters, vol. 19, no. 9, pp. 6173-6181, 2019/09/11 2019,
doi: 10.1021/acs.nanolett.9b02209.
[104] S. P. Wells et al., "Cardiomyocyte functional screening: interrogating comparative
electrophysiology of high-throughput model cell systems," American Journal of
Physiology-Cell Physiology, vol. 317, no. 6, pp. C1256-C1267, 2019/12/01 2019, doi:
10.1152/ajpcell.00306.2019.
[105] H. Waddell, S. Wells, C. Sim, E. Porrello, L. Delbridge, and J. Bell, "Microelectrode
Array Screening of Different Cardiomyocyte Cultures Reveals Inherent Disparities in
Cardiac Cell Electrophysiology," Heart, Lung and Circulation, vol. 28, p. S147, 2019,
doi: 10.1016/j.hlc.2019.06.035.
[106] Z. C. Lin et al., "Accurate nanoelectrode recording of human pluripotent stem cellderived cardiomyocytes for assaying drugs and modeling disease," Microsystems &
Nanoengineering, vol. 3, no. 1, p. 16080, 2017/03/13 2017, doi:
10.1038/micronano.2016.80.
191

[107] I. C. Marcu, A. Illaste, P. Heuking, M. E. Jaconi, and N. D. Ullrich, "Functional
Characterization and Comparison of Intercellular Communication in Stem Cell-Derived
Cardiomyocytes," STEM CELLS, vol. 33, no. 7, pp. 2208-2218, 2015/07/01 2015, doi:
10.1002/stem.2009.
[108] N. Milani-Nejad and P. M. L. Janssen, "Small and large animal models in cardiac
contraction research: Advantages and disadvantages," Pharmacology & Therapeutics,
vol. 141, no. 3, pp. 235-249, 2014/03/01/ 2014, doi:
https://doi.org/10.1016/j.pharmthera.2013.10.007.
[109] P. Konopelski and M. Ufnal, "Electrocardiography in rats: a comparison to human," (in
eng), Physiol Res, vol. 65, no. 5, pp. 717-725, 2016/11// 2016, doi:
10.33549/physiolres.933270.
[110] G. Hasenfuss, "Animal models of human cardiovascular disease, heart failure and
hypertrophy," Cardiovascular Research, vol. 39, no. 1, pp. 60-76, 1998, doi:
10.1016/S0008-6363(98)00110-2.
[111] S. G. Marcela et al., "Chronological and Morphological Study of Heart Development in
the Rat," The Anatomical Record, vol. 295, no. 8, pp. 1267-1290, 2012/08/01 2012, doi:
10.1002/ar.22508.
[112] K. S. Louis and A. C. Siegel, "Cell Viability Analysis Using Trypan Blue: Manual and
Automated Methods," in Mammalian Cell Viability: Methods and Protocols, M. J.
Stoddart Ed. Totowa, NJ: Humana Press, 2011, pp. 7-12.
[113] R. Amin et al., "3D-printed microfluidic devices," Biofabrication, vol. 8, no. 2, p.
022001, 2016/06/20 2016, doi: 10.1088/1758-5090/8/2/022001.

192

[114] A. K. Au, W. Huynh, L. F. Horowitz, and A. Folch, "3D-Printed Microfluidics,"
Angewandte Chemie International Edition, vol. 55, no. 12, pp. 3862-3881, 2016, doi:
10.1002/anie.201504382.
[115] N. Bhattacharjee, A. Urrios, S. Kang, and A. Folch, "The upcoming 3D-printing
revolution in microfluidics," Lab on a Chip, 10.1039/C6LC00163G vol. 16, no. 10, pp.
1720-1742, 2016, doi: 10.1039/C6LC00163G.
[116] B. C. Gross, J. L. Erkal, S. Y. Lockwood, C. Chen, and D. M. Spence, "Evaluation of 3D
Printing and Its Potential Impact on Biotechnology and the Chemical Sciences,"
Analytical Chemistry, vol. 86, no. 7, pp. 3240-3253, 2014/04/01 2014, doi:
10.1021/ac403397r.
[117] T. D. Ngo, A. Kashani, G. Imbalzano, K. T. Q. Nguyen, and D. Hui, "Additive
manufacturing (3D printing): A review of materials, methods, applications and
challenges," Composites Part B: Engineering, vol. 143, pp. 172-196, 2018/06/15/ 2018,
doi: https://doi.org/10.1016/j.compositesb.2018.02.012.
[118] Y. Ni, R. Ji, K. Long, T. Bu, K. Chen, and S. Zhuang, "A review of 3D-printed sensors,"
Applied Spectroscopy Reviews, vol. 52, no. 7, pp. 623-652, 2017/08/09 2017, doi:
10.1080/05704928.2017.1287082.
[119] J. U. Pucci, B. R. Christophe, J. A. Sisti, and E. S. Connolly, "Three-dimensional
printing: technologies, applications, and limitations in neurosurgery," Biotechnology
Advances, vol. 35, no. 5, pp. 521-529, 2017/09/01/ 2017, doi:
https://doi.org/10.1016/j.biotechadv.2017.05.007.

193

[120] S. Waheed et al., "3D printed microfluidic devices: enablers and barriers," Lab on a
Chip, 10.1039/C6LC00284F vol. 16, no. 11, pp. 1993-2013, 2016, doi:
10.1039/C6LC00284F.
[121] O. Moreno-Rivas, D. Hernández-Velázquez, V. Piazza, and S. Marquez, "Rapid
prototyping of microfluidic devices by SL 3D printing and their biocompatibility study
for cell culturing," Materials Today: Proceedings, vol. 13, pp. 436-445, 2019/01/01/
2019, doi: https://doi.org/10.1016/j.matpr.2019.03.189.
[122] G. Grigalevičiūtė, D. Baltriukienė, E. Balčiūnas, L. Jonušauskas, and M. Malinauskas,
Fabrication of flexible microporous 3D scaffolds via stereolithography and optimization
of their biocompatibility (SPIE OPTO). SPIE, 2018.
[123] W. Asghar, Y.-T. Kim, A. Ilyas, J. Sankaran, Y. Wan, and S. M. Iqbal, "Synthesis of
nano-textured biocompatible scaffolds from chicken eggshells," Nanotechnology, vol. 23,
no. 47, p. 475601, 2012/10/30 2012, doi: 10.1088/0957-4484/23/47/475601.
[124] E. Babaliari et al., "Engineering Cell Adhesion and Orientation via Ultrafast Laser
Fabricated Microstructured Substrates," (in eng), Int J Mol Sci, vol. 19, no. 7, p. 2053,
2018, doi: 10.3390/ijms19072053.
[125] N. J. Shirtcliffe, R. Toon, and P. Roach, "Surface Treatments for Microfluidic
Biocompatibility," in Microfluidic Diagnostics: Methods and Protocols, G. Jenkins and
C. D. Mansfield Eds. Totowa, NJ: Humana Press, 2013, pp. 241-268.
[126] T.-S. Jang, H.-D. Jung, H. M. Pan, W. T. Han, S. Chen, and J. Song, "3D printing of
hydrogel composite systems: Recent advances in technology for tissue engineering,"
2018, hydrogel composites; 3D printing; tissue engineering vol. 4, no. 1, 2018-01-19
2018, doi: 10.18063/ijb.v4i1.126.
194

[127] H. M. P. Eric Luis, Swee Leong Sing, Anil Kumar Bastola, Guo Dong Goh, Guo Liang
Goh, Heang Kuan Joel Tan, Ram Bajpai, Juha Song, and Wai Yee Yeong, "Silicone 3D
Printing: Process Optimization, Product Biocompatibility, and Reliability of Silicone
Meniscus Implants," 3D Printing and Additive Manufacturing, vol. 6, no. 6, pp. 319-332,
2019, doi: 10.1089/3dp.2018.0226.
[128] E. Luis, H. M. Pan, S. L. Sing, R. Bajpai, J. Song, and W. Y. Yeong, "3D Direct Printing
of Silicone Meniscus Implant Using a Novel Heat-Cured Extrusion-Based Printer,"
Polymers, vol. 12, no. 5, p. 1031, 2020. [Online]. Available:
https://www.mdpi.com/2073-4360/12/5/1031.
[129] F. Alifui-Segbaya and R. George, "Biocompatibility of 3D-Printed Methacrylate for
Hearing Devices," Inventions, vol. 3, no. 3, p. 52, 2018. [Online]. Available:
https://www.mdpi.com/2411-5134/3/3/52.
[130] M. Carve and D. Wlodkowic, "3D-Printed Chips: Compatibility of Additive
Manufacturing Photopolymeric Substrata with Biological Applications," Micromachines,
vol. 9, no. 2, p. 91, 2018. [Online]. Available: https://www.mdpi.com/2072-666X/9/2/91.
[131] H. N. Chia and B. M. Wu, "Recent advances in 3D printing of biomaterials," Journal of
Biological Engineering, vol. 9, no. 1, p. 4, 2015/03/01 2015, doi: 10.1186/s13036-0150001-4.
[132] R. Gautam, R. D. Singh, V. P. Sharma, R. Siddhartha, P. Chand, and R. Kumar,
"Biocompatibility of polymethylmethacrylate resins used in dentistry," Journal of
Biomedical Materials Research Part B: Applied Biomaterials, vol. 100B, no. 5, pp. 14441450, 2012, doi: 10.1002/jbm.b.32673.

195

[133] C. Kurzmann et al., "Evaluation of Resins for Stereolithographic 3D-Printed Surgical
Guides: The Response of L929 Cells and Human Gingival Fibroblasts," BioMed
Research International, vol. 2017, p. 11, 2017, Art no. 4057612, doi:
10.1155/2017/4057612.
[134] R. P. Rimington, A. J. Capel, D. J. Player, R. J. Bibb, S. D. R. Christie, and M. P. Lewis,
"Feasibility and Biocompatibility of 3D-Printed Photopolymerized and Laser Sintered
Polymers for Neuronal, Myogenic, and Hepatic Cell Types," Macromolecular
Bioscience, vol. 18, no. 7, p. 1800113, 2018, doi: 10.1002/mabi.201800113.
[135] M. Schuster, C. Turecek, B. Kaiser, J. Stampfl, R. Liska, and F. Varga, "Evaluation of
Biocompatible Photopolymers I: Photoreactivity and Mechanical Properties of Reactive
Diluents," Journal of Macromolecular Science, Part A, vol. 44, no. 5, pp. 547-557,
2007/03/01 2007, doi: 10.1080/10601320701235958.
[136] M. Sharafeldin, A. Jones, and J. F. Rusling, "3D-Printed Biosensor Arrays for Medical
Diagnostics," Micromachines, vol. 9, no. 8, p. 394, 2018. [Online]. Available:
https://www.mdpi.com/2072-666X/9/8/394.
[137] S. Takenaga et al., "Fabrication of biocompatible lab-on-chip devices for biomedical
applications by means of a 3D-printing process," physica status solidi (a), vol. 212, no. 6,
pp. 1347-1352, 2015, doi: 10.1002/pssa.201532053.
[138] F. Zhu, T. Friedrich, D. Nugegoda, J. Kaslin, and D. Wlodkowic, "Assessment of the
biocompatibility of three-dimensional-printed polymers using multispecies toxicity tests,"
(in eng), Biomicrofluidics, vol. 9, no. 6, pp. 061103-061103, 2015, doi:
10.1063/1.4939031.

196

[139] F. Zhu, J. Skommer, T. Friedrich, J. Kaslin, and D. Wlodkowic, 3D printed polymers
toxicity profiling: a caution for biodevice applications (SPIE Micro+Nano Materials,
Devices, and Applications). SPIE, 2015.
[140] FormLabs. "Clear Resin MSDS." https://formlabsmedia.formlabs.com/datasheets/Safety_Data_Sheet_EN_-_Clear.pdf (accessed.
[141] FormLabs. "High Temp MSDS." https://formlabsmedia.formlabs.com/datasheets/Safety_Data_Sheet_EN_-_High_Temp.pdf (accessed.
[142] FormLabs. "Flexible Resin MSDS." https://formlabsmedia.formlabs.com/datasheets/Safety_Data_Sheet_EN_-_Flexible.pdf (accessed.
[143] FormLabs. "Dental LT Resin MSDS." https://formlabsmedia.formlabs.com/datasheets/Safety_Data_Sheet_EN-EU_-_Dental_LT_Clear.pdf
(accessed.
[144] P. d. Medical. "GR-10 MSDS." https://www.pro3dure.com/media/pdf/80/57/9e/GR10guide-E.pdf (accessed.
[145] A. Kundu, C. Nattoo, S. Fremgen, S. Springer, T. Ausaf, and S. Rajaraman,
"Optimization of makerspace microfabrication techniques and materials for the
realization of planar, 3D printed microelectrode arrays in under four days," RSC
Advances, 10.1039/C8RA09116A vol. 9, no. 16, pp. 8949-8963, 2019, doi:
10.1039/C8RA09116A.
[146] C. Hart, K. S. Kumar, J. Li, J. Thomas, and S. Rajaraman, "Investigation of the Enhanced
Sensitivity of Interdigitated Electrodes for Cellular Biosensing With Geometric,
Nanostructured Surface Area, and Surface Plasmon Resonance Modes," Journal of

197

Microelectromechanical Systems, vol. 29, no. 5, pp. 1109-1111, 2020, doi:
10.1109/JMEMS.2020.3012277.
[147]

C. M. Didier, A. Kundu, and S. Rajaraman, "Facile, Packaging Substrate-Agnostic,
Microfabrication and Assembly of Scalable 3D Metal Microelectrode Arrays for in Vitro
Organ-on-a-Chip and Cellular Disease Modeling," in 2019 20th International Conference
on Solid-State Sensors, Actuators and Microsystems & Eurosensors XXXIII
(TRANSDUCERS & EUROSENSORS XXXIII), 23-27 June 2019 2019, pp. 1686-1689,
doi: 10.1109/TRANSDUCERS.2019.8808364.

[148] A. Kundu, T. Ausaf, and S. Rajaraman, "3D Printing, Ink Casting and Micromachined
Lamination (3D PICLμM): A Makerspace Approach to the Fabrication of Biological
Microdevices," Micromachines, vol. 9, no. 2, p. 85, 2018. [Online]. Available:
https://www.mdpi.com/2072-666X/9/2/85.
[149] S. P. Lacour et al., "Flexible and stretchable micro-electrodes for in vitro and in vivo
neural interfaces," Medical & Biological Engineering & Computing, vol. 48, no. 10, pp.
945-954, 2010/10/01 2010, doi: 10.1007/s11517-010-0644-8.
[150] D. K. Patel, A. H. Sakhaei, M. Layani, B. Zhang, Q. Ge, and S. Magdassi, "Highly
Stretchable and UV Curable Elastomers for Digital Light Processing Based 3D Printing,"
Advanced Materials, vol. 29, no. 15, p. 1606000, 2017, doi: 10.1002/adma.201606000.
[151] S. Sivashankar, S. Agambayev, K. Alamoudi, U. Buttner, N. Khashab, and K. N. Salama,
"Compatibility analysis of 3D printer resin for biological applications," Micro &amp;
Nano Letters, vol. 11, no. 10, pp. 654-659. [Online]. Available: https://digitallibrary.theiet.org/content/journals/10.1049/mnl.2016.0530

198

[152]

S. Sivashankar, S. Agambayev, U. Buttner, and K. N. Salama, "Characterization of solid
UV curable 3D printer resins for biological applications," in 2016 IEEE 11th Annual
International Conference on Nano/Micro Engineered and Molecular Systems (NEMS),
17-20 April 2016 2016, pp. 305-309, doi: 10.1109/NEMS.2016.7758255.

[153] W. A. Rutala, M. M. Stiegel, and F. A. Sarubbi, "Decontamination of laboratory
microbiological waste by steam sterilization," Applied and Environmental Microbiology,
vol. 43, no. 6, pp. 1311-1316, 1982. [Online]. Available:
https://aem.asm.org/content/aem/43/6/1311.full.pdf.
[154] W.-M. Chan, P. E. Gloor, and A. E. Hamielec, "A kinetic model for olefin
polymerization in high-pressure autoclave reactors," AIChE Journal, vol. 39, no. 1, pp.
111-126, 1993, doi: 10.1002/aic.690390112.
[155] R. Durkan, Ouml, M. B. Zel, B. Bagis, and A. Usanmaz, "In vitro Comparison of
Autoclave Polymerization on the Transverse Strength of Denture Base Resins," Dental
Materials Journal, vol. 27, no. 4, pp. 640-642, 2008, doi: 10.4012/dmj.27.640.
[156] B. G. Kwag and K. Y. Choi, "Effect of Initiator Characteristics on High-Pressure
Ethylene Polymerization in Autoclave Reactors," (in English), Ind. Eng. Chem. Res., vol.
33, no. 2, pp. 211-217, 1994, doi: 10.1021/ie00026a006.
[157] E. Technology. "EPO-TEK 353ND."
https://www.epotek.com/site/administrator/components/com_products/assets/files/Style_
Uploads/MED-353ND.pdf (accessed.
[158] Promega. "CellTiter-Glo Luminescent Cell Viability Assay Technical Bulletin."
https://www.promega.com/-/media/files/resources/protocols/technicalbulletins/0/celltiter-glo-luminescent-cell-viability-assay-protocol.pdf?la=en (accessed.
199

[159] D. A. Tipton and J. W. Lewis, "Effects of a hindered amine light stabilizer and a UV light
absorber used in maxillofacial elastomers on human gingival epithelial cells and
fibroblasts," (in eng), J Prosthet Dent, vol. 100, no. 3, pp. 220-31, Sep 2008, doi:
10.1016/s0022-3913(08)60182-1.
[160] K. L. Van Landuyt et al., "Evaluation of cell responses toward adhesives with different
photoinitiating systems," Dental Materials, vol. 31, no. 8, pp. 916-927, 2015/08/01/
2015, doi: https://doi.org/10.1016/j.dental.2015.04.016.
[161] M. Popal, J. Volk, G. Leyhausen, and W. Geurtsen, "Cytotoxic and genotoxic potential of
the type I photoinitiators BAPO and TPO on human oral keratinocytes and V79
fibroblasts," (in eng), Dent Mater, vol. 34, no. 12, pp. 1783-1796, Dec 2018, doi:
10.1016/j.dental.2018.09.015.
[162] N. M. Al-Namnam, K. H. Kim, W. L. Chai, K. O. Ha, C. H. Siar, and W. C. Ngeow, "A
biocompatibility study of injectable poly(caprolactone-trifumarate) for use as a bone
substitute material," Frontiers in Life Science, vol. 8, no. 3, pp. 215-222, 2015/07/03
2015, doi: 10.1080/21553769.2015.1051240.
[163] N. Azim et al., "Fabrication and Characterization of a 3D Printed, MicroElectrodes
Platform With Functionalized Electrospun Nano-Scaffolds and Spin Coated 3D
Insulation Towards Multi- Functional Biosystems," Journal of Microelectromechanical
Systems, vol. 28, no. 4, pp. 606-618, 2019, doi: 10.1109/JMEMS.2019.2913652.
[164] K. Kadimisetty et al., "Fully 3D printed integrated reactor array for point-of-care
molecular diagnostics," Biosensors and Bioelectronics, vol. 109, pp. 156-163,
2018/06/30/ 2018, doi: https://doi.org/10.1016/j.bios.2018.03.009.

200

[165]

A. Kundu, T. Ausaf, P. Rajasekaran, and S. Rajaraman, "Multimodal Microfluidic
Biosensor With Interdigitated Electrodes (IDE) And Microelectrode Array (MEA) For
Bacterial Detection And Identification," in 2019 20th International Conference on SolidState Sensors, Actuators and Microsystems & Eurosensors XXXIII (TRANSDUCERS &
EUROSENSORS XXXIII), 23-27 June 2019 2019, pp. 1199-1202, doi:
10.1109/TRANSDUCERS.2019.8808696.

[166]

Y. Liu, E. Smela, N. M. Nelson, and P. Abshire, "Cell-lab on a chip: a CMOS-based
microsystem for culturing and monitoring cells," in The 26th Annual International
Conference of the IEEE Engineering in Medicine and Biology Society, 1-5 Sept. 2004
2004, vol. 1, pp. 2534-2537, doi: 10.1109/IEMBS.2004.1403729.

[167] N. P. Macdonald et al., "Assessment of biocompatibility of 3D printed photopolymers
using zebrafish embryo toxicity assays," Lab on a Chip, 10.1039/C5LC01374G vol. 16,
no. 2, pp. 291-297, 2016, doi: 10.1039/C5LC01374G.
[168] Y. Zhao et al., "JMEMS Letters An Adhesive and Corrosion-Resistant Biomarker
Sensing Film for Biosmart Wearable Consumer Electronics," Journal of
Microelectromechanical Systems, pp. 1-3, 2020, doi: 10.1109/JMEMS.2020.3012101.
[169] W. Strober, "Trypan Blue Exclusion Test of Cell Viability," Current Protocols in
Immunology, vol. 21, no. 1, pp. A.3B.1-A.3B.2, 1997, doi:
10.1002/0471142735.ima03bs21.
[170] M. Eimre et al., "Distinct organization of energy metabolism in HL-1 cardiac cell line
and cardiomyocytes," Biochimica et Biophysica Acta (BBA) - Bioenergetics, vol. 1777,
no. 6, pp. 514-524, 2008/06/01/ 2008, doi: https://doi.org/10.1016/j.bbabio.2008.03.019.

201

[171] C. Didier, A. Kundu, and S. Rajaraman, "Capabilities and limitations of 3D printed
microserpentines and integrated 3D electrodes for stretchable and conformable biosensor
applications," Microsystems & Nanoengineering, vol. 6, no. 1, p. 15, 2020/04/20 2020,
doi: 10.1038/s41378-019-0129-3.
[172] A. K. Makoto Nakamura, Fumio Takagi, Akihiko Watanabe, Yuko Hiruma, Katsuhiro
Ohuchi, Yasuhiko Iwasaki, Mikio Horie, Ikuo Morita, and Setsuo Takatani.,
"Biocompatible Inkjet Printing Technique for Designed Seeding of Individual Living
Cells," Tissue Engineering, vol. 11, no. 11-12, pp. 1658-1666, 2005, doi:
10.1089/ten.2005.11.1658.
[173] G. Gao, Y. Huang, A. F. Schilling, K. Hubbell, and X. Cui, "Organ Bioprinting: Are We
There Yet?," Advanced Healthcare Materials, vol. 7, no. 1, p. 1701018, 2018, doi:
10.1002/adhm.201701018.
[174] B. R. Ringeisen, C. M. Othon, J. A. Barron, D. Young, and B. J. Spargo, "Jet-based
methods to print living cells," Biotechnology Journal, vol. 1, no. 9, pp. 930-948, 2006,
doi: 10.1002/biot.200600058.
[175] E. A. Roth, T. Xu, M. Das, C. Gregory, J. J. Hickman, and T. Boland, "Inkjet printing for
high-throughput cell patterning," Biomaterials, vol. 25, no. 17, pp. 3707-3715,
2004/08/01/ 2004, doi: https://doi.org/10.1016/j.biomaterials.2003.10.052.
[176] L. Zhao, K. C. Yan, R. Yao, F. Lin, and W. Sun, "Modeling on Microdroplet Formation
for Cell Printing Based on Alternating Viscous-Inertial Force Jetting," Journal of
Manufacturing Science and Engineering, vol. 139, no. 1, 2016, doi: 10.1115/1.4032768.

202

[177] A. Skardal and A. Atala, "Biomaterials for Integration with 3-D Bioprinting," Annals of
Biomedical Engineering, vol. 43, no. 3, pp. 730-746, 2015/03/01 2015, doi:
10.1007/s10439-014-1207-1.
[178] L. Koch et al., "Skin tissue generation by laser cell printing," Biotechnology and
Bioengineering, vol. 109, no. 7, pp. 1855-1863, 2012, doi: 10.1002/bit.24455.
[179] B. Guillotin and F. Guillemot, "Cell patterning technologies for organotypic tissue
fabrication," Trends in Biotechnology, vol. 29, no. 4, pp. 183-190, 2011/04/01/ 2011, doi:
https://doi.org/10.1016/j.tibtech.2010.12.008.
[180] A. Faulkner-Jones, S. Greenhough, J. A King, J. Gardner, A. Courtney, and W. Shu,
"Development of a valve-based cell printer for the formation of human embryonic stem
cell spheroid aggregates," Biofabrication, vol. 5, no. 1, p. 015013, 2013/02/04 2013, doi:
10.1088/1758-5082/5/1/015013.
[181] T. Boland, T. Xu, B. Damon, and X. Cui, "Application of inkjet printing to tissue
engineering," Biotechnology Journal, vol. 1, no. 9, pp. 910-917, 2006, doi:
10.1002/biot.200600081.
[182] T. Boland et al., "Drop-on-demand printing of cells and materials for designer tissue
constructs," Materials Science and Engineering: C, vol. 27, no. 3, pp. 372-376,
2007/04/01/ 2007, doi: https://doi.org/10.1016/j.msec.2006.05.047.
[183] D. Chahal, A. Ahmadi, and K. C. Cheung, "Improving piezoelectric cell printing
accuracy and reliability through neutral buoyancy of suspensions," Biotechnology and
Bioengineering, vol. 109, no. 11, pp. 2932-2940, 2012, doi: 10.1002/bit.24562.

203

[184] X. Cui, T. Boland, D. D. D'Lima, and M. K. Lotz, "Thermal inkjet printing in tissue
engineering and regenerative medicine," (in eng), Recent Pat Drug Deliv Formul, vol. 6,
no. 2, pp. 149-155, 2012, doi: 10.2174/187221112800672949.
[185] B. Derby, "Bioprinting: inkjet printing proteins and hybrid cell-containing materials and
structures," Journal of Materials Chemistry, 10.1039/B807560C vol. 18, no. 47, pp.
5717-5721, 2008, doi: 10.1039/B807560C.
[186] B. Lorber, W.-K. Hsiao, I. M. Hutchings, and K. R. Martin, "Adult rat retinal ganglion
cells and glia can be printed by piezoelectric inkjet printing," Biofabrication, vol. 6, no.
1, p. 015001, 2013/12/17 2013, doi: 10.1088/1758-5082/6/1/015001.
[187] J. A. Park et al., "Freeform micropatterning of living cells into cell culture medium using
direct inkjet printing," Scientific Reports, vol. 7, no. 1, p. 14610, 2017/11/03 2017, doi:
10.1038/s41598-017-14726-w.
[188] R. E. Saunders, J. E. Gough, and B. Derby, "Delivery of human fibroblast cells by
piezoelectric drop-on-demand inkjet printing," Biomaterials, vol. 29, no. 2, pp. 193-203,
2008/01/01/ 2008, doi: https://doi.org/10.1016/j.biomaterials.2007.09.032.
[189] J. He, X. Zhao, J. Chang, and D. Li, "Microscale Electro-Hydrodynamic Cell Printing
with High Viability," Small, vol. 13, no. 47, p. 1702626, 2017, doi:
10.1002/smll.201702626.
[190] J. Jang, J. Y. Park, G. Gao, and D.-W. Cho, "Biomaterials-based 3D cell printing for
next-generation therapeutics and diagnostics," Biomaterials, vol. 156, pp. 88-106,
2018/02/01/ 2018, doi: https://doi.org/10.1016/j.biomaterials.2017.11.030.

204

[191] D. O. Visscher et al., "Advances in Bioprinting Technologies for Craniofacial
Reconstruction," Trends in Biotechnology, vol. 34, no. 9, pp. 700-710, 2016/09/01/ 2016,
doi: https://doi.org/10.1016/j.tibtech.2016.04.001.
[192] C. J. Ferris, K. G. Gilmore, G. G. Wallace, and M. in het Panhuis, "Biofabrication: an
overview of the approaches used for printing of living cells," Applied Microbiology and
Biotechnology, vol. 97, no. 10, pp. 4243-4258, 2013/05/01 2013, doi: 10.1007/s00253013-4853-6.
[193] A. U. Chen and O. A. Basaran, "A new method for significantly reducing drop radius
without reducing nozzle radius in drop-on-demand drop production," Physics of Fluids,
vol. 14, no. 1, pp. L1-L4, 2002/01/01 2001, doi: 10.1063/1.1427441.
[194] I. T. Ozbolat and M. Hospodiuk, "Current advances and future perspectives in extrusionbased bioprinting," Biomaterials, vol. 76, pp. 321-343, 2016/01/01/ 2016, doi:
https://doi.org/10.1016/j.biomaterials.2015.10.076.
[195] T. Boland, V. Mironov, A. Gutowska, E. A. Roth, and R. R. Markwald, "Cell and organ
printing 2: Fusion of cell aggregates in three-dimensional gels," The Anatomical Record
Part A: Discoveries in Molecular, Cellular, and Evolutionary Biology, vol. 272A, no. 2,
pp. 497-502, 2003, doi: 10.1002/ar.a.10059.
[196] V. Mironov, R. P. Visconti, V. Kasyanov, G. Forgacs, C. J. Drake, and R. R. Markwald,
"Organ printing: Tissue spheroids as building blocks," Biomaterials, vol. 30, no. 12, pp.
2164-2174, 2009/04/01/ 2009, doi: https://doi.org/10.1016/j.biomaterials.2008.12.084.
[197] K. Jakab, C. Norotte, F. Marga, K. Murphy, G. Vunjak-Novakovic, and G. Forgacs,
"Tissue engineering by self-assembly and bio-printing of living cells," Biofabrication,
vol. 2, no. 2, p. 022001, 2010/06/01 2010, doi: 10.1088/1758-5082/2/2/022001.
205

[198] A. N. Mehesz et al., "Scalable robotic biofabrication of tissue spheroids," Biofabrication,
vol. 3, no. 2, p. 025002, 2011/05/12 2011, doi: 10.1088/1758-5082/3/2/025002.
[199] J. H. Y. Chung et al., "Bio-ink properties and printability for extrusion printing living
cells," Biomaterials Science, 10.1039/C3BM00012E vol. 1, no. 7, pp. 763-773, 2013, doi:
10.1039/C3BM00012E.
[200] S. Khalil and W. Sun, "Bioprinting Endothelial Cells With Alginate for 3D Tissue
Constructs," Journal of Biomechanical Engineering, vol. 131, no. 11, 2009, doi:
10.1115/1.3128729.
[201] J. Malda et al., "25th Anniversary Article: Engineering Hydrogels for Biofabrication,"
Advanced Materials, vol. 25, no. 36, pp. 5011-5028, 2013, doi:
10.1002/adma.201302042.
[202] S. V. Murphy, A. Skardal, and A. Atala, "Evaluation of hydrogels for bio-printing
applications," Journal of Biomedical Materials Research Part A, vol. 101A, no. 1, pp.
272-284, 2013, doi: 10.1002/jbm.a.34326.
[203] R. Levato, J. Visser, J. A. Planell, E. Engel, J. Malda, and M. A. Mateos-Timoneda,
"Biofabrication of tissue constructs by 3D bioprinting of cell-laden microcarriers,"
Biofabrication, vol. 6, no. 3, p. 035020, 2014/07/22 2014, doi: 10.1088/17585082/6/3/035020.
[204] F. Pati et al., "Printing three-dimensional tissue analogues with decellularized
extracellular matrix bioink," Nature Communications, vol. 5, no. 1, p. 3935, 2014/06/02
2014, doi: 10.1038/ncomms4935.

206

[205] M. Gou et al., "Bio-inspired detoxification using 3D-printed hydrogel nanocomposites,"
Nature Communications, vol. 5, no. 1, p. 3774, 2014/05/08 2014, doi:
10.1038/ncomms4774.
[206] B. Duan, L. A. Hockaday, K. H. Kang, and J. T. Butcher, "3D Bioprinting of
heterogeneous aortic valve conduits with alginate/gelatin hydrogels," Journal of
Biomedical Materials Research Part A, vol. 101A, no. 5, pp. 1255-1264, 2013, doi:
10.1002/jbm.a.34420.
[207] A. B. Dababneh and I. T. Ozbolat, "Bioprinting Technology: A Current State-of-the-Art
Review," Journal of Manufacturing Science and Engineering, vol. 136, no. 6, 2014, doi:
10.1115/1.4028512.
[208] S. Boularaoui, G. Al Hussein, K. A. Khan, N. Christoforou, and C. Stefanini, "An
overview of extrusion-based bioprinting with a focus on induced shear stress and its
effect on cell viability," Bioprinting, vol. 20, p. e00093, 2020/12/01/ 2020, doi:
https://doi.org/10.1016/j.bprint.2020.e00093.
[209] S. Khalil and W. Sun, "Biopolymer deposition for freeform fabrication of hydrogel tissue
constructs," Materials Science and Engineering: C, vol. 27, no. 3, pp. 469-478,
2007/04/01/ 2007, doi: https://doi.org/10.1016/j.msec.2006.05.023.
[210] L. E. Bertassoni et al., "Direct-write bioprinting of cell-laden methacrylated gelatin
hydrogels," Biofabrication, vol. 6, no. 2, p. 024105, 2014/04/03 2014, doi: 10.1088/17585082/6/2/024105.
[211] T. Xu, J. Jin, C. Gregory, J. J. Hickman, and T. Boland, "Inkjet printing of viable
mammalian cells," Biomaterials, vol. 26, no. 1, pp. 93-99, 2005/01/01/ 2005, doi:
https://doi.org/10.1016/j.biomaterials.2004.04.011.
207

[212] N. B. M. Fidaleo, M. Schulte, M.C. Flickinger, "Ink-Jet Printing of Gluconobacter
oxydans: Micropatterned Coatings as High Surface-to-Volume Ratio Bio-Reactive
Coatings," Coatings, vol. 4, pp. 1-17, 2014.
[213] F. Turcu, K. Tratsk-Nitz, S. Thanos, W. Schuhmann, and P. Heiduschka, "Ink-jet printing
for micropattern generation of laminin for neuronal adhesion," Journal of Neuroscience
Methods, vol. 131, no. 1, pp. 141-148, 2003/12/30/ 2003, doi:
https://doi.org/10.1016/j.jneumeth.2003.08.001.
[214] "Axion Biosystems: Explore Life's Circuitry."
[215] J. Shi, B. Wu, S. Li, J. Song, B. Song, and W. F. Lu, "Shear stress analysis and its effects
on cell viability and cell proliferation in drop-on-demand bioprinting," Biomedical
Physics & Engineering Express, vol. 4, no. 4, p. 045028, 2018/06/13 2018, doi:
10.1088/2057-1976/aac946.
[216] A. Tirella and A. Ahluwalia, "The impact of fabrication parameters and substrate
stiffness in direct writing of living constructs," Biotechnology Progress, vol. 28, no. 5,
pp. 1315-1320, 2012, doi: 10.1002/btpr.1586.
[217] J. Snyder, A. Rin Son, Q. Hamid, C. Wang, Y. Lui, and W. Sun, "Mesenchymal stem cell
printing and process regulated cell properties," Biofabrication, vol. 7, no. 4, p. 044106,
2015/12/22 2015, doi: 10.1088/1758-5090/7/4/044106.
[218] K. Nair et al., "Characterization of cell viability during bioprinting processes,"
Biotechnology Journal, vol. 4, no. 8, pp. 1168-1177, 2009, doi: 10.1002/biot.200900004.
[219] L. Ouyang, R. Yao, Y. Zhao, and W. Sun, "Effect of bioink properties on printability and
cell viability for 3D bioplotting of embryonic stem cells," Biofabrication, vol. 8, no. 3, p.
035020, 2016/09/16 2016, doi: 10.1088/1758-5090/8/3/035020.
208

[220] G. O. a. D. Juncker, "Multiplexed co-culture patterning in 2D and 3D using low-cost 3D
printed monolithic pin-heads," presented at the 22nd International Conference on
Miniaturized Systems for Chemistry and Life Sciences, Kaohsiung, Taiwan, 2018.
[221] P. Fisch, M. Holub, and M. Zenobi-Wong, "Improved accuracy and precision of
bioprinting through progressive cavity pump-controlled extrusion," bioRxiv, p.
2020.01.23.915868, 2020, doi: 10.1101/2020.01.23.915868.
[222] D. Sher. "Top 15 Bioprinters." 3D Printing Industry.
https://3dprintingindustry.com/news/top-10-bioprinters-55699/. (accessed.
[223] C. L. Sciences. "Microplate Dimensions for Corning Cell Culture Microplates." Corning.
https://www.corning.com/catalog/cls/documents/drawings/MD_Microplate_Dimension_
Sheets_Multiple_Well.pdf (accessed 11/02/2020, 2020).
[224] N. Chaturvedi, Baban, N. S., Sofela, S. O., Orozaliev, A., Giakoumidis, N., Kim, J.,
Gunsalus, K. C., & Song, Y. A., "A single pressure pulse-actuated 3D-printed
microfluidic tip for high throughput dispensing of C. elegans worms," presented at the
22nd International Conference on Miniaturized Systems for Chemistry and Life Sciences,
MicroTAS 2018, Kaohsiung, Taiwain, November 11 -15, 2018.
[225] F. Grinnell and M. K. Feld, "Fibronectin adsorption on hydrophilic and hydrophobic
surfaces detected by antibody binding and analyzed during cell adhesion in serumcontaining medium," (in eng), J Biol Chem, vol. 257, no. 9, pp. 4888-93, May 10 1982.
[226] M. P. M. Thery, Micropatterning in Cell Biology: Part A. New York: Academic, 2014.
[227] C. Oleaga et al., "Multi-Organ toxicity demonstration in a functional human in vitro
system composed of four organs," Scientific Reports, vol. 6, no. 1, p. 20030, 2016/02/03
2016, doi: 10.1038/srep20030.
209

[228] F. Cotel, R. Exley, S. J. Cragg, and J.-F. Perrier, "Serotonin spillover onto the axon initial
segment of motoneurons induces central fatigue by inhibiting action potential initiation,"
Proceedings of the National Academy of Sciences, vol. 110, no. 12, pp. 4774-4779, 2013,
doi: 10.1073/pnas.1216150110.
[229] D. A. Wagenaar, J. Pine, and S. M. Potter, "Effective parameters for stimulation of
dissociated cultures using multi-electrode arrays," Journal of Neuroscience Methods, vol.
138, no. 1, pp. 27-37, 2004/09/30/ 2004, doi:
https://doi.org/10.1016/j.jneumeth.2004.03.005.
[230] X. Jiang, F. Tian, K. Mearow, P. Okagaki, and R. H. Lipsky, "The excitoprotective effect
of N-methyl-d-aspartate receptors is mediated by a brain-derived neurotrophic factor
autocrine loop in cultured hippocampal neurons," Journal of Neurochemistry, vol. 94, no.
3, pp. 713-722, 2005, doi: 10.1111/j.1471-4159.2005.03200.x.
[231] K. L. Williamson and K. J. Broadley, "Do both adrenaline and noradrenaline stimulate
cardiac α-adrenoceptors to induce positive inotropy of rat atria?," British Journal of
Pharmacology, vol. 98, no. 2, pp. 597-611, 1989, doi: 10.1111/j.14765381.1989.tb12634.x.
[232] R. Simó, M. Villarroel, L. Corraliza, C. Hernández, and M. Garcia-Ramírez, "The Retinal
Pigment Epithelium: Something More than a Constituent of the Blood-Retinal Barrier—
Implications for the Pathogenesis of Diabetic Retinopathy," Journal of Biomedicine and
Biotechnology, vol. 2010, p. 190724, 2010/02/17 2010, doi: 10.1155/2010/190724.
[233] O. Strauss, "The Retinal Pigment Epithelium in Visual Function," Physiological Reviews,
vol. 85, no. 3, pp. 845-881, 2005, doi: 10.1152/physrev.00021.2004.

210

[234] J. A. DiMasi, H. G. Grabowski, and R. W. Hansen, "Innovation in the pharmaceutical
industry: New estimates of R&D costs," Journal of Health Economics, vol. 47, pp. 20-33,
2016/05/01/ 2016, doi: https://doi.org/10.1016/j.jhealeco.2016.01.012.
[235] J. Zhou et al., "Assessment of cadmium-induced hepatotoxicity and protective effects of
zinc against it using an improved cell-based biosensor," Sensors and Actuators A:
Physical, vol. 199, pp. 156-164, 2013/09/01/ 2013, doi:
https://doi.org/10.1016/j.sna.2013.05.006.
[236] D. Millard et al., "Cross-Site Reliability of Human Induced Pluripotent stem cell-derived
Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a
Blinded CiPA Pilot Study," Toxicological Sciences, vol. 164, no. 2, pp. 550-562, 2018,
doi: 10.1093/toxsci/kfy110.
[237] S. Michaelis, J. Wegener, and R. Robelek, "Label-free monitoring of cell-based assays:
Combining impedance analysis with SPR for multiparametric cell profiling," Biosensors
and Bioelectronics, vol. 49, pp. 63-70, 2013/11/15/ 2013, doi:
https://doi.org/10.1016/j.bios.2013.04.042.
[238] A. B. Dahlin, "Sensing applications based on plasmonic nanopores: The hole story,"
Analyst, 10.1039/C4AN02258K vol. 140, no. 14, pp. 4748-4759, 2015, doi:
10.1039/C4AN02258K.
[239] N. Hu et al., "Comparison between ECIS and LAPS for establishing a cardiomyocytebased biosensor," Sensors and Actuators B: Chemical, vol. 185, pp. 238-244, 2013/08/01/
2013, doi: https://doi.org/10.1016/j.snb.2013.04.093.

211

[240] C. M. Othon, X. Wu, J. J. Anders, and B. R. Ringeisen, "Single-cell printing to form
three-dimensional lines of olfactory ensheathing cells," Biomedical Materials, vol. 3, no.
3, p. 034101, 2008/08/08 2008, doi: 10.1088/1748-6041/3/3/034101.
[241] R. Ehret, W. Baumann, M. Brischwein, A. Schwinde, K. Stegbauer, and B. Wolf,
"Monitoring of cellular behaviour by impedance measurements on interdigitated
electrode structures," Biosensors and Bioelectronics, vol. 12, no. 1, pp. 29-41,
1997/01/01/ 1997, doi: https://doi.org/10.1016/0956-5663(96)89087-7.
[242] A. Bratov et al., "Three-dimensional interdigitated electrode array as a transducer for
label-free biosensors," Biosensors and Bioelectronics, vol. 24, no. 4, pp. 729-735,
2008/12/01/ 2008, doi: https://doi.org/10.1016/j.bios.2008.06.057.
[243] S. M. Radke and E. C. Alocilja, "Design and fabrication of a microimpedance biosensor
for bacterial detection," IEEE Sensors Journal, vol. 4, no. 4, pp. 434-440, 2004, doi:
10.1109/JSEN.2004.830300.
[244] W. Laureyn et al., "Nanoscaled interdigitated titanium electrodes for impedimetric
biosensing," Sensors and Actuators B: Chemical, vol. 68, pp. 360-370, 08/01 2000, doi:
10.1016/S0925-4005(00)00489-5.
[245] S. Partel, S. Kasemann, P. Choleva, C. Dincer, J. Kieninger, and G. A. Urban, "Novel
fabrication process for sub-micron interdigitated electrode arrays for highly sensitive
electrochemical detection," Sensors and Actuators B: Chemical, vol. 205, pp. 193-198,
2014/12/15/ 2014, doi: https://doi.org/10.1016/j.snb.2014.08.065.
[246] A. F. M. Mansor, I. Ibrahim, A. A. Zainuddin, I. Voiculescu, and A. N. Nordin,
"Modeling and development of screen-printed impedance biosensor for cytotoxicity

212

studies of lung carcinoma cells," Medical & Biological Engineering & Computing, vol.
56, no. 1, pp. 173-181, 2018/01/01 2018, doi: 10.1007/s11517-017-1756-1.
[247]

T. Tasakaren, M. K. M. Arshad, M. N. M. N, I. Letchumanan, M. F. M. Fathil, and C.
Ibau, "Fabrication and Characterization of Aluminium Interdigitated Electrodes (IDE)
Hybrid with Zinc Oxide (ZnO) Nanoparticles for Detection of Cardiac Troponin I (cTnI)
Biomarker," in 2019 IEEE International Conference on Sensors and Nanotechnology,
24-25 July 2019 2019, pp. 1-4, doi: 10.1109/SENSORSNANO44414.2019.8940039.

[248] "ACEA Biosciences Inc." Agilent. https://www.aceabio.com/ (accessed.
[249] "EIS Equivalent Circuits," in Electrochemical Impedance Spectroscopy in PEM Fuel
Cells: Fundamentals and Applications, X.-Z. Yuan, C. Song, H. Wang, and J. Zhang Eds.
London: Springer London, 2010, pp. 139-192.
[250] X. Chen, Y. Shirai, M. Yanagida, and K. Miyano, "Effect of Light and Voltage on
Electrochemical Impedance Spectroscopy of Perovskite Solar Cells: An Empirical
Approach Based on Modified Randles Circuit," The Journal of Physical Chemistry C,
vol. 123, no. 7, pp. 3968-3978, 2019/02/21 2019, doi: 10.1021/acs.jpcc.8b10712.
[251] I. Giaever and C. R. Keese, "Use of Electric Fields to Monitor the Dynamical Aspect of
Cell Behavior in Tissue Culture," IEEE Transactions on Biomedical Engineering, vol.
BME-33, no. 2, pp. 242-247, 1986, doi: 10.1109/TBME.1986.325896.
[252] J. Henzie, J. Lee, M. H. Lee, W. Hasan, and T. W. Odom, "Nanofabrication of Plasmonic
Structures," Annual Review of Physical Chemistry, vol. 60, no. 1, pp. 147-165,
2009/05/01 2009, doi: 10.1146/annurev.physchem.040808.090352.
[253] A. G. Brolo, "Plasmonics for future biosensors," Nature Photonics, vol. 6, no. 11, pp.
709-713, 2012/11/01 2012, doi: 10.1038/nphoton.2012.266.
213

[254] A. B. Dahlin et al., "Electrochemical plasmonic sensors," Analytical and Bioanalytical
Chemistry, vol. 402, no. 5, pp. 1773-1784, 2012/02/01 2012, doi: 10.1007/s00216-0115404-6.
[255] A. G. Brolo, R. Gordon, B. Leathem, and K. L. Kavanagh, "Surface Plasmon Sensor
Based on the Enhanced Light Transmission through Arrays of Nanoholes in Gold Films,"
Langmuir, vol. 20, no. 12, pp. 4813-4815, 2004/06/01 2004, doi: 10.1021/la0493621.
[256] U. Thi Phuong Lien et al., "Scanning the plasmonic properties of a nanohole array with a
single nanocrystal near-field probe," (in English), Nanophotonics, vol. 9, no. 4, pp. 793801, 01 Apr. 2020 2020, doi: https://doi.org/10.1515/nanoph-2019-0409.
[257] H. Wang, Y. Wu, M. Wang, Y. Zhang, G. Li, and L. Zhang, "Fabrication and
magnetotransport properties of ordered sub-100 nm pseudo-spin-valve element arrays,"
Nanotechnology, vol. 17, no. 6, pp. 1651-1654, 2006/02/27 2006, doi: 10.1088/09574484/17/6/019.
[258] M. Altissimo, "E-beam lithography for micro-/nanofabrication," Biomicrofluidics, vol. 4,
no. 2, p. 026503, 2010, doi: 10.1063/1.3437589.
[259] M. Kovylina et al., "Tuning exchange bias in Ni/FeF2 heterostructures using antidot
arrays," Applied Physics Letters, vol. 95, no. 15, p. 152507, 2009, doi:
10.1063/1.3248306.
[260] S. Pal, S. Chandra, M.-H. Phan, P. Mukherjee, and H. Srikanth, "Carbon nanostraws:
nanotubes filled with superparamagnetic nanoparticles," Nanotechnology, vol. 20, no. 48,
p. 485604, 2009/10/30 2009, doi: 10.1088/0957-4484/20/48/485604.

214

[261] S. Y. Chou, P. R. Krauss, and P. J. Renstrom, "Imprint of sub‐25 nm vias and trenches in
polymers," Applied Physics Letters, vol. 67, no. 21, pp. 3114-3116, 1995, doi:
10.1063/1.114851.
[262] P. Chantharasupawong, L. Tetard, and J. Thomas, "Coupling Enhancement and Giant
Rabi-Splitting in Large Arrays of Tunable Plexcitonic Substrates," The Journal of
Physical Chemistry C, vol. 118, no. 41, pp. 23954-23962, 2014/10/16 2014, doi:
10.1021/jp506091k.
[263] B. Duong et al., "Printed Sub-100 nm Polymer-Derived Ceramic Structures," ACS
Applied Materials & Interfaces, vol. 5, no. 9, pp. 3894-3899, 2013/05/08 2013, doi:
10.1021/am400587z.
[264] B. Duong et al., "Enhanced Magnetism in Highly Ordered Magnetite Nanoparticle-Filled
Nanohole Arrays," Small, vol. 10, no. 14, pp. 2840-2848, 2014, doi:
10.1002/smll.201303809.
[265] S. L. Peterson, A. McDonald, P. L. Gourley, and D. Y. Sasaki, "Poly(dimethylsiloxane)
thin films as biocompatible coatings for microfluidic devices: Cell culture and flow
studies with glial cells," Journal of Biomedical Materials Research Part A, vol. 72A, no.
1, pp. 10-18, 2005, doi: 10.1002/jbm.a.30166.
[266] A. Sokolov, B. C. Hellerud, A. Pharo, E. A. Johannessen, and T. E. Mollnes,
"Complement activation by candidate biomaterials of an implantable microfabricated
medical device," Journal of Biomedical Materials Research Part B: Applied
Biomaterials, vol. 98B, no. 2, pp. 323-329, 2011, doi: 10.1002/jbm.b.31855.

215

[267] "Application of Real-Time Cell Electronic Sensing (RT-CES) Technology to Cell-Based
Assays," ASSAY and Drug Development Technologies, vol. 2, no. 4, pp. 363-372, 2004,
doi: 10.1089/adt.2004.2.363.
[268] C. W. S. S.D. Lamore, M.F. Peters, "Cardiomyocyte Impedance Assays," in Assay
Guidance Manual, A. G. G.S. Sittampalam, K. Brimacombe Ed. Bethesda, MD: Eli Lilly
& Company and the National Center for Advancing Translational Sciences, 2015.
[269] J. Min and A. J. Baeumner, "Characterization and Optimization of Interdigitated
Ultramicroelectrode Arrays as Electrochemical Biosensor Transducers," Electroanalysis,
vol. 16, no. 9, pp. 724-729, 2004, doi: 10.1002/elan.200302872.
[270] F. Abdel-Rahman, B. Okeremgbo, F. Alhamadah, S. Jamadar, K. Anthony, and M. A.
Saleh, "Caenorhabditis elegans as a model to study the impact of exposure to light
emitting diode (LED) domestic lighting," Journal of Environmental Science and Health,
Part A, vol. 52, no. 5, pp. 433-439, 2017/04/16 2017, doi:
10.1080/10934529.2016.1270676.
[271] J. Icha, M. Weber, J. C. Waters, and C. Norden, "Phototoxicity in live fluorescence
microscopy, and how to avoid it," BioEssays, vol. 39, no. 8, p. 1700003, 2017, doi:
https://doi.org/10.1002/bies.201700003.
[272] C. A. Thomas, P. A. Springer, G. E. Loeb, Y. Berwald-Netter, and L. M. Okun, "A
miniature microelectrode array to monitor the bioelectric activity of cultured cells,"
Experimental Cell Research, vol. 74, no. 1, pp. 61-66, 1972/09/01/ 1972, doi:
https://doi.org/10.1016/0014-4827(72)90481-8.

216

[273] U. Frey et al., "Switch-Matrix-Based High-Density Microelectrode Array in CMOS
Technology," IEEE Journal of Solid-State Circuits, vol. 45, no. 2, pp. 467-482, 2010,
doi: 10.1109/JSSC.2009.2035196.
[274] C. D. James et al., "Extracellular recordings from patterned neuronal networks using
planar microelectrode arrays," IEEE Transactions on Biomedical Engineering, vol. 51,
no. 9, pp. 1640-1648, 2004, doi: 10.1109/TBME.2004.827252.
[275] A. Stett et al., "Biological application of microelectrode arrays in drug discovery and
basic research," Analytical and Bioanalytical Chemistry, vol. 377, no. 3, pp. 486-495,
2003/10/01 2003, doi: 10.1007/s00216-003-2149-x.
[276] B. C. Wheeler and Y. Nam, "In Vitro Microelectrode Array Technology and Neural
Recordings," vol. 39, no. 1, pp. 45-61, 2011-03-30 2011, doi:
10.1615/CritRevBiomedEng.v39.i1.40.
[277] "Axion Biosystems: Explore life's circuitry," ed: Axion Biosystems.
[278] "Multichannel Systems." Harvard Bioscience Inc. https://www.multichannelsystems.com
(accessed.

217

